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Abstract
The Continuous Mortality Investigation (CMI) of the Institute of Actuaries and the
Faculty of Actuaries in the UK established, in CMI Report 12 (1991), a multiple state
model consisting of three states (Healthy, Sick and Dead) for the analysis of Income
Protection Insurance (IPI) data. The transition intensities between states, estimated
using a set of homogeneous male IPI data from 1975-78, are also presented in this re-
port. Based on these estimated transition intensities, premium and reserve in respect
of IPI business can be calculated. By using this model, in which there is only one Sick
state to represent all causes of sickness, a whole portfolio of claims, regardless of their
cause of sickness, will be subject to the same termination assumption. With cause
of sickness as an important source of heterogeneity among IPI claimants, Cordeiro
(1998, 2002) further developed this model so that it can be used to analyse IPI data
by cause of sickness and obtained approximations to the cause-specific transition in-
tensities defined in this new model. The main application of obtaining cause-specific
termination assumptions is in the area of reserving more reliably for a portfolio of
claims consisting of different causes of sickness.
In this thesis, we present methods and results for the estimation of the recovery and
mortality intensities from sick by cause of sickness using IPI data provided by the CMI.
There are 70 possible causes of sickness. The recovery intensity model for each cause
of sickness assumes a multiplicative structure and is estimated in a structured manner
with the use of the Cox model (Cox, 1972) and generalised linear models (GLM). The
mortality intensity from sick is modelled using an additive relative survival model
in which the excess mortality as a result of being sick is measured relative to the
mortality intensity for a standard population. Finally, two applications of the recovery
and mortality intensities from sick by cause of sickness are presented.
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Introduction
Income protection insurance (IPI) is a class of long-term insurance that provides an
income while the insured is unable to work due to sickness or disability for a period
longer than the deferred period specified in the policy. It is known as disability
insurance in the US, disability income insurance in Australia and was formerly known
as permanent health insurance in the UK.
As with other insurance contracts, the insurer needs to assess the future expected
cash outflows associated with a portfolio of IPI contracts so that a suitable premium
can be set. These cash outflows will be dominated by benefits payable to insured
lives who subsequently become unable to work as a result of sickness or disability.
To make sure that the insurer can meet its future obligation while remaining solvent,
the actuary is required to assess the magnitude and timing of these uncertain future
cash flows and to recommend a suitable premium rate that will meet these future
benefit payments to ensure the profitablity of the business. The largest and most
uncertain future cash flow in the management of IPI buiness is the payment of the
insured benefit which can vary considerably in terms of the timing of the claim and the
duration of the claim. To assist the actuary in the assessment of the future liabilities
in relation to IPI business, a number of morbidity tables, based on data collected from
life offices, have been produced in various countries. The tables published outside of
the UK include the 1985 Commissioners Individual Disability A Table (CIDA) from
US and IAD 89-93 Standard Table from Australia.
In the UK, the Institute of Actuaries and Faculty of Actuaries set up the Continu-
ous Mortality Investigation (CMI) to carry out research into mortality and morbidity
experience using data collected from UK life insurers. In particular, the Income Pro-
tection (IP) Sub-committee of the CMI is devoted to analysis of IPI data. In the early
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years of their investigation, the methodology adopted by the IP Sub-committee was
to compare the actual weeks of sickness to the expected weeks of sickness calculated
on the basis of the Manchester Unity table. The Manchester Unity table (1893-197)
is a morbidity table constructed based on the sickness experience in England in the
late nineteenth century.
The CMI, in CMI Report 12 (1991), established a new methodology for the analysis
of IPI data in the form of a multiple state model with three states: Healthy, Sick and
Dead. This model is defined in terms of transition intensities between the states:
sickness inception intensity (i.e. transition from Healthy state to Sick state), recovery
intensity (i.e. transition from Sick state to Healthy state), mortality intensity from sick
(i.e. transition from Sick state to Dead state) and mortality intensity from healthy
(i.e. transition from Healthy state to Dead state). In order to make this model
operational for pricing and reserving purposes, these transition intensities have to be
estimated. For this purpose, CMI Report 12 (1991) presented graduation formulae for
the sickness inception intensity, recovery intensity and mortality intensity from sick
based on a set of homogeneous male IPI data from 1975-1978. This set of graduation
intensities, known as SM1975-78, is used as a yardstick against which the sickness
experience for subsequent years is compared using the actual/expected ratios. The
results of such analyses were published in a series of CMI reports.
In the three-state model introduced in CMI Report 12 (1991), there is only one
Sick state which the IPI policyholder enters when he becomes sick, regardless of his
cause of sickness. In recognition of the cause of sickness or disability as an important
observable source of heterogeneity among IPI claimants, Cordeiro (1998, 2002) pre-
sented a new multiple state model for the analysis of IPI data by cause of sickness or
disability, in which the Sick state in the model defined in the previous paragraph is
replaced by n different Sick states, one for each cause of sickness. This new model,
which consists of n + 2 states, is also defined in terms of transition intensities which
are n sickness inception intensities (i.e. transitions from Healthy to each of the n
Sick states), n recovery intensities (i.e. transitions from each of the n Sick states to
Healthy state), n mortality intensities from sick (i.e. transitions from each of the n
Sick states to Dead state) and mortality intensity from healthy (i.e. transition from
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Healthy state to Dead state). Constrained by a much less detailed set of IPI data
which makes it impossible to obtain graduations for these transition intensities in
a similar manner to the graduations obtained in CMI Report 12, Cordeiro (1998)
devised a way to derive continuous functions which can be taken as approximations
to these transition intensities using IPI male data from 1975 to 1978 classified by 18
sickness categories. The motivation behind this approximation is that these transition
intensities, possibly for some cause of sickness, may share the same feature or shape as
the corresponding graduated intensities proposed in CMI Report 12 but having a dif-
ferent level to the latter, which is verified by conducting tests of hypotheses based on
the distributions of average sickness durations. In connection with this new multiple
state model, Cordeiro (1998) also defined the basic probabilities which are required
for the calculation of quantities concerning IPI business and presented formulae for
the basic probabilities. The estimated transition intensities are then fed into these
probabilities which are evaluated efficiently using numerial algorithms.
A later attempt to analyse IPI data by cause of sickness was carried out by the CMI
Cause of Disability Working Party which was set up by the CMI IP Sub-committee
in 2004 to analyse the IP sickness experience and possibly obtain graduations of ter-
mination experience by cause of sickness using a huge amount of IPI per policy data
by cause of sickness from 1975 to 2002. In their first published report, CMI Working
Paper 23 (2006), they presented an initial analysis of the claim inceptions and claim
terminations (recovery and death) by major cause group using the actual/expected
ratios on the basis of SM1975-78. The benefit of analysing IP sickness experience
was also discussed in this working paper. It is reckoned that the area of most po-
tential benefit to IPI practitioners is the ability to reserve more reliably for claims
in payment. By using cause-specific termination assumptions, the resulting aggre-
gate reserve for a whole portfolio of claims will be more reliable than one which is
calculated using a single aggregate termination assumption. This is because if the
termination assumption is cause-specific, the aggregate reserve can take into account
the changing mix of underlying causes in the portfolio and any cause-specific medical
advancement in the future. In addition to that, the study of IPI claims by cause is
useful to the underwriting and claim control processes because it gives a better indi-
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cation of the relative importance of the various causes to claims costs and a better
understanding of the average length of claim by cause. The underwriting and claim
control procedures adopted by life offices can have an impact on the profitability of
their IPI business (Sanders and Silby, 1986).
The main purpose of this thesis is to estimate the recovery intensity and mortality
intensity by cause of sickness as defined in Cordeiro (1998). This thesis can be viewed
as an extension to the work in Cordeiro (1998) and CMI Working Paper 23 (2006). To
achieve our objective, we were provided by the CMI with a large amount of IPI claim
data, each of which contains various data fields describing the attributes of the IPI
policy and the insured person as well as the cause of disability that gives rise to the
claim. This thesis will highlight the role that a number of survival model techniques
have to play in the analysis of IPI data. In particular, the Cox proportional hazards
model, generalised linear models and relative survival models will be considered and
their suitability for morbidity modelling in respect of IPI will be discussed. The
structure of the thesis is as follows:
In Chapter 1 we describe IPI and present the multiple state model as proposed in
CMI Report 12 (1991). Then, we present a multiple state model which enables the
analysis of IPI claims by cause of sickness as proposed in Cordeiro (1998). Finally,
we review the actuarial literature and CMI reports concerning the analysis of sickness
experience among UK IPI claimants, which will place the research in Chapter 3 in an
appropriate context.
In Chapter 2 we describe in detail the data set which is used for the graduation of
the recovery intensity and mortality intensity from sick by cause of sickness. This set
of IPI data comprises claim records for which payments have been made from 1975
to 2002 inclusive. We also describe the information included for each IPI claim and
present the classification of the 70 possible causes of sickness into 12 sickness categories
to enable meaningful comparison of results at the exploratory analysis stage.
In Chapter 3 we present the estimation of the recovery intensity model for each
cause of sickness. The recovery intensity model takes on a multiplicative structure
consisting of two components. The first component is the baseline intensity which
is a function of sickness duration alone while the second component is the relative
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risk which describes the multiplicative effects of covariates. The parameterisation for
each component is carried out separately. The relative risk component is estimated
separately from the baseline intensity by using the Cox model (Cox, 1972). Implicit
in the Cox model is that covariate effects remain constant for all sickness durations
(i.e the proportional hazards assumption). This assumption will be assessed by using
a graphical diagnostic check based on the Schonefeld residuals (Schoenfeld, 1982). In
the case that the covariate effects are duration-dependent, the Cox model is extended
to include a duration-varying coefficient by expressing it as the constant coefficient of a
suitably defined duration-dependent covariate. To parameterise the baseline intensity,
we assume a piecewise constant structure and graduate the estimates by using a
mathematical formula. Finally, with a fully parameterised recovery intensity model,
all the parameters are estimated together using maximum likelihood estimation. The
fitted model then undergoes a series of test to assess its goodness of fit. This chapter
concludes with the presentation of the estimated recovery intensity models for a few
causes of sickness with the remainder in Appendix B.
In Chapter 4 we propose a mortality intensity from sick model which is the sum of
two different components. The first component is the ‘base’ mortality intensity which
is derived from a standard population while the second component is the excess mor-
tality intensity which can be interpreted as the mortality in excess of that experienced
by a standard population as a result of being sick. In the case of IPI claimants, we
regard the UK assured lives population as a reasonably comparable group from which
the base mortality intensity can be obtained. This chapter is dedicated to the mod-
elling of the ‘base’ mortality intensity, in which we present a structured approach to
the estimation of the ‘base’ mortality intensity, separately for males and females, in
the GLM framework by using the UK assured lives data set.
In Chapter 5 we estimate the ‘excess mortality intensity’, which is the other con-
stituent component in the mortality intensity from sick model as proposed in Chapter
4. We show that by having a multiplicative structure for the excess mortality inten-
sity model, all the parameters in the model can be estimated by using a GLM with
Poisson error structure and a specially constructed link function. As in the recovery
intensity model, the parameterisation of the excess mortality intensity is carred out
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in a structured manner. We also describe the steps involved in transforming the IPI
per policy data from the CMI so that it can be used for GLM analysis. Given the
low number of deaths in the large majority of causes of sickness, we classify the 70
causes of sickness into 15 sickness groups which are then further grouped into 5 dif-
ferent sickness categories according to the shape of their mortality curves. Finally, we
present the estimated excess mortality model for each of the 5 sickness categories.
In Chapter 6, we show the application of using the estimated recovery intensities
and mortality intensities from sick by cause of sickness presented in Chapters 3 – 5
in the following two aspects:
(i) Calculating the expected present values of annuities by cause of sickness.
(ii) Deriving the aggregate recovery intensity and mortality intensity from sick.
Finally, in Chapter 7, we present our contributions and ideas for further research.
6
Chapter 1
Background
1.1 Introduction
In this chapter we give some background to the work presented in this thesis. In
Section 1.2 we describe in general terms the nature of Income Protection Insurance
(IPI). In Section 1.3 we present the multiple state model as proposed in CMI Report
12 (1991) to analyse IPI claims data. A generalisation of this multiple state model
which enables analyses of IPI claims by cause of sickness is presented in Section
1.4. Finally, in Section 1.5, we present the results published in CMI reports and the
actuarial literature which will serve as a useful introduction to Chapter 3.
1.2 Income Protection Insurance
Income protection insurance (IPI), formerly known as permanent health insurance in
the UK, is a class of long-term insurance that provides an income while the insured is
unable to work due to sickness or disability. Once an IPI policy is effected, it cannot
be cancelled by the insurer, other than in very exceptional circumstances specified in
the policy.
There are two main types of IPI policy: individual policies and group policies. In
this thesis we will focus on the claim experience in relation to individual IPI policies.
The basic features of an IPI policy are illustrated in Figure 1.1. The symbols ‘H’,‘S’
and ‘DP’ in this diagram represent ‘healthy’, ‘sick’ and ‘deferred period’, respectively.
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Under an individual IPI policy, the insurer is obliged to pay the policyholder income
during periods of disability longer than the deferred period. In other words, a poli-
cyholder has to remain sick for at least as long as the deferred period of his policy
in order to make a claim and receive benefit. The claim payments will stop once the
claimant recovers from the sickness/disability. However, if the same sickness recur
within a very short period of recovery, it will usually be treated as claim revival by
the insurance company with the deferred period requirement being waived so as to
encourage earlier recovery. In exchange for these benefits, the policyholder has to pay
premium from the time he/she effects the policy until the end of the policy term or
to the retirement age of 60 for women and 65 for men, except when the policyholder
is in receipt of benefit. The common deferred periods in the UK market are 1 week,
4 weeks, 13 weeks, 26 weeks and 52 weeks. In this thesis, they are represented by the
symbols DP1, DP4, DP13, DP26 and DP52, respectively.
Both benefit and premium can take many forms. The benefit received may be
in the form of a regular income, increasing income linked to inflation or income that
includes an investment element on a unit-linked or with-profit basis. In all cases, the
benefit received is usually less than a set percentage of the claimant’s previous income
so as to provide an incentive for the claimant to return to work. The premium paid
may be renewable or reviewable after a period of a few years or guaranteed for the
policy term.
While the basic features of various individual IPI policy issued by different com-
panies are generally the same, the individual IPI product is a complex and highly
variable product because the specific policy conditions can vary considerably between
insurers. These policy conditions include the definition of disability that triggers ben-
efit payment, exclusion of certain cause of claims, the size of benefit relative to the
insured’s pre-disability income and age at entry of the policyholder. The varying pol-
icy conditions adopted by each insurer that write IPI business in UK can be found in
Kluwer’s Income Protection Insurance (2001).
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Figure 1.1: Policy design of IPI.
1.3 A Multiple State Model for IPI
The CMI introduced a semi-Markov model for pricing and reserving in respect of IPI
business in CMI Report 12 (1991). This model consists of three states: Healthy (H),
Sick (S) and Dead (D). A diagrammatic representation of this three-state model is
shown in Figure 1.2 and will be used to give an intuitive explanation of this model.
Healthy H Sick S
Dead D
-
ff
A
A
A
A
A
AU






σx
ρx,z
µx νx,z
Figure 1.2: A multiple state model for IPI in which a policyholder may move between
these three states, with death as an absorbing state.
Once an IPI policy is effected, at which time the policyholder is supposed to be
healthy, he enters state H. From this state, he may transfer at any future time either
to state S (i.e. he becomes sick) or to state D (i.e. he dies). The transition intensities
associated with these two transitions are denoted σx and µx, respectively. Both these
transition intensities are dependent only on x, the policyholder’s attained age.
Once the policyholder is in state S, he may transfer either back to state H (i.e.
he recovers) or to state D (i.e. he dies). The transition intensities in connection
with these transitions are denoted by ρx,z and νx,z, respectively. Both these transition
intensities depend on both x, the policyholder’s attained age, and on z, the duration
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of his current sickness (no account is taken of previous sickness). Both states H and
S are transitive while state D is absorbing.
The movement of a policyholder in this multiple states model can be described by
a pair of continuous time stochastic processes
{Y (x), Z(x)} x > 0 and y > 0 (1.1)
where Y (x) denotes the state in which the policyholder is at age x and Z(x) denotes
the duration of his sojourn so far in the current state Y (x). In formal terms, Z(x) is
defined as follows:
Z(x) = max{t : t ≤ x and Y (x− h) = Y (x) ∀ h : 0 ≤ h ≤ t}. (1.2)
Y (x) can takes any of the three values H,S and D while Z(x) takes value in the set
[0,∞).
The joint process (1.1) is assumed to be a Markov process so that the future of
the process depends only on the values of Y (x) and Z(x) and not on any information
prior to age x. This means that if a policyholder has just become sick, his transition
probability into either stateH or stateD takes no account of his prior sickness history.
On the other hand, the transition probability from state H to state S is the same for a
healthy policyholder who has just effected his policy as for a policyholder of the same
age who is healthy but has just recovered from a long sickness. We make this strong
assumption because it is not possible to infer any prior sickness history (e.g. whether
or not the person has just recovered from the same or another sickness) about the
claimant from the available data to enable the fitting of a more realistic model.
1.4 A Multiple State Model for IPI by Cause of
Sickness
In the three-state semi-Markov model presented in Figure 1.2, there is only one sick
state to represent all possible causes of sickness which the policyholder enters whenever
he becomes sick. This model assumes that regardless of the cause of sickness, all IPI
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claimants are subject to the same recovery and mortality intensities.
Cordeiro (1998, 2002) developed a new multiple state model which enables the
analysis of IPI claims by cause of disability. Figure 1.3 gives a diagrammatic rep-
resentation of this new multiple state model by cause of disability. There are n + 2
states in this new multiple state model. In addition to states H and D, there are
n sick states (S1, S2, . . . , Sn), each of which represents a specific cause of sickness, in
place of a single sick state to represent all of them.
As in the three-state semi-Markov model in Section 1.3, a policyholder enters
state H when his policy is effected. From there, he can transfer at any future time
to state D or to one of the n sick states depending on his disability or sickness. The
transition intensities associated with these transitions are respectively denoted by
σ(i)x: H → Si (i = 1, 2, . . . , n) and µx : H → D. Both σ(i)x and µx depend only on
x, the policyholder’s attained age.
From the sick state Si (i = 1, 2, . . . , n), a person can return to either state H (i.e.
recover) or state D (i.e. die) at any future time. The transition intensities associated
with these transitions are respectively denoted by ρ(i)x,z: Si → H (i = 1, 2, . . . , n)
and ν(i)x,z : Si → D. Both ρ(i)x,z and ν(i)x,z depend on the policyholder’s attained
age x, and the duration of his sickness z.
It should be noted that in this new multiple state model, transitions between the
n sickness states, which represent different cause of disability are not allowed. We
assume that a person who falls sick from a specific sickness cannot develop another
disease until after he recovers (returns to state H) from his original sickness. This
is despite the fact that it is entirely possible, for example, for a person who suffers
from diabetes to develop stroke without having to recover from diabetes first. If an IP
claimant is affected by another illness while he is claiming under the original sickness,
it is common practice for insurance companies to continue with the payment of benefit
under the original cause of disability. The nature of the data gives us no information
about any transition between the sickness states and thus, these transition intensities
cannot be modelled.
As in Section 1.3, the movement of a policyholder in this new multiple state model
can also be described by a pair continuous time stochastic processes
11
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Figure 1.3: A multiple state model for the analysis of IPI claims by cause of disability.
{Y (x), Z(x)} x > 0 (1.3)
where Y (x) is the state in which the policyholder is at age x and Z(x) denotes the
duration of the sojourn so far in the current state Y (x). In this new multi-state model,
Y (x) takes values in the set H,S1, S2, . . . , Sn, D while Z(x), as defined by Equation
(1.2), takes values in [0,∞]. As in Section 1.3, the joint process (1.3) is assumed to
be a Markov process.
1.5 A Review of Past Results
The main focus of this thesis is the graduation of recovery intensities and mortality
intensities from sick by cause of sickness associated with the multiple state model by
cause of sickness as presented in Figure 1.3. There are a number of papers that deal
with statistical and actuarial problems in related fields, such as long-term care and
Continuing Care Retirement Communities. In particular, Jones (1992) used a Markov
process to analyse US statistical data concerning long-term care and Jones (1995)
presented a multi-state stochastic model for analyzing continuing care retirement
community populations.
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Despite having a large database of information relating to cause of sickness, the
CMI has not carried out such an analysis and only limited use has been made of this
dataset to date. Nevertheless, the CMI has, in the past, produced graduated recovery
intensities and mortality intensities from sick using aggregate data from all causes of
sickness. For example, CMI Report 12 (1991) presented both the graduation of the
recovery intensity and mortality intensity from sick in Part B and the graduation of
the sickness inception intensity in Part C. These graduated intensities, derived from
a set of homogenous IPI data from 1975-78, are collectively referred to as SM1975-
78 and form the basis for comparison for subsequent quadrenniums. In addition to
SM1975-78, CMI Working Paper 5 (2004) presented recovery and mortality intensities
from sick based on more recent sickness experience by using IPI data during the period
1991-1998. This set of intensities is referred to as IPM91-98.
As a prelude to Chapter 3 which centres on estimating the recovery intensity by
cause of sickness, we examine, in this Section, the modelling techniques used in the
graduation of recovery intensities as presented in both the CMI reports mentioned
above as well as their relevant important findings. Subsequently, in search of the
evidence of year trend in the sickness experience, we examine results on the basis
of SM1975-78 for the sickness experience for each quadrennium in the period 1975 –
2002 as published in a series of CMI Reports. We also present findings from Renshaw
and Haberman (2000) who studied year trends in the sickness experience. Finally, we
summarise the main findings of these past analyses.
CMI Report 12 (1991)
In association with the three-state semi-Markov Model for IPI business (see Section
1.3), CMI Report 12 (1991), in Part B, presented the graduation of the recovery
intensity S → H using male ‘Standard’ data for 1975-78. The idea of ‘Standard’ data,
first introduced in CMI Report 7 (1987), refers to a more homogeneous subset of the
total data that consists of policies issued in the UK, policies without occupational
rating or known health impairment and with a regular benefit payment.
The general form of the graduation formula was developed by investigating the
age and durational effects. At the exploratory analysis phase, a multiplicative model
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of durational factors and age factors was fitted for each deferred period. For DP1,
a plot of the log of the durational factors for up to one year against the square root
of duration produced a graph that was approximately linear and decreasing. Apart
from 4-week ‘run-in’ periods of lower recovery intensities immediately after the end of
the deferred period, a similar linearity was found for DP4, DP13 and DP26 and there
was no significant difference between deferred periods. The linear trend, however, is
not continued for sickness durations exceeding one year. The ‘run-in’ phenomenon
was discussed at some length in CMI Report 12, Part B, Section 3.3. It is generally
regarded as being caused by people who do not submit a claim when their recoveries
are imminent at the end of their deferred period. To assess the variation of recovery
intensity by age, the age factors for each deferred period were plotted against age. It
transpired that there is a broadly linear relationship of the factors with age with no
great disparity between the deferred periods. Apart from the need to make special
adjustment for the ‘run-in’ periods, the data from all deferred periods was combined
to recalculate the age and durational factors. A detailed diagnostic check revealed
that such a simple multiplicative model fails to fit the data sufficiently well. Further
piecewise adjustment was made to account for the change in the slope of the log linear
variation of recovery intensity with duration after one year and the linear dependency
of age with
√
z with a steeper negative slope before four weeks of sickness duration.
For practical reasons, the recovery intensities depend only on attained age after five
years of sickness (i.e z > 5).
The complete graduation formula for the recovery intensity in SM1975-78 is as
follows:
ρy+z,z = r {a+ b(1 + q(4− wz)+)
√
Z(Y − 50)} e−c
√
Z (1.4)
where Y is a function of the exact age y (in years) at sickness inception while Z is a
function of sickness duration z in years, such that
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Y =
 y for z ≤ 5y + z − 5 for z > 5 Z =

z for z ≤ 1
1 + s(z − 1) for 1 < z ≤ 5
1 + 4s for z > 5
and r is defined as
r =
 1 for DP1min{(p+ wz − d)(1− p)/4, 1} for DP4, DP13, DP26
where w= 52.18 (assuming that there are 52.18 weeks in a year), d is the deferred
period measured in weeks, and
a = 51.057202 b = −2.687089 c = 4.914441
p = 0.205111 q = 1.419428 s = 0.362456
Figure 1.4 provides a visual comparison of the graduated recovery intensities for
a male aged 40 at sickness inception for the different deferred periods as a function of
sickness duration. This figure shows the ‘run-in’ periods for DP4, DP13 and DP26,
the change of slope before four weeks of sickness duration and after one year of sickness
duration.
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Figure 1.4: The recovery intensities for a male IPI claimant aged 40 at sickness
inception according to SM1975-78.
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CMI Working Paper 5 (2004)
In addition to SM1975-78, a set of graduated recovery intensities based on more recent
sickness experience was published in CMI Working Paper 5 (2004). The data used
in this graduation is from IP males, occupational class 1 from 1991 to 1998 inclusive.
Despite the data spanning eight years, the calendar year effect was not investigated
because preliminary investigation by the author revealed no clear time trend. The
combined data from each year was used for the graduation. In common with SM1975-
78, the recovery intensity after five years of sickness is dependent only on attained age
and similar exploratory analysis techniques to those adopted in CMI Report 12 (1991)
were used. While there are broad similarities in the recovery pattern between this
graduation and that of SM1975-78, there are a few distinctive differences too. The
resulting graduation formula is an additive log linear function of age y at sickness
inception, duration z and deferred period d given by
log ρ(d, y, z) = sd + gz + qz + rz + fyz + hyz.
In view of the rather elaborate terms comprised in each of the components above,
the full graduation formula is presented in Appendix D. In essence, the meanings of
the various components in the above model are as follows:
(i) sd consists of factors that account for the differences in the level of recovery
intensity between different deferred periods.
(ii) gz consists of piecewise linear terms of the transformed duration variable, t(z),
such that t(z) = w/(1 + 0.025w) where w = 365z/7.
(iii) qz is a piece-wise linear function of t(z) aimed to adjust for the change in slope
during 8 < w ≤ 16 in DP4.
(iv) rz consists of piece-wise linear terms that account for the increasing linear trend
during the four weeks of run-in period noticeable in DP4 and DP13.
(v) fyz is a cubic function of age y with the coefficient of the linear age term varying
negatively with t(z).
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(vi) hyz is a function of age y and duration z applicable only to sickness durations
less than four weeks.
To give a visual impression of features (i) to (iv), the graduated recovery intensities
for a male aged 40 at sickness inception, computed separately for each deferred period,
are shown in Figure 1.5.
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Figure 1.5: The graduated recovery intensities for a male IPI claimant aged 40 for
separate deferred periods.
This set of graduated intensities is referred to as IPM91-98 and is used as a com-
parison basis for other males and females occupational classes from the 1991-1998
data. The results of such an analysis are reported in CMI Working Paper 7 (2004).
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Other CMI Reports
The standard table SM1975-78 has been used by the CMI to assess future sickness
experience. The methods used by the CMI to analyse IPI claims experience are based
on a comparison of actual number (A) of recoveries and deaths versus expected (E)
on the basis of SM1975-78. The detailed methodology was set out in CMI Report 15
(1996).
The IPI data is typically grouped by quadrennia before such comparisons are
carried out. For the years 1975-1990, the analysis is based on ‘Standard’ data; for
years since 1991, it is based on the ‘Standard*’ data. This new subset of the total
data called ‘Standard*’ data, introduced in CMI Report 18 (2000), is designed to
make use of the ‘occupational class’ information collected since 1991. This set of data
is created by using the same criteria as for the ‘Standard’ data but ignores the content
of the ‘occupational rating’ field. A description of the data fields included in each
IPI data can be found in Section 2.2. The ‘Standard*’ data therefore forms a larger
subset of the total data than the ‘Standard’ data. The results are then published
in a series of CMI Reports, i.e. CMI Report 15 (1996) for the 1975-78, 1979-82,
1983-86 and 1987-90 experience, CMI Report 18 (2000) for the 1991-94 experience,
CMI Report 20 (2001) for the 1995-98 experience and CMI Report 22 (2005) for the
1999-02 experience.
Using the A/E values obtained from these CMI Reports, Figure 1.6 shows 100A/E
for the number of recoveries by deferred period and quadrennium over 1975-2002 for
all sickness durations combined, separately for males and females. Figure 1.7 depicts
the 100A/E for the number of recoveries by sickness duration and quadrennium over
1975-2002 for all deferred periods combined, separately for males and females. From
these graphs, we see that
(i) There is a strong declining trend in both males and females recovery intensities
over the period 1975-2002 for all deferred periods apart from DP1.
(ii) The sickness experiences for the first 3-4 weeks, in both males and females, seem
to depart from the general falling trend observed in sickness durations greater
than 3 weeks. No explanation is given by the IP Sub-committee for this feature.
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Figure 1.6: Values of 100A/E (all durations combined) by deferred periods and qua-
drennium over 1975-2002. Standard data for 1975-1990; Standard* data, all occu-
pational classes for 1991-2002. Expected values based on SM1975-78. All values
obtained from CMIR 15, 18, 20 and 22.
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Figure 1.7: Values of 100A/E (all DP combined) by sickness durations and quadren-
nium over 1975-2002. Standard data for 1975-1990; Standard* data, all occupational
classes for 1991-2002. Expected values based on SM1975-78. All values obtained from
CMIR 15, 18, 20 and 22.
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Renshaw and Haberman (2000)
In both CMI Report 12 (1991) and CMI Working Paper 5 (2004), no time trend
is incorporated in the recovery intensity model due to the relatively short period of
calendar years that the data covers. Both Figures 1.6 and 1.7 show evidence of a
general declining trend in the sickness experience from 1975 to 2002. The results
from Renshaw and Haberman (2000) lend support to this phenomenon.
Renshaw and Haberman (2000) studied the presence of any significant time trend
in the sickness experience of UK IPI claimants for males and females separately by
using IPI data spanning 20 calendar years from 1975 to 1994 inclusive. To do so, they
make use of the results in an earlier paper, Renshaw and Haberman (1995), which
used a GLM based approach to model the transition intensities in the IPI multiple-
state model separately for each deferred period by using IPI male ‘Standard’ data for
1975-78, the same set of data used in the graduation of the recovery intensity in CMI
Report 12 (1991). The underlying method in Renshaw and Haberman (2000) is to
use the model structure for each deferred period found in Renshaw and Haberman
(1995) as their starting point and let the parameters in each model vary by every
single calendar year from 1975 to 1994.
To illustrate how their method works, we focus on the recovery intensity for males
DP1 as an example. Using the same notation as in Renshaw and Haberman (2000),
we take ρy+z,z as the recovery intensity for a person aged y (in years) at sickness
inception and has been sick for duration z (in years). The model structure for males
DP1 in Renshaw and Haberman (1995) is given by
log(ρy+z,z) = β0 + β1
√
z + β2z + β3y + β4y
√
z + β5yz
In the search for a time trend, the parameters in the above model are to vary
by every single calendar year from 1975 to 1994. Each set of these year-dependent
coefficients is tested for statistical significance and is plotted against calendar year t
to examine the trend of dependency. The recovery intensity as a log-linear function
of age y, duration z and year t for males DP1 in Renshaw and Haberman (2000) is
log(ρy+z,z,t) = (β0+β6t)+(β1+β7t)
√
z+(β2+β8t)z+β3y+β4y
√
z+β5yz+β9y
2+β10y
3
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where
β0 = 2.76175 β1 = −9.9429× 10−1 β2 = 3.2281× 10−2 β3 = 1.6973× 10−1
β4 = 5.6928× 10−3 β5 = −3.4555× 10−4 β6 = 4.2984× 10−2 β7 = −2.633× 10−2
β8 = 1.3632× 10−3 β9 = −4.4399× 10−3 β10 = 2.9982× 10−5
Renshaw and Haberman (2000) interpreted this model from three perspectives,
which include the following:
(i) The log recovery intensity varies linearly with year for fixed z. The coefficient
of year is duration dependent and is given by 4.2984× 10−2− 2.633× 10−2√z+
1.3632×10−3z. This implies that the recovery intensities have increased over
the years for sickness durations less than three weeks and over 307 weeks, i.e.
a positive year coefficient. For other sickness durations, the recovery intensity
decreases over the years investigated, i.e. a negative year coefficient. This
conclusion is generally consistent with the observations in Figure 1.7.
(ii) The log recovery intensity can be viewed as a quadratic function in
√
z. The
coefficient of (
√
z)2 is 3.2281 × 10−2 + 1.3632 × 10−3t − 3.4555 × 10−4y and is
positive for all y and t values within the domain of data. Thus, it is a convex
function with the minimum turning point lying beyond the domain of data.
(iii) The log recovery intensity is a cubic function in age y. The coefficient of the
linear age y term is a quadratic function of
√
z while the coefficients for y2 and
y3 are constant terms.
The recovery intensity for males and other deferred periods are investigated sep-
arately in the same manner. For each deferred period, the following model structure
is adopted:
log(ρy+z,z,t) = β0 + β6t+ β1y + β2z + β3(z − z0)+ + β4(z − z1)+ + β5y(z − z0)+
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for DP4, DP13, DP26 with β3 = β5 = β6 = 0 for DP52. The value for z0 is set equal
to the length of the respective deferred period plus four weeks in view of the the 4
weeks of ‘run-in’ period reported in CMI Report 12 (1991). The authors found that
this feature persists throughout the 20 investigation years. The location of z1 is found
by varying its locations in the model and examining the resulting deviance profile.
The value of z1 is 60.88 weeks for DP4 and 65.22 weeks for both DP13 and DP26.
The coefficient for β6 is negative for all deferred period, indicating a drop in recovery
intensity over the years investigated.
Conclusions
After reviewing the results from the above four sources, we know that
(i) The year effect does not stay constant for all sickness durations. For sickness
duration less than three weeks, the recovery intensity increases over the years
but it decreases over the years thereafter (see Figures 1.6 and 1.7 and Renshaw
and Haberman (2000)).
(ii) The age effect is duration-dependent (see CMI Report 12 (1991), CMI Working
Paper 5 (2004) and Renshaw and Haberman (2000)).
(iii) The existence of a lower but linearly increasing recovery intensity during the
4 weeks of ‘run-in’ period that occur after the end of DP4, DP13 and DP26
respectively (CMI Report 12, 1991; see Figure 1.4). In CMI Working Paper 5
(2004), such a phenomenon is not observed in DP26 (see Figure 1.5).
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Chapter 2
Data
2.1 Introduction
We wish to develop models for income protection insurance by cause of sickness.
For this purpose, we were provided by the CMI with a set of IPI data, comprising
claim records for which payments have been made during each investigation year from
1975 to 2002 inclusive. This claim data was contributed to the CMI for analysis by
UK life insurance companies that write IPI business. In Section 2.2 we present the
information included in each IPI claim data. For the purpose of presenting the IPI
data split by 70 causes of sickness in a way that meaningful comparisons and contrasts
can be made when exploratory analysis of the IPI data is conducted in Section 2.4,
we present in Section 2.3 the classification of these causes of sickness into 12 sickness
categories after reviewing various such groupings in the IPI literature.
2.2 Structure of the Data
Each IPI claim record contains various data fields which contain information about
the claimant, attributes of the IPI policy and the nature of the claim. The coding
of the data fields is set out in CMI Report 2 (1976). From 1991, the CMI started to
collect ‘occupational class’ information by asking the life offices to submit their own
occupational class code which is then converted by the CMI to its equivalent CMI
occupational class code. The information included in each claim record is as follows:
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(a) Sex: male and female are coded as 1 and 2, respectively
(b) Deferred period: 1, 4, 13, 26 and 52 weeks and are coded as 1, 2, 3, 4 and 5,
respectively
(c) Occupational rating: no rating, rated and more rated are coded as 0, 1 and 2,
respectively
(d) Age last birthday at sickness inception, taking values from 17 to 69
(e) Calendar year of the claim payment, taking values from 1975 to 2002
(f) Occupational class: The four occupational classes employed by the CMI are
translated into codes 1, 2, 3 and 4, respectively. These occupational classess are
described in CMI Report 18 (2000) and they are reproduced here as follows:
Class 1 Professional, managerial, executive, administrative and clerical classes not
engaged in manual labour
Class 2 Master craftsmen and tradesmen engaged in management and supervision;
skilled operatives engaged in light manual work in non-hazardous occupa-
tions
Class 3 Skilled operatives engaged in manual work in non-hazardous occupations
Class 4 Skilled and semi-skilled operatives engaged in heavy manual work or sub-
ject to special hazard
(g) Cause of claim: There are 70 possible causes of sickness and they are coded as
1-70 according to the Abbreviated List C in the Eighth Revision of the Manual
of the International Statistical Classification of Diseases, Injuries and Causes
of Death. In this thesis, this list will be referred to as ‘ICD8’. A copy of this
list is produced in Appendix A.
(h) Month and year of birth
(i) Date of sickness inception
(j) Date of payment commencement
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(k) Mode of payment commencement: continuation of claim payment from preced-
ing year, new claim, new claim after interruption, revival and benefit change
are coded as 0, 1, 2, 3 and 4, respectively. New claim after interruption refers
to new claim that starts after certain interruptions during the deferred period
while revival refers to claim which is revived due to recurrence of the same sick-
ness within a very short period of recovery. In the investigation of recovery and
mortaliy intensities by cause of sickness in the subsequent chapters, no account
is taken of the mode of payment commencement
(l) Date of payment cessation
(m) Mode of payment cessation: recovery, death, expiry and continuation of claim
payment in succeeding year are coded as 0, 1, 2, 3 and 4, respectively
As noted above, the CMI did not collect ‘occupational class’ code information
until 1990. However, for IPI data collected before 1990, we find values of 0, 1 or
blank in the ‘occupational class’ field. The blank is not the same as 0 and is changed
to 5 instead. Despite the collection of occupational class information, the field for
‘occupational rating’ is still being used after 1990. The majority of claim records
with occupational class = 2, 3 or 4 have occupational rating = 1. However, there
are some claim records with occupational class = 1 but with occupational rating =
1. Thus, for the purpose of using the data set for the entire 28 year-period from 1975
to 2002 in our analysis, we reckon that the best available interpretation is to regard
those with occupational classes = 0, 1 and 5 and with occupational rating = 1 as
“non-rated” and everything else (i.e. occupational class= 0, 1, 5 with occupational
rating = 1 or 2 and also occupational class = 2, 3, 4 regardless of occupational rating)
as “rated”.
Using the information described above, we are able to calculate the following
quantities for each claim record:
(i) Sickness duration at the start of the claim payment. This is given by the dif-
ference between the date of payment commencement and the date of sickness
inception. Note that a claimant’s sickness duration at the start of the claim
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payment should be equal to or longer than the deferred period specified in the
claimant’s policy.
(ii) Sickness duration at the end of the claim payment. This is given by the difference
between the date of payment cessation and the date of sickness inception.
(iii) Exact age at the start of claim payment. With only month and year of birth
given, we will assume that 15th is the day of birth. The exact age of the
claimant at the start of claim payment is given by the difference between the
date of payment commencement and the date of birth.
Due to the data being collected and recorded on a yearly basis, an individual
who is still sick at the end of each investigation year will have his/her observation
right-censored and will probably (but not always owing to the lack of homegeneity
in the offices that contribute data from year to year) enter into our study in the
subsequent investigation year with ‘continuation of claim payment’ as the mode of
claim commencement. Hence, until an IPI claimant experiences either recovery or
death, he or she may have multiple claim records, one for each investigation year
visited until the IPI policy expires.
The IPI claim data submitted by life offices undergoes screening and is scrutinised
for possible errors of coding by the CMI. There is also a procedure in place to identify
and remove duplicate claims that arise as a result of an individual having more than
one IPI policy. Despite such scrutiny, during the preliminary investigation of the data,
we detected and removed erroneous data as a result of
1. New claims that start and end on the same day.
2. New claims for which the sickness duration at the date of payment commence-
ment is less than the pre-specified deferred period. CMI Working Paper 6 (2004)
reveals a small percentage of new claims that start a few days before or after
the pre-specified deferred period. For example, some claim payments belonging
to DP4 policies only start at 30 or 31 days (1 month) after sickness inception.
In view of this, an allowance of ± 3 days from the pre-specified deferred period
is used to identify genuine new claims.
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3. Claims with other modes of commencement for which the sickness duration
at the date of payment commencement is less than the pre-specified deferred
period.
Table 2.1 gives a summary of data removed due to the above three reasons. Nev-
ertheless, it is impossible to ensure that the data is flawless because there may be
unidentifiable errors such as coding mistakes by the administrative personnel in some
life offices when preparing the claim data for submission to the CMI.
Table 2.1: A summary of erroneous IPI claim records removed from analysis.
DP1 DP4 DP13 DP26 DP52
Intial number of claim records 63,584 60,722 51,900 42,912 17,541
Cause of removal
1 153 329 423 135 117
2 76 937 1500 829 369
3 - 203 303 235 170
Number of claim records removed 229 1,469 2,226 1,199 656
(%) 0.36% 2.42% 4.29% 2.79% 3.74%
Final number of claim records 63,355 59,253 49,674 41,713 16,885
2.3 Grouping of Causes of Sickness
Since this set of IPI claim data will be used to obtain recovery intensity and mortality
intensity from sick by cause of sickness in the following chapters, we will describe
the data in greater detail. There are a total of 70 causes of sickness. Such a large
number of causes of sickness does not lend itself readily for presentation. As many
of the individual causes of sickness have a small amount of data, we wish to group
these 70 causes of sickness into fewer sickness categories. For this purpose, we review
the various groupings of causes of sickness by ICD8 code in the context of IPI. CMI
Report 8 (1986) decided to group the causes of sickness into 14 sickness categories
purely on medical grounds using IPI claim data from 1975-78. In their grouping,
causes of sickness regarded to be of little significance are amalgamated together while
any cause of sickness that accounts for at least 5% of the total experience was included
as a specific category. Cordeiro (1998) analysed the IPI claim data classified by
CMI Report 8 (1986)’s grouping for the same 4-year period and, for computational
convenience, decided to further categorise them into the following five classes based
on their levels of recovery intensity approximated by statistical properties.
Class I Very high recovery intensities
Class II High recovery intensities
Class III Medium recovery intensities
Class IV Low recovery intensities
Class V Very low recovery intensities and very high mortality from sick intensities
In CMI Working Paper 23 (2006), the 70 causes of sickness are grouped into 11
sickness categories in such a way that the number of terminations (recovery and death)
in each category is sufficiently large and no causes of sickness that show dissimilar
termination patterns are put in the same category. To achieve the latter aim, the
actual number of terminations (A) for each cause of sickness is compared to that
expected (E) under SM1975-78 by using the A/E ratio. This analysis is conducted
by using combined data from 1991-2002, both sexes, DP4-DP52 and occupational
class 1. The classification of 70 causes of sickness into different sickness categories
adopted by these three different investigations into IPI claim experience is shown in
Table 2.2.
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Table 2.2: The different grouping of 70 causes of sickness (represented by their ICD8
code) by CMI Report 8 (1986), CMI Working Paper 23 (2006) and Cordeiro (1998)
ICD8 CMI Report 8 (1986) CMI Working Paper 23 (2006) Cordeiro (1998)
01-19 Other infective Infections & acute respiratory Class II
20 Neoplasms Neoplasms Class V
21 Neoplasms Neoplasms Class II
22-26 Endocrine & Metabolic All other known causes Class IV
27 Mental Mental illness Class IV
28-30 All Others Nervous system & sensory organs Class III
31 Nervous Nervous system & sensory organs Class III
32-33 All others Circulatory Class III
34-38 Circulatory Circulatory Class III
39-41 Acute respiratory Infections & acute respiratory Class I
42-45 Chronic respiratory All other known causes Class II
46 All others All other known causes Class III
47-51 Digestive Digestive (non-infectious) Class III
52-55 Genito-urinary Genito-urinary Class II
56-58 All others All other known causes Class III
59 All others Infections & acute respiratory Class III
60 All others All other known causes Class III
61 Musculoskeletal Arthritis Class IV
62 Musculoskeletal Musculoskeletal Class III
63-65 All others All other known causes Class III
66 Road traffic accident injuries Injuries Class III
67-70 Other injuries Injuries Class III
With reference to the different groupings shown in Table 2.2, we eventually decided
to classify the 70 causes of sickness (as represented by their ICD8 codes) into 12
sickness categories as set out in Table 2.3. Note that the grouping we adopted is very
similar to that used by CMI Working Paper 23 (2006). We include in Table 2.3, for
each sickness category, the total number of claim inceptions during the investigation
years, the total exposed to risk of claim termination (recovery or death) calculated in
days and the total number of recoveries and deaths. The total exposed to risk gives the
total IPI claims duration during the period under review and therefore includes claims
which were already in force at the outset of the period of investigation. The largest
five sickness categories in terms of number of inceptions are ‘G10 Musculoskeletal’,
‘G11 Injuries’, ‘G7 Respiratory’, ‘G6 Circulatory’ and ‘G4 Mental Illness’. In terms of
exposed to risk, ‘G5 Nervous system & sensory organs’ replaced ‘G7 Respiratory’ in
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these top five sickness categories. With the exception of ‘G2 Neoplasms’, the numbers
of recoveries for other sickness cateogories are a lot higher than the number of deaths.
The number of deaths from ‘G2 Neoplasms’ constitues about half of the total number
of deaths.
Table 2.3: The grouping of the 70 causes of sickness into 12 sickness categories.
Sickness Category ICD8 Number of Exposed to Number of
code inceptions risk (days) Recoveries Deaths
G1 Infections & acute 01–19 6,355 527,121 4,895 39
respiratory
G2 Neoplasms 20, 21 4,499 2,188,366 2,165 1,765
G3 Endocrine & Metabolic 22–26 868 640,812 596 48
G4 Mental illness 27 8,512 8,616,813 5,280 207
G5 Nervous system 28–31 4,473 3,795,765 2,861 194
& sensory organs
G6 Circulatory 32–38 9,360 7,773,247 6,163 549
G7 Respiratory 39–45 14,041 955,585 10,440 103
G8 Digestive 47–51 6,115 1,016,999 5,752 113
(non-infectious)
G9 Genito-urinary 52–55 2,986 509,259 2,603 56
G10 Musculoskeletal 61, 62 17,200 9,519,873 13,125 139
G11 Injuries 66–70 15,636 4,234,648 13,749 85
G12 All other known causes 46,
56–60, 6,542 527,121 4,895 39
63–65
All Sickness Categories 96,587 40,305,609 72,524 3,337
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2.4 Exploratory Analysis of Data
We wish to investigate the distribution of duration from the onset of sickness (i.e.
including the deferred period) for IPI claims which ended due to recovery or death of
the claimant during the period of investigation. For this purpose, we use a box plot
to convey visually the important aspects of a distribution through its five-number
summaries: the smallest observation (not considered as an outlier), lower quartile,
median, upper quartile, and the largest observation (not considered as an outlier).
These five numbers are represented by five horizontal lines, arranged from bottom to
top, in a box plot. The smallest and largest observations not considered as an outlier
are no more than 1.5 times the interquartile range away from the lower and upper
quartiles respectively. Those observations that lie beyond these two observations are
considered as outliers and are represented by dots.
Figure 2.1 shows the box plots of duration since onset of sickness until recovery on
a logarithmic scale by sickness category for each deferred period. Note that these box
plots only include sickness durations for individuals who recover during the period of
investigation and have ignored the presence of right-censored durations. Therefore,
these box plots should not be construed to indicate the true distribution of the sickness
duration until recovery. They are meant as descriptive statistics and are not relied
upon in the estimation of recovery intensities in Chapter 3. The number of recoveries
upon which each box plot is constructed is indicated at the bottom of the box plot.
These box plots show that the sickness duration until recovery is heavily skewed to the
right, in which case, the median is a better measure than the mean. For comparison
purposes, we present in Figure 2.2 the medians (represented by lines) by sickness
category for each deferred period. The numbers underneath the lines are the number
of recoveries used in the derivation of their respective median. This graph shows
that the median increases with longer deferred periods for all sickness categories. In
both DP1 and DP4, where most of the recoveries are concentrated, ‘G1 Infections &
acute respiratory’ and ‘G7 Respiratory’ have lower medians than the others while ‘G2
Neoplasms’, ‘G4 Mental illness’ and ‘G6 Circulatory’ have higher medians.
Due to the low number of deaths in most of the sickness categories, we will use
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combined data from all deferred periods to construct a box plot of duration since
onset of sickness until death. These box plots, presented on a logarithmic scale in
Figure 2.3, show that the sickness duration until death is skewed to the right. The
medians for ‘G4 Mental illness’, ‘G5 Nervous system & sensory organs’ and ‘G10
Musculoskeletal’ rank higher than the others.
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Figure 2.1: The box plots of sickness duration until recovery by sickness category for
each deferred period.
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Figure 2.2: Median of sickness duration until recovery by sickness category for each
deferred period.
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Figure 2.3: Box plots of sickness duration until death by sickness category.
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We show in Table 2.4 the number of recoveries expressed as percentages of the total
for each sickness duration interval by sickness category. In terms of the percentage
of the total recoveries that occur within the first eight weeks of sickness, it is 83%
and 92% for ‘G1 Infections & acute respiratory’ and ‘G7 Respiratory’, respectively,
between 55% and 63% for ‘G5 Nervous system & sensory organs’, ‘G8 Digestive’,
‘G9 Genito-urinary’ and ‘G12 All other known causes’, between 45% and 49% for
‘G3 Endocrine & Metabolic’, ‘G10 Musculoskeletal’ and ‘G11 Injuries’, 33% for ‘G6
Circulatory’, 31% for ‘G4 Mental illness’ and 26% for ‘G2 Neoplasms’. Both ‘G2
Neoplasms’ and ‘G4 Mental Illness’, with 18% and 24%, respectively, have the largest
percentage of their total number of recoveries remaining after one year.
Table 2.5 shows the number of deaths expressed as percentages of the total for
each sickness duration interval by sickness category. In contrast to the percentage of
recoveries in Table 2.4, a large percentage of deaths occur at longer sickness durations
for all sickness categories. At 33.3%, ‘G1 Infections & acute respiratory’ has the least
percentage of its total deaths remaining after one year, followed by ‘G8 Digestive’,
‘G2 Neoplasms’ and ‘G9 Genito-urinary’. The other eight sickness categories have
more than 50% of their total deaths remaining after one year.
Tables 2.6 and 2.8 show, respectively, the median of sickness duration until re-
covery and until death for each quadrennium by sickness category. The numbers of
recoveries and deaths used to derive these medians are presented in Table 2.7 and 2.9,
respectively. Apart from ‘G1 Infections & acute respiratory’, ‘G5 Nervous system &
sensory organs’, ‘G7 Respiratory’ and ‘G8 Digestive’, the median of sickness duration
until recovery generally increases over the quadrennia. For ‘G2 Neoplasms’ and ‘G6
Circulatory’, the two sickness categories which contain a significant number of deaths,
the median of sickness duration until death increases over the quadrennia.
Tables 2.10–2.19 show the exposed to risk of claim termination (recovery or death)
as a percentage of the total for each age group by sex and deferred period. For males,
‘G4 Mental illness’, ‘G6 Circulatory’ and ‘G10 Musculoskeletal’, in general, assume
greater importance than the other sickness categories. In particular, the exposed to
risk for ‘G6 Circulatory’ as a percentage of the total increases with age for males
across all deferred periods. The exposed to risk for ‘G11 Injuries’ dominates younger
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age groups. For females, both ‘G4 Mental illness’ and ‘G10 Musculoskeletal’ are the
two most important sickness categories in terms of exposed to risk. The exposed to
risk for ‘G1 Infections & acute respiratory’ is concentrated in the youngest age group
of DP1 for both sexes.
Tables 2.20–2.21 show for each sickness category the total exposed to risk of claim
termination (recovery or death), the number of recoveries and deaths as well as per-
centages of these totals by sex and rating indicator. We also present in each table
the median of sickness duration in days until recovery and deaths using all data and
subdivisions of it by sex and rating indicator. We note that
(i) Males’ exposed to risk is higher than females’ for all sickness categories.
(ii) With the exception of ‘G11 Injuries’, the exposed to risk for ‘non-rated’ is higher
than ‘rated’ for the other sickness categories
(iii) The median of sickness duration until recovery is higher in ‘rated’ than in ‘non-
rated’ for all sickness categories.
(iv) The median of sickness duration until recovery is noticeably higher in fe-
males than in males for ‘G2 Neoplasms’, ‘G4 Mental Illness’, ‘G3 Endocrine
& Metabolic’, ‘G9 Genito-urinary’ and ‘G12 All other known causes’. Apart
from ‘G6 Circulatory’, where the median for males is higher than females, the
median is broadly similar for both sexes for the remaining six sickness categories.
Figure 2.4 shows for each sickness category, the exposed to risk of claim termina-
tion (recovery or death) as a proportion of the total over each successive quadrennium
in 1975-2002. For all sickness categories, the percentage of exposed to risk spent in
the first sickness duration interval and last sickness duration interval decreases and
increases, respectively, over the quadrennia.
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Table 2.4: Percentages of recoveries for each sickness duration interval by sickness category.
G1 G2 G3 G4 G5 G6 G7 G8 G9 G10 G11 G12
1-2wks 48.09 6.24 14.09 6.63 24.64 7.43 61.30 8.59 18.09 16.31 10.61 21.64
2-4wks 22.47 8.59 14.60 9.39 18.94 11.36 22.09 16.67 16.75 14.13 11.14 15.90
4-8wks 12.50 10.81 18.46 15.47 19.19 14.67 8.86 31.87 25.12 18.20 24.14 18.07
8-13wks 6.23 11.59 12.58 11.95 10.38 14.31 3.23 18.12 17.52 14.43 18.15 12.27
13-26wks 5.78 20.88 14.77 16.65 10.52 24.53 2.31 15.68 13.64 16.72 19.27 14.47
26-39wks 1.78 15.70 8.72 9.85 4.19 10.03 0.67 4.16 4.15 6.32 6.97 5.13
39-1yr 0.92 8.55 4.03 6.48 2.69 4.85 0.45 1.63 1.61 3.61 3.01 3.13
1-2yrs 1.33 11.59 6.71 12.44 4.23 6.96 0.62 2.29 1.96 5.92 4.27 4.78
2-5yrs 0.80 5.31 4.70 8.43 3.46 4.11 0.34 0.70 0.92 3.41 1.96 3.24
5-12yrs 0.10 0.74 1.34 2.71 1.75 1.75 0.12 0.30 0.23 0.95 0.49 1.38
Total number
of recoveries 4,895 2,165 596 5,280 2,861 6,163 10,440 5,752 2,603 13,125 13,749 4,895
Table 2.5: Percentages of deaths for each sickness duration interval by sickness category.
G1 G2 G3 G4 G5 G6 G7 G8 G9 G10 G11 G12
1-2wks 2.56 0.17 0.00 0.97 0.00 0.91 1.94 0.88 0.00 0.00 0.00 0.73
2-4wks 0.00 0.34 0.00 0.97 0.00 0.91 2.91 3.54 0.00 0.72 0.00 2.92
4-8wks 5.13 2.49 2.08 0.97 1.03 4.01 1.94 7.96 14.29 2.88 3.53 4.38
8-13wks 5.13 4.87 2.08 1.93 1.55 3.10 4.85 5.31 1.79 3.60 7.06 5.11
13-26wks 28.21 16.15 8.33 6.76 6.19 8.56 5.83 15.04 16.07 5.76 8.24 10.22
26-39wks 12.82 17.62 6.25 3.86 5.15 6.92 12.62 13.27 12.50 5.04 12.94 13.14
39-1yr 12.82 13.03 12.50 5.80 3.09 4.74 13.59 11.50 7.14 5.04 12.94 8.76
1-2yrs 17.95 28.61 31.25 18.36 19.59 16.58 18.45 15.04 14.29 12.95 12.94 21.90
2-5yrs 10.26 13.82 20.83 26.57 29.38 28.60 21.36 18.58 17.86 32.37 23.53 21.17
5-12yrs 5.13 2.89 16.67 33.82 34.02 25.68 16.50 8.85 16.07 31.65 18.82 11.68
Total number
of recoveries 39 1,765 48 207 194 549 103 113 56 139 85 39
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Table 2.6: Median of sickness duration until recovery (days) for each quadrennium by sickness category.
G1 G2 G3 G4 G5 G6 G7 G8 G9 G10 G11 G12
75-78 15.0 73.0 46.0 62.5 39.0 79.0 13.0 44.0 37.0 44.5 47.0 31.5
79-82 15.0 73.0 65.0 85.5 39.0 84.0 13.0 47.0 35.0 47.0 51.0 34.0
83-86 15.0 103.0 61.0 89.0 41.0 92.0 13.0 48.0 42.0 59.0 58.0 32.0
87-90 15.0 96.5 55.5 82.5 38.0 93.5 12.0 55.0 48.0 59.0 62.0 56.0
91-94 14.0 154.0 68.0 127.0 43.0 115.0 11.0 59.0 55.0 64.0 76.0 70.5
95-98 14.0 199.0 85.0 190.0 22.0 111.0 11.0 48.0 46.0 63.0 78.0 88.0
99-02 13.0 265.0 106.5 252.5 31.0 125.0 11.0 52.0 60.5 90.0 90.0 90.0
Table 2.7: Number of recoveries for each quadrennium by sickness category.
G1 G2 G3 G4 G5 G6 G7 G8 G9 G10 G11 G12
75-78 861 212 85 594 350 874 2026 1101 382 1226 1902 734
79-82 766 231 77 518 388 887 1544 1014 343 1429 1780 711
83-86 1004 294 106 596 425 1022 1961 1014 444 1853 2506 1092
87-90 917 292 102 761 475 990 1806 939 458 2327 2991 915
91-94 691 364 81 862 460 997 1379 757 411 2610 2136 757
95-98 365 323 77 936 409 724 1045 478 344 1925 1272 435
99-02 293 449 68 1025 358 680 679 450 224 1761 1175 449
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Table 2.8: Median of sickness duration until death (days) for each quadrennium by sickness category.
G1 G2 G3 G4 G5 G6 G7 G8 G9 G10 G11 G12
75-78 107.0 214.0 307.0 184.0 491.0 592.0 228.0 79.0 49.0 53.0 140.0 194.5
79-82 181.0 220.5 521.0 1390.0 914.0 596.0 411.5 268.0 250.0 324.0 306.0 437.0
83-86 217.0 249.0 860.0 1312.0 1411.0 685.5 337.0 189.5 333.0 629.0 561.0 130.5
87-90 274.0 293.0 447.5 492.0 1130.0 881.0 274.0 468.0 748.0 655.0 791.0 409.0
91-94 447.0 328.0 501.0 1011.0 842.5 1020.0 580.0 522.0 196.0 1161.5 246.0 353.0
95-98 209.5 397.0 369.0 1272.0 1326.5 1373.0 2004.0 203.5 459.0 1338.0 839.0 1140.5
99-02 322.0 434.0 1338.5 1051.0 1616.5 1101.0 685.0 971.5 1595.0 2051.5 1574.0 1654.5
Table 2.9: Number of deaths for each quadrennium by sickness category.
G1 G2 G3 G4 G5 G6 G7 G8 G9 G10 G11 G12
75-78 4 127 3 16 21 63 15 12 5 7 4 16
79-82 6 146 7 19 22 61 14 25 10 9 7 11
83-86 5 193 7 17 35 89 13 14 4 9 16 17
87-90 9 281 8 37 28 113 22 20 8 17 20 27
91-94 5 327 13 57 38 82 25 20 12 32 18 31
95-98 8 340 6 38 45 82 9 10 15 31 12 18
99-02 3 353 4 36 31 63 5 14 4 39 12 18
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Table 2.10: Exposed to risk of claim termination (recovery or death) as percentage of
totals for each age group: Males - DP1.
Sickness Category 17-29 30-39 40-49 50-59 60-65 All ages
G1 Infections 10.7 6.4 2.3 1.5 1.3 2.3
G2 Neoplasms 2.0 1.2 3.6 4.2 6.2 3.9
G3 Endocrine & Metabolic 2.0 0.7 0.7 0.8 2.1 0.9
G4 Mental Illness 11.0 19.7 25.3 18.6 8.1 19.2
G5 Nervous 4.4 12.3 9.0 7.4 10.1 8.5
G6 Circulatory 0.8 6.1 17.0 28.6 34.3 23.5
G7 Respiratory 11.8 8.3 4.4 3.7 6.0 4.7
G8 Digestive 3.5 3.0 2.9 3.0 4.4 3.2
G9 Genito-Urinary 0.7 1.0 1.2 1.6 2.5 1.5
G10 Musculoskeletal 17.7 19.7 21.4 22.1 16.9 21.0
G11 Injuries 25.6 16.5 8.1 4.6 5.4 7.2
G12 All others 9.8 5.2 4.1 3.8 2.6 4.0
Total exposed to 100,557 487,956 1,299,354 2,629,099 539,422 5,056,388
risk (days)
Table 2.11: Exposed to risk of claim termination (recovery or death) as percentage of
totals for each age group: Male - DP4.
Sickness Category 17-29 30-39 40-49 50-59 60-65 All ages
G1 Infections 1.8 2.3 1.0 0.6 1.0 1.2
G2 Neoplasms 1.7 3.3 4.0 5.6 8.2 4.5
G3 Endocrine & Metabolic 0.4 0.5 0.9 1.8 1.5 1.2
G4 Mental Illness 12.0 14.2 15.0 14.1 8.7 14.0
G5 Nervous 5.0 8.9 8.3 6.8 7.2 7.6
G6 Circulatory 2.0 6.5 14.7 26.8 34.2 17.7
G7 Respiratory 2.1 1.7 2.6 2.8 5.8 2.6
G8 Digestive 4.0 2.7 3.9 2.6 3.3 3.2
G9 Genito-Urinary 0.6 0.8 1.0 1.3 1.2 1.0
G10 Musculoskeletal 22.8 27.7 26.0 25.2 19.3 25.5
G11 Injuries 39.8 24.8 17.0 7.5 5.2 15.8
G12 All others 7.9 6.6 5.6 4.9 4.4 5.6
Total exposed to 572,618 1,958,324 3,035,909 3,581,860 477,553 9,626,264
risk (days)
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Table 2.12: Exposed to risk of claim termination (recovery or death) as percentage of
totals for each age group: Male - DP13.
Sickness Category 17-29 30-39 40-49 50-59 60-65 All ages
G1 Infections 0.9 1.2 1.3 0.6 1.2 1.0
G2 Neoplasms 2.1 3.6 5.1 5.6 10.4 5.2
G3 Endocrine & Metabolic 2.6 1.3 1.5 1.6 1.9 1.6
G4 Mental Illness 11.8 19.1 18.1 16.7 6.6 16.8
G5 Nervous 4.2 11.2 10.6 9.1 8.7 9.8
G6 Circulatory 4.4 7.0 15.3 26.8 33.6 19.3
G7 Respiratory 1.1 1.5 1.6 2.4 4.2 2.0
G8 Digestive 2.4 2.0 2.5 2.4 1.7 2.3
G9 Genito-Urinary 0.9 1.1 0.9 0.9 1.2 0.9
G10 Musculoskeletal 24.2 23.8 23.3 22.0 23.5 22.9
G11 Injuries 35.3 20.1 13.4 6.5 3.0 11.8
G12 All others 10.1 8.1 6.5 5.5 4.0 6.3
Total exposed to 348,802 1,726,361 3,453,957 4,176,970 589,271 10,295,361
risk (days)
Table 2.13: Exposed to risk of claim termination (recovery or death) as percentage of
totals for each age group: Male - DP26.
Sickness Category 17-29 30-39 40-49 50-59 60-65 All ages
G1 Infections 4.1 2.3 1.2 1.2 0.3 1.3
G2 Neoplasms 4.5 6.0 3.5 3.9 9.9 4.4
G3 Endocrine & Metabolic 2.4 2.5 1.3 1.6 2.5 1.7
G4 Mental Illness 26.4 21.9 29.0 21.4 7.6 23.3
G5 Nervous 10.6 13.8 11.5 9.3 10.8 10.6
G6 Circulatory 2.7 5.3 17.1 30.5 35.0 23.2
G7 Respiratory 0.0 1.1 2.1 2.4 5.7 2.3
G8 Digestive 1.8 1.7 2.3 1.6 1.7 1.8
G9 Genito-Urinary 0.7 1.1 0.5 1.0 0.5 0.8
G10 Musculoskeletal 16.8 19.2 16.2 17.8 19.2 17.5
G11 Injuries 18.6 16.7 7.8 4.2 2.2 6.8
G12 All others 11.4 8.5 7.5 5.0 4.7 6.3
Total exposed to 145,293 920,185 2,948,554 4,283,308 515,025 8,812,365
risk (days)
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Table 2.14: Exposed to risk of claim termination (recovery or death) as percentage of
totals for each age group: Male - DP52.
Sickness Category 17-29 30-39 40-49 50-59 60-65 All ages
G1 Infections 0.9 0.4 1.2 0.7 0.5 0.8
G2 Neoplasms 3.0 3.1 4.4 3.5 9.2 4.0
G3 Endocrine & Metabolic 0.0 2.6 1.0 1.0 2.6 1.2
G4 Mental Illness 22.1 27.4 35.4 25.8 8.3 28.2
G5 Nervous 3.5 10.6 12.3 8.6 7.9 9.9
G6 Circulatory 0.6 4.9 10.4 27.8 34.0 19.7
G7 Respiratory 4.0 1.7 0.8 1.3 4.8 1.4
G8 Digestive 0.0 1.2 1.5 1.6 2.5 1.5
G9 Genito-Urinary 0.0 0.5 0.2 0.8 1.3 0.6
G10 Musculoskeletal 17.3 28.0 16.2 19.1 19.7 18.9
G11 Injuries 31.8 8.0 7.8 3.6 2.3 5.9
G12 All others 16.9 11.6 8.9 6.2 6.9 7.8
Total exposed to 72,736 299,603 1,211,592 1,800,952 178,182 3,563,065
risk (days)
Table 2.15: Exposed to risk of claim termination (recovery or death) as percentage of
totals for each age group: Female - DP1.
Sickness Category 17-29 30-39 40-49 50-59 60-65 All ages
G1 Infections 11.8 4.4 2.0 2.0 0.4 3.3
G2 Neoplasms 2.6 3.4 7.0 5.5 6.0 5.3
G3 Endocrine & Metabolic 1.1 2.0 0.8 3.9 0.0 2.1
G4 Mental Illness 10.5 10.5 13.1 14.8 19.8 13.1
G5 Nervous 1.7 4.5 6.2 11.4 4.2 7.2
G6 Circulatory 0.4 12.2 3.6 7.9 10.7 6.8
G7 Respiratory 9.7 9.2 5.0 3.1 3.2 5.6
G8 Digestive 4.7 2.2 5.0 1.5 0.0 3.1
G9 Genito-Urinary 2.0 6.5 9.3 4.1 0.7 6.1
G10 Musculoskeletal 20.3 12.6 29.7 37.8 16.8 27.6
G11 Injuries 19.9 19.0 10.8 5.6 26.4 12.0
G12 All others 15.5 13.4 7.5 2.3 11.9 7.8
Total exposed to 36,379 90,894 147,130 144,377 11,973 430,753
risk (days)
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Table 2.16: Exposed to risk of claim termination (recovery or death) as percentage of
totals for each age group: Female - DP4.
Sickness Category 17-29 30-39 40-49 50-59 60-65 All ages
G1 Infections 1.5 2.4 1.4 1.2 0.0 1.6
G2 Neoplasms 5.3 3.6 9.4 10.5 8.8 7.6
G3 Endocrine & Metabolic 0.8 1.8 1.4 0.8 0.0 1.3
G4 Mental Illness 22.4 20.2 20.4 13.7 17.4 19.3
G5 Nervous 0.9 10.8 7.7 7.8 7.3 7.7
G6 Circulatory 2.0 6.0 6.4 3.5 25.5 5.3
G7 Respiratory 1.2 0.8 0.8 2.2 0.1 1.1
G8 Digestive 3.1 4.2 1.5 1.2 10.5 2.4
G9 Genito-Urinary 5.1 4.2 5.2 3.8 6.0 4.6
G10 Musculoskeletal 24.8 21.1 26.2 29.6 8.0 25.2
G11 Injuries 21.2 12.8 11.3 9.4 15.7 12.7
G12 All others 11.6 12.0 8.3 16.3 0.6 11.3
Total exposed to 1,707,59 345,058 517,799 263,949 9,391 1,306,956
risk (days)
Table 2.17: Exposed to risk of claim termination (recovery or death) as percentage of
totals for each age group: Female - DP13.
Sickness Category 17-29 30-39 40-49 50-59 60-65 All ages
G1 Infections 1.8 2.2 0.8 1.0 0.0 1.3
G2 Neoplasms 2.3 7.3 11.1 10.3 5.2 9.1
G3 Endocrine & Metabolic 2.1 4.0 1.5 2.4 0.0 2.4
G4 Mental Illness 26.0 25.1 27.0 17.2 0.0 23.9
G5 Nervous 8.3 9.6 8.0 6.7 0.0 8.1
G6 Circulatory 6.6 2.8 4.2 9.9 13.7 5.5
G7 Respiratory 3.6 1.7 2.3 1.8 0.3 2.1
G8 Digestive 3.3 1.6 2.1 1.0 12.4 1.8
G9 Genito-Urinary 1.9 2.0 1.9 3.5 0.0 2.3
G10 Musculoskeletal 18.9 19.9 24.0 30.8 68.1 24.3
G11 Injuries 10.3 10.7 7.6 6.8 0.3 8.4
G12 All others 14.9 13.1 9.4 8.6 0.0 10.7
Total exposed to 163,422 436,809 683,209 416,496 8,695 1,708,631
risk (days)
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Table 2.18: Exposed to risk of claim termination (recovery or death) as percentage of
totals for each age group: Female - DP26.
Sickness Category 17-29 30-39 40-49 50-59 60-65 All ages
G1 Infections 0.9 3.2 0.8 1.0 0.0 1.4
G2 Neoplasms 4.6 5.8 6.9 8.8 8.6 7.1
G3 Endocrine & Metabolic 5.4 2.6 2.0 2.0 1.5 2.3
G4 Mental Illness 31.7 31.0 33.3 23.8 21.1 29.7
G5 Nervous 5.4 8.2 9.4 9.9 13.3 9.1
G6 Circulatory 3.9 3.7 5.7 8.2 17.2 6.0
G7 Respiratory 0.6 0.5 0.6 2.2 7.3 1.1
G8 Digestive 0.0 2.5 2.5 1.6 0.0 2.1
G9 Genito-Urinary 1.0 0.7 2.3 1.3 0.0 1.6
G10 Musculoskeletal 24.9 22.6 23.0 29.3 30.8 25.0
G11 Injuries 7.1 5.0 4.6 4.2 0.3 4.7
G12 All others 14.4 14.4 9.0 7.6 0.0 10.0
Total exposed to 124,062 490,698 1,008,985 727,423 8,303 2,359,471
risk (days)
Table 2.19: Exposed to risk of claim termination (recovery or death) as percentage of
totals for each age group: Female - DP52.
Sickness Category 17-29 30-39 40-49 50-59 60-65 All ages
G1 Infections 0.0 2.6 1.4 0.4 0.0 1.2
G2 Neoplasms 11.9 4.1 5.9 6.2 29.9 5.9
G3 Endocrine & Metabolic 7.1 1.1 2.8 0.9 0.0 2.1
G4 Mental Illness 22.9 35.0 36.2 27.2 0.0 32.6
G5 Nervous 1.4 6.7 8.1 9.4 0.0 7.9
G6 Circulatory 11.4 4.3 4.6 9.5 0.0 6.4
G7 Respiratory 0.0 0.4 0.9 2.5 24.7 1.3
G8 Digestive 2.4 1.1 2.6 0.7 0.0 1.7
G9 Genito-Urinary 0.6 1.2 0.8 1.2 0.0 1.0
G10 Musculoskeletal 15.7 19.6 20.9 31.0 45.4 23.6
G11 Injuries 11.5 10.3 4.1 3.4 0.0 5.4
G12 All others 15.2 13.6 11.9 7.5 0.0 11.0
Total exposed to 56,234 236,005 573,450 394,718 1,065 1,261,472
risk (days)
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Table 2.20: Exposed to risk of claim termination (recovery or death), number of
recoveries and deaths, median of sickness duration until recovery and death for sickness
categories G1 – G6.
Exposed to Number Median of sickness duration (days)
risk (days) recovery death recovery death
G1 Infections & acute respiratory
Total 527,121 4,895 39 15.0 257.0
Male 81.47 85.58 100.00 15.0 257.0
Female 18.53 14.42 0.00 16.0 NA
Non-rated 72.25 91.62 74.36 14.0 274.0
Rated 27.75 8.38 25.64 65.5 195.5
G2 Neoplasms
Total 2,188,366 2,165 1,765 139.0 328.0
Male 76.56 73.44 86.40 128.5 306.0
Female 23.44 26.56 13.60 181.0 437.0
Non-rated 70.68 79.17 74.16 118.5 328.0
Rated 29.32 20.83 25.84 202.0 330.0
G3 Endocrine & Metabolic
Total 640,812 596 48 63.0 539.0
Male 77.52 79.87 85.42 56.5 521.0
Female 22.48 20.13 14.58 111.5 818.0
Non-rated 67.76 76.68 91.67 48.0 539.0
Rated 32.24 23.32 8.33 103.0 1147.0
G4 Mental Illness
Total 8,616,813 5,280 207 119.0 1061.0
Male 79.20 80.64 89.37 104.0 1063.0
Female 20.80 19.36 10.63 212.5 1004.5
Non-rated 79.45 80.30 88.89 100.0 1072.0
Rated 20.55 19.70 11.11 194.0 695.0
G5 Nervous
Total 3,795,765 2,861 194 35.0 1094.0
Male 85.25 87.14 94.33 35.5 1127.0
Female 14.75 12.86 5.67 34.5 949.0
Non-rated 72.92 82.17 78.87 26.0 964.0
Rated 27.08 17.83 21.13 97.0 1449.0
G6 Circulatory
Total 7,773,247 6,163 549 96.0 843.0
Male 94.92 95.31 98.18 98.0 843.0
Female 5.08 4.69 1.82 62.0 786.0
Non-rated 75.35 78.26 80.51 87.0 881.0
Rated 24.65 21.74 19.49 136.0 762.0
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Table 2.21: Exposed to risk of claim termination (recovery or death), number of
recoveries and deaths, median of sickness duration until recovery and death for sickness
categories G7 – G12.
Exposed to Number Median of sickness duration (days)
risk (days) recovery death recovery death
G7 Respiratory
Total 955,585 10,440 103 12.0 509.0
Male 88.97 86.59 93.20 12.0 520.0
Female 11.03 13.41 6.80 13.0 396.0
Non-rated 65.94 92.28 73.79 12.0 513.0
Rated 34.06 7.72 26.21 47.0 396.0
G8 Digestive
Total 1,016,999 5,752 113 49 309.0
Male 86.29 92.65 97.35 49 294.0
Female 13.71 7.35 2.65 54 539.0
Non-rated 59.83 68.29 66.37 39 329.0
Rated 40.17 31.71 33.63 75 300.0
G9 Genito-Urinary
Total 509,259 2,603 56 45.0 304.5
Male 67.77 67.61 91.07 35.0 301.0
Female 32.23 32.39 8.93 69.0 308.0
Non-rated 69.35 85.25 64.29 39.0 259.0
Rated 30.65 14.75 35.71 88.5 355.0
G10 Musculoskeletal
Total 9,519,873 13,125 139 59.0 1179.0
Male 82.25 88.58 90.65 58.0 1192.0
Female 17.75 11.42 9.35 69.0 828.0
Non-rated 52.19 65.67 66.19 34.0 1161.5
Rated 47.81 34.33 33.81 115.0 1205.0
G11 Injuries
Total 4,234,648 13,749 85 62.0 519.0
Male 87.86 90.89 97.65 62.0 519.0
Female 12.14 9.11 2.35 65.0 1419.5
Non-rated 42.49 55.07 60.00 42.0 764.0
Rated 57.51 44.93 40.00 89.0 363.5
G12 All others
Total 2,857,232 5,087 137 47.0 409.0
Male 74.77 79.91 90.51 42.0 390.5
Female 25.23 20.09 9.49 77.0 1101.0
Non-rated 64.48 72.03 71.53 28.0 415.5
Rated 35.52 27.97 28.47 90.0 409.0
47
0.0 0.2 0.4 0.6 0.8 1.0
>5yrs
3−5yrs
2−3yrs
1−2yrs
26wks−1yr
13−26wks
4−13wks
1−4w
ks
G
1 Infections
G
2 Neoplasm
G
3 Endocrine
G
4 M
ental
G
5 Nervous
G
6 Circulatory
G
7 Resp.(cs39−41)
75−78
75−78
75−78
75−78
75−78
75−78
75−78
79−82
79−82
79−82
79−82
79−82
79−82
79−82
83−86
83−86
83−86
83−86
83−86
83−86
83−86
87−90
87−90
87−90
87−90
87−90
87−90
87−90
91−94
91−94
91−94
91−94
91−94
91−94
91−94
95−98
95−98
95−98
95−98
95−98
95−98
95−98
99−02
99−02
99−02
99−02
99−02
99−02
99−02
0.0 0.2 0.4 0.6 0.8 1.0
>5yrs
3−5yrs
2−3yrs
1−2yrs
26wks−1yr
13−26wks
4−13wks
1−4w
ks
G
7 Resp.(cs42−45)G
8 Digestive
G
9 G
enito−urinary
G
10 M
usculo.
G
11 Injuries
G
12 All O
thers
75−78
75−78
75−78
75−78
75−78
75−78
79−82
79−82
79−82
79−82
79−82
79−82
83−86
83−86
83−86
83−86
83−86
83−86
87−90
87−90
87−90
87−90
87−90
87−90
91−94
91−94
91−94
91−94
91−94
91−94
95−98
95−98
95−98
95−98
95−98
95−98
99−02
99−02
99−02
99−02
99−02
99−02
F
igu
re
2.4:
B
arp
lots
sh
ow
in
g
th
e
ex
p
osed
to
risk
as
p
rop
ortion
of
totals
for
each
sick
n
ess
d
u
ration
in
terval
b
y
q
u
ad
ren
n
iu
m
an
d
sick
n
ess
category.
48
Chapter 3
Modelling the Recovery Intensity
3.1 Introduction
The purpose of this chapter is to present methods and results fot the estimation of the
recovery intensity model by cause of sickness using the IPI claim data by ICD8 cause
as described in Chapter 2. In terms of substantial work done on the analysis of IPI
claim experience by cause of sickness, CMI Working Paper 23 (2006) examined the
variation of sickness experience by quadrennium, deferred period and occupational
class for each sickness category, separately for both sexes, using IPI ‘standard*’ data
from 1991–2002. The sickness categories employed by CMI Working Paper 23 (2006)
and the causes of sickness (represented by their ICD8 code) which constitute each
sickness category are presented in Table 2.2. This one-way analysis of claim experience
is conducted by comparing the ratio between the actual number (A) of recoveries and
deaths and that expected (E) under SM1975–78. The key conclusions from this report
are as follows:
(i) There is a wide variation in both recovery and mortality from sick experience
by sickness category. The 100A/E values for ‘Infections & acute respiratory’,
‘Digestive’ and ‘Genito-urinary’ are relatively higher than the rest of the sickness
categories.
(ii) The 100A/E values for recoveries for each sickness category and both sexes
decline over the quadrennia.
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(iii) There is a general trend of slight reduction in 100A/E values for recoveries
with increasing deferred period in each sickness category with the exception
that 100A/E values for recoveries increase with longer deferred period for ‘Neo-
plasms’.
(iv) There is little variation in both recovery and mortality from sick experience by
occupational class in all sickness categories with the exception that the occupa-
tional class 1 100A/E values for recoveries for ‘Musculoskeletal’ and ‘Injuries’
are slightly higher than those of the other occupational classes.
The marginal analyses presented in CMI Working Paper 23 (2006) do not shed
light on how the covariates jointly relate to the recovery and mortality intensities from
sick. We therefore require a regression-type model to incorporate the dependence of
recovery intensity on covariates. There are examples of regression-type models in in-
surance modelling. In respect of long-term care insurance, Czabo and Rudolph (2002)
studied the effect of the covariates on the transition intensities between possible states
by using the Cox regression model (Cox, 1972). Jones (1997) also presented the Cox
model approach and demonstrated the methodology in analysing continuing care re-
tirement community (CCRC) data. Pitt (2007) used a mixture parametric regression
model that takes into account the probability of being totally and permanently dis-
abled in the modelling of claim duration for IPI policyholders.
We let the recovery intensity model for a specific cause of sickness take on a mul-
tiplicative structure consisting of a baseline intensity and a relative risk component.
The baseline intensity, denoted by ρ0(z), is a function of sickness duration z alone.
The relative risk component, represented by exp(xβ(z)), describes the multiplicative
covariate effects of sex, age, deferred period, rating indicator and calendar year (de-
noted by covariate vector x), where β(z) represents the vector of duration-varying
coefficients of x. We make such an allowance because when aggregate data from
all causes of sickness is analysed, there is evidence that some of the covariate effects
are duration-dependent (see Section 1.5). Thus, the recovery intensity for a particular
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cause of sickness, allowing for the possible duration-varying effects of covariates, can
be written as
ρ(z,x) = ρ0(z) exp(xβ(z)) . (3.1)
The parameterisation of the recovery intensity model is split into three stages.
The first stage, presented in Section 3.2 involves estimating the relative risk, a task
that includes
(i) Assuming a proportional hazards (PH) model for the recovery intensity (i.e.
β(z) = β ) and selecting which covariates to include in the relative risk.
(ii) Testing the PH assumption for the covariates.
(iii) Relaxing the PH assumption, if necessary, by modelling the duration-varying
effect of the covariates.
The second stage is about finding a suitable parametric formula for the baseline
intensity while the last stage involves estimating all the parameters in the recovery
intensity model by using maximum likelihood estimation. These last two stages are
described in Sections 3.3 and 3.4, respectively. The goodness-of-fit of the estimated
model is assessed by using methods presented in Section 3.5. Finally, the estimated
recovery intensity models for several causes of sickness are presented in Section 3.6,
with the remainders given in Appendix B.
3.2 Parameterisation of the Relative Risk
The Cox PH model
As a starting point, the covariate effects are assumed to stay constant for all sickness
durations z. Let β denote the vector of duration-fixed regression coefficients. We
therefore have a PH model for the recovery intensity given by
ρ(z,x) = ρ0(z) exp(xβ) (3.2)
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The Cox PH model (Cox, 1972) enables the estimation of β without making any
assumption about the functional form of ρ0(z) through the use of the partial likelihood,
Lp(β), as given by
Lp(β) =
r∏
j=1
exp(x(j)β)∑
l∈R(z(j)) exp(xlβ)
(3.3)
where {z(j)} is the set of unique event times, sorted in ascending order such that
z(1) < z(2) < · · · < z(r), R(z(j)) denotes the set of individuals at risk at event time z(j),
x(j) denotes the covariate vector for the individual who experiences the event at time
z(j) and xl denotes the covariate vector of individuals belonging to each risk set.
The log partial likelihood obtained by taking the log on both sides of Equation (3.3)
is given by lp(β), where
lp(β) = logLp(β) =
r∑
j=1
xjβ − log
 ∑
l∈R(z(j))
exp(xlβ)

 . (3.4)
While the partial likelihood does not use all the information available from the
data (information between event times is discarded), it has been shown to maintain
the properties of a full likelihood (Andersen and Gill, 1982). The estimate of β,
βˆ, found by maximising either Lp(β) or lp(β) is asymptotically normal, consistent,
efficient and unbiased.
The partial likelihood in Equation (3.3) is developed by treating time as continuous
and assuming that there are no ties in the event times. The recovery time in the IPI
claim data is measured in days and it is very common to find more than one recovery
at any event time. The exact partial likelihood for ties in event time is based on a
discrete time process where events do happen at exactly the same time. For each risk
set R(z(j)), let dj be the number of tied recoveries at event time z(j) and let D(z(j))
denote the set of dj tied recoveries. Let Q(z(j)) be the set of all possible subsets of dj
individuals which can be selected from R(z(j)). The exact partial likelihood is given
by
Lp(β) =
r∏
j=1
∏
k∈D(z(j)) exp(xkβ)∑
l∈Q(z(j)) exp(xlβ)
. (3.5)
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This method involves numerous permutations of the possible risk set at each tied
event time and can be very time consuming to calculate if there is a large number
of events at each tied event time. For example, if there were 20 tied recoveries at a
particular recovery time from a pool of 60 individuals in the risk set, the sum in the
denominator would be over all
(
60
20
)
subsets, which is computationally prohibitive to
calculate.
We will use Efron’s approximation (1977) to the exact partial likelihood. Efron’s
approximation treats time as continuous and ties happen because of imprecise mea-
surement. To explain the intuition behind Efron’s approximation, suppose that there
are four individuals in a particular risk set with a tied recovery time happening to
individuals 1 and 4. The risk set for the first recovery will contain all four individuals.
If the first recovery were to happen to individual 1, then the risk set for the second
recovery would consist of individuals 2, 3 and 4. On the other hand, if individual 4
were to recover first, the risk set for the second recovery would consist of individuals
1, 2 and 3. Since both cases are equally likely to happen, each of the two possible risk
sets has a probability of 0.5 of being the second risk set. Efron’s approximate partial
likelihood is given by
Lp(β) =
r∏
j=1
∏
k∈D(z(j)) exp(xkβ)∏dj
g=1
[∑
l∈R(z(j)) exp(xlβ)−
g−1
dj
∑
l∈D(z(j)) exp(xlβ)
] . (3.6)
Selection of covariates
The information provided in each individual claim record is presented in Section 2.2.
Table 3.1 gives a description of the information which can be included as explanatory
variables in the regression model for the recovery intensity.
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Table 3.1: The potential explanatory variables for the recovery intensity model.
Predictor Description
Age Age at sickness inception (17-69)
Year Attained calendar year (1975-2002)
Rating Indicator Indicator variable for rated; rated=1, non-rated=0
Sex Indicator variable for female; female=1, male=0
Deferred Period Possible values are deferred period of 1 week (DP1),
4 weeks (DP4), 13 weeks (DP13), 26 weeks (DP26)
and 52 weeks (DP52)
Both age and year are continuous covariates and, for computational stability, their
values are scaled and are represented by xage and xyear respectively, where
xage = (age− 43)/26, xyear = (year− 1988)/13
so that xage ranges from -1 to 1 when age ranges from 17 to 69 and xyear ranges from
-1 to 1.076923 (≈ 1) when year ranges from 1975 to 2002.
The age and calendar year effects are modelled by using Chebycheff polynomi-
als. The Chebycheff polynomial Cn(xage) of degree n is generated by the following
recurrence relation
C0(xage) = 1, C1(xage) = xage, Cn+1(xage) = 2(xage)Cn(xage)−Cn−1(xage) for n ≥ 1
so that by denoting xagei = Ci(xage), i = 2, 3, 4
xage0 = 1, xage1 = xage, xage2 = 2x
2
age−1, xage3 = 4x3age−3xage, xage4 = 8x4age−8x2age+1,
are approximately an orthogonal basis (see Forfar et al, 1988). The Chebycheff poly-
nomials for xyear are constructed and defined in the same manner.
54
The discrete covariates sex, rated and deferred period are coded in the following way:
xsex =
 1 for female0 for male xrated =
 1 for rated0 for non-rated
xdp4 =
 1 for DP40 for other deferred periods xdp13 =
 1 for DP130 for other deferred periods
xdp26 =
 1 for DP260 for other deferred periods xdp52 =
 1 for DP520 for other deferred periods
Let S be the set comprising the covariates in Table 3.1, the Chebycheff polynomials
of age and year up to degree four and all possible interaction terms. To determine
which covariates in S to include in the Cox model, we rely on the Akaike Information
Criterion (AIC) (Akaike, 1974) defined by
AIC = −2 log(Lp(βˆ)) + 2n (3.7)
where Lp(βˆ) is the partial likelihood evaluated at the estimated coefficient vector
βˆ and n is the number of parameters in the model. The AIC values from models
fitted with varying numbers and combinations of covariates from S are compared
and the model that gives the lowest AIC value is selected. This model selection
procedure is carried out by using the ‘stepAIC’ function in the ‘R’ statistical package
which enables various models to be explored and their AIC values compared in an
automated manner. It is should be noted that selection of covariates based on AIC
may lead to inclusion of non-significant or marginally significantly covariates.
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Testing of PH assumptions
The key assumption in using the Cox model is that the PH assumptions for all the
covariates are valid. Suppose that a Cox regression model is fitted with n covariates
and let βˆ be the vector of estimated regression coefficients. The Schoenfeld residual
(Schoenfeld, 1982) is useful for identifying violation of proportionality assumption.
It compares the observed and expected covariate value and is calculated for each
covariate at observed event times. The Schoenfeld residual, rsji , is defined as the jth
covariate value for the individual who experiences the event at time zi, x
(i)
j , minus its
expected value at that time, aˆ
(i)
j . This expected value is a weighted average of the
covariate, with the weight given by the likelihood of risk for each individual in the
risk set at the event time. Hence
rsji = x
(i)
j − aˆ(i)j (3.8)
where
aˆ
(i)
j =
∑
l∈R(zi) xjl exp(xlβˆ)∑
l∈R(zi) exp(xlβˆ)
. (3.9)
The Schoenfeld residulas assess the relative magnitude of an individual’s covariate
value in comparison to what we expect given his or her event time. If the propor-
tionality assumption holds, the Schoenfeld residuals will be unrelated to time and a
plot of the Schoenfeld residuals versus observed event time should reveal no consistent
trend.
Let rsi= (rs1i , rs2i , . . . , rsni)
T denote the vector of Schoenfeld residuals. The scaled
Schoenfeld residuals as proposed by Therneau and Grambsch (1994), r∗sji , are the
improved version of the original Schoenfeld residuals and are the components of the
vector
r∗si = drvar(βˆ)rsi (3.10)
where dr is the total number of recoveries and var(βˆ) is the variance-covariance ma-
trix of the parameter estimates in the fitted Cox regression model. Therneau and
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Grambsch (1994) show that
E(r∗sji) + βˆj ≈ βj(zi) (3.11)
where βˆj is the Cox’ estimate for βj and βj(z) is the duration-varying coefficient.
By plotting r∗sji + βˆj against event time zi or some function of event time g(zi),
we obtain an approximation to the functional form of βj(z). Interpretation of such a
plot is facilitated by using smoothing splines on the residuals. If the PH assumption
is valid, such a smoothed plot should reveal a horizontal line that suggests that the
coefficient of xj stays constant for all durations. Otherwise, the examination of such a
plot will reveal the form of deviation from the PH assumption. There exists a formal
test, developed by Grambsch and Therneau (1994), to detect a linear relationship
between the scaled Schoenfeld residuals and g(z). The test statistic used in this test
is shown to be analogous to the standard test of assessing the correlation between
two variables and has an asymptotic χ21 distribution when the PH assumption is true.
However, this test may fail to detect a non-linear association between these residuals
and g(z). It is therefore recommended to examine graphically the smoothed plot
of scaled Schoenfeld residuals. Hess (1995) advocates the smoothed plots of scaled
Schoenfeld residuals following a review of eight graphical methods of assessing the PH
assumption on three different data sets.
Estimation of coefficients using GLM
To estimate the duration-varying coefficients, the functional form of duration depen-
dency of the coefficient must be specified parametrically. Suppose that the coefficient
of covariate x varies with duration z and is included in the model as xβ(z) where
β(z) = β0 + β1f(z). The functional form of f(z) can be specified by examining the
smoothed plot of the scaled Schoenfeld residuals. The term xβ(z) can also be writ-
ten as xβ0 + x(z)β1 where x(z) = xf(z) is a duration-dependent variable. Thus,
estimating β(z) involves estimating the coefficients of x and xf(z). The Cox model,
developed assuming PH (i.e. constant coefficients for the covariates), can be extended
to estimate a duration-varying coefficient by expressing it as the constant coefficient
of a suitably defined duration-dependent covariate.
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As the partial likelihood in Equation (3.3) requires the relative risk of every indi-
vidual in the risk set at each ordered event time to be included in the denominator,
the duration-dependent covariate has to be evaluated at every event time over the
follow-up time of each individual claim record. Thus, a set of pseudo-observations de-
signed to accommodate this duration-varying covariate has to be generated for each
individual claim record. Depending on the size of the original data set and the form
of the duration-dependent covariates used, such an exercise can potentially increase
the size of the data set to the extent that estimation of parameters is no longer
computationally viable.
To reduce data storage and computational time, we can group the data according
to their covariate pattern (distinct combinations of the covariate values) and estimate
the parameters by using the grouped data version of the Cox partial likelihood. From
the original individual claim records, the data is cross classified by sex (2 levels: male
and female), deferred period (5 levels: 1, 4, 13, 26 and 52 weeks), occupational rating
(2 levels: rated and non-rated), age last birthday at sickness inception (49 levels: 20
to 69), calendar year (28 levels: 1975 to 2002) and sickness duration partitioned into
149 discrete intervals of
• single days from 7 to 133 days (or 19 weeks) of sickness (i.e. intervals of 7–8
days, 8–9 days, . . ., 132–133 days).
• single weeks from 19 weeks to 30 weeks of sickness (i.e. intervals of 19–20
weeks, 20–21 weeks, . . ., 29–30 weeks) followed by intervals of 30–39 weeks and
39 weeks–1 year.
• single years from 1 year to 8 years of sickness (i.e intervals of 1–2 years, 2–3
years , . . ., 7–8 years) followed by 8–12 years and 12–16 years.
We refer the above partition of sickness duration as partitioning system A to
differentiate it from other types of partition found in later sections. The exposed-to-
risk and the number of recoveries for each distinct combination of covariate pattern,
indexed by l, and sickness duration interval, indexed by m, are calculated and are
denoted by rlm and dlm respectively. Let zm be the mid-point of the mth sickness
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duration interval. In grouped data, the duration-dependent covariate x(zm) = xf(zm)
is treated as an interaction term between the covariate x and f(zm). With duration-
varying coefficients expressed in terms of duration-dependent covariates, the grouped
data version of Cox’s partial likelihood, Lg(β), is given by
Lg(β) =
∏
l,m
(
exp(xl(zm)βg)∑
l rlm exp(xl(zm)βg)
)dlm
. (3.12)
Although the use of grouped data will result in the loss of efficiency in parameter
estimation due to discretisation of continuous covariates, the reduction in computa-
tional time outweighs this drawback. Breslow (1985) compared the grouped and con-
tinuous Cox model analysis using the Montana smelter workers data set and found
that both approaches give similar results. He also commented on the considerable
saving in computational time by using the grouped data.
There is a total of 149 sickness duration intervals. Holford (1976) showed that
Equation (3.12) can be obtained by assuming that the baseline intensity in each
sickness duration interval is constant. To illustrate this, we let the sickness duration
interval cut-points be τm (m = 1, . . . ,M) and set ρ0(z) = ρm for m ∈ [τm−1, τm). The
likelihood of the data is given by
L =
∏
l,m
exp(−rlmρm exp(xl(zm)β))(ρm exp(xl(zm)β))dlm . (3.13)
The log likelihood of the data obtained by taking logs on both sides of Equation (3.13)
is given by
logL =
∑
l,m
{−rlmρm exp(xl(zm)β) + dlm log(ρm) + dlmxl(zm)β} . (3.14)
Setting the derivative of Equation (3.14) with respect to ρm equal to zero yields
ρˆm =
∑
l dlm∑
l rlm exp(xl(zm)β)
(3.15)
which can be substituted into Equation (3.14) to give
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logL(β) =
∑
l,m
dlm(xl(zm)β)−
∑
m
(∑
l
dlm
)
log
(∑
l
rlm exp(xl(zm)β)
)
+C (3.16)
where C is a constant term. By exponentiating Equation (3.16), we obtain Equation
(3.12).
Holford (1980) and Laird and Oliver (1981) pointed out that we can maximise the
likelihood in Equation (3.13) by using a Poisson regression model in the GLM. To
illustrate this, we assume that the observed number of recoveries dlm follows a Poisson
distribution with mean
µlm = E(dlm) = rlmρm exp(xl(zm)β) . (3.17)
The kernel of the likelihood by treating dlm with the above mean coincides with the log
likelihood under a piece-wise constant baseline intensity in Equation (3.13). Taking
logs on both sides of Equation (3.17), we obtain
log(µlm) = log(rlm) + log(ρm) + xl(zm)β . (3.18)
As Equation (3.12) is also the maximum likelihood estimator for β in a Poisson
regression model, we can use a GLM with a Poisson error structure, log link function
and log(rlm) as an offset term to estimate β. However, such estimation requires the
piece-wise constant baseline intensities, as represented by binary indicators, to be
estimated alongside β. The sickness duration has been partitioned into 149 intervals
(i.e. partitioning system A) when we transform individual claim record data into
grouped data. If 149 binary indicators are to be estimated, the computational time
will increase dramatically. Since our primary purpose is to estimate β, we will use
only 32 binary indicators to represent the following 32 sickness intervals: 1–2 weeks,
2–3 weeks, 3–4 weeks, . . . , 15–16 weeks, 16–18 weeks, 18–20 weeks, 20–23 weeks, 23–
26 weeks, 26–30 weeks, 30–39 weeks, 39 weeks – 1 year, 1–2 years, 2–3 years, . . . , 7–8
years, 8–12 years, 12–16 years and 16–20 years. We are aware that the reduction in
computational time is achieved at the expense of efficiency of parameter estimation.
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3.3 Parameterisation of the Baseline Intensity
There are two ways to estimate the piece-wise constant baseline intensity. The more
direct or convenient way is to estimate jointly the piece-wise constant baseline inten-
sity and the relative risk by using the Poisson regression approach in a GLM (see
Section 3.2). Alternatively, we can obtain the parameter estimator, βˆg, by maximis-
ing Equation (3.12) and setting β = βˆg in Equation (3.15). Both approaches will
produce the same estimate for the piece-wise constant baseline intensity.
However, there is a need to obtain a smooth baseline intensity because the true
recovery intensity is assumed to be a reasonably smooth mathematical function so that
functions of practical importance calculated from the model will share this property
as well.
The piecewise constant baseline intensity can be graduated by using either a para-
metric or non-parametric method. For non-parametric smoothing methods such as
moving weighted average graduation and kernel smoothing, the degree of smoothness
is varied by the choice of bandwidth and this often involves an element of subjectivity.
We will therefore graduate the piece-wise constant baseline intensities parametrically
by using Chebycheff polynomials, such that
ρ0(z,b) = exp
(
s∑
i=0
biCi(tk(z))
)
where b represents the vector of regression coefficients and Ci(tk(z)) denotes the
Chebycheff polynomial in tk(z) of degree i with tk(z) being a function of duration z
defined as tk(z) = z/(1 + kz), so that by letting y = tk(z)
C0(y) = 1, C1(y) = y, C2(y) = 2y
2 − 1
C3(y) = 4y
3 − 3y, C4(y) = 8y4 − 8y2 + 1.
The transformed duration variable tk(z) is used in the baseline intensity because it
will tend towards an upper limit of 1/k as z increases without limit so that when the
recovery intensity for very long sickness durations is calculated by extrapolating the
graduation formula beyond the data range, the results obtained are more likely to be
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sensible. This transformed duration variable is also used in CMI Working Paper 15
(2004) due to this property.
We need to explore which degree of Chebycheff polynomial is suitable as the base-
line intensity and what value of k should be used in the duration transformation. This
involves trying out a range of k values for varying degrees of Chebycheff polynomials
and comparing their maximised likelihoods. When the total number of parameters
(for both β and b) or the size of the data is large, such a procedure can be very time
consuming. Since our interest lies in finding the optimal structure for the baseline
intensity and its associated k value, we will fix β at its estimated value, βˆg. By
substituting ρm = ρ0(zm,b) and removing constant terms, Equation (3.14) becomes
logL(b) =
∑
l,m
{
−rklρ0(zm,b) exp(xlβˆg) + dkl log(ρ0(zm,b))
}
. (3.19)
By putting the Chebycheff polynomial of degree s (s = 1, . . . , 6) in turn as the
baseline intensity, we will maximise Equation (3.19) by using a range of k values, say
k = 0.0, 0.1, . . . , 4.0, and the value of k that yields the largest log likelihood is selected.
The optimal degree of polynomial is selected by examining the values of the log like-
lihood produced by the selected k for each degree of polynomial. Twice the difference
in the log likelihood between two different degrees of polynomial is approximated by
a χ2 distribution with degrees of freedom equal to the difference in the number of
parameters used.
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3.4 Fully Parameterised Recovery Intensity Model
The general expression for a fully parameterised recovery intensity model is as follows:
ρ(z,x) = exp(
n∑
i=0
biCi(tk(z))) exp(xsexβsex(z) + xratedβrated(z) (3.20)
+xdp4βdp4(z) + xdp13βdp13(z) + xdp26βdp26(z) + xdp52βdp52(z)
+
n∑
i=1
xyeariβyeari(z) +
n∑
i=1
xageiβagei(z) +Φ)
where each subscripted β(z) denotes the duration-varying coefficient of its correspond-
ing subscripted covariate x and Φ denotes the interaction terms.
The duration-varying coefficient can take many forms. To describe the possi-
ble forms taken, we take βdp4(z) as an example. In the case of duration-fixed co-
variate effect, βdp4(z) = αdp4. In the case of duration-dependent covariate effect,
βdp4(z) = αdp4 + fdp4(z). It transpires that the duration-varying effect can either
persist for all durations or only for a certain period of sickness duration. In the latter
case, the point at which the duration-varying effect started or ended is known as the
“break-point”. We use tk(z) and z to model, respectively, a long period and a short
period of duration-varying effect. Therefore, fdp4(z) consists of one or several of the
following components that represent different types of duration dependency.
(i) γdp4(τdp4 − z)+
(ii) θdp4iCi(tk(z)), i = 1, 2, . . .
(iii) ζdp4i(C1(tk(τdp4))− C1(tk(z)))i+, i = 1, 2, . . .
(iv) φdp4i(C1(tk(z))− C1(tk(τdp4)))i+, i = 1, 2, . . .
where γdp4, θdp4i , ζdp4i and φdp4i are regression parameters, τdp4 is a break point and
y+ = y if y > 0 and 0 otherwise. Note that θdp41 = θdp4, ζdp41 = ζdp4 and φdp41 = φdp4.
In the case of two breakpoints, we will refer to the first one as τdp41 and the second
one as τdp42 . The breakpoint (if any) is placed after examining the variation of the log
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hazard ratio with duration as revealed by the smoothed plot of the scaled Schoenfeld
residuals. The “partial residual effects” plot, which will be discussed in Section 3.5,
is also used to guide the placement of breakpoint.
Since the recovery intensity model in Equation (3.20) can be written as an addi-
tive log-linear model, all the parameters can be estimated by using a Poisson regres-
sion model with log link function in a GLM.
3.5 Model Assessment
Let ρ0(z,b) exp(xβ(z)) be a fully estimated recovery intensity model for a specific
cause of sickness where bˆ and βˆ are the maximum likelihood estimates of b and β
respectively.
“Partial residual effects” and “residual effects” plots
We wish to check whether the estimated covariate effects, be it duration-fixed or
duration-dependent, give a reasonable representation of the actual recovery pattern.
Let the covariate vector x be partitioned into x = (x1,x2) where
x1 is a discrete covariate that takes the value 0 or 1. Gray (1990) refers to “residual
effects” as the intensity from which all covariate effects have been removed while “par-
tial residual effects” of x1 means all covariate effects except x1 have been removed.
Gray (1990) proposed using the “residual effects” and “partial residual effects” plots
to indicate the approximate form of ρ0(z) and ρ0(z) exp(x1β1(z)), respectively and
estimated these intensities by applying kernel-based smoothing to the Breslow (1974)
estimator for the cumulative baseline intensity but suggested using piece-wise constant
hazards and other smoothing methods as alternatives to kernel-based smoothing.
We will estimate ρ0(z) exp(x1β1(z)) using data for which x1 = 1, by partitioning
the sickness duration into 64 intervals of
• three days from 7 to 133 days (19 weeks) of sickness (i.e. intervals of 7–10 days,
10–13 days, . . ., 127–130 days, 130–133 days).
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• single weeks from 19 weeks to 30 weeks of sickness (i.e. intervals of 19–20
weeks, 20–21 weeks, . . ., 29–30 weeks) followed by intervals of 30–39 weeks and
39 weeks–1 year.
• single years from 1 year to 8 years of sickness (i.e intervals of 1–2 years, 2–3
years, . . ., 7–8 years) followed by 8–12 years and 12–16 years.
Note that the above partition of sickness duration is different to that in partitioning
system A and will be referred to as partitioning system B. We assume that the in-
tensity in each interval is constant. By using the notation of grouped data described
in Section 3.2, the “partial residual” effect of x1 in the mth interval (m = 1, . . . , 64),
ρ(zm, x1) = ρ0(zm) exp(x1β1(zm)), is estimated by ρˆ(zm, x1) where
ρˆ(zm, x1) =
∑
l dlm∑
l rlm exp(x2lβˆ2(z))
. (3.21)
Note that the covariate x1 is not included in the exponential term in the denominator
and therefore the effect of x1 is not “removed” from the estimate. The“partial residual
effects” plot provides a direct way of estimating the intensity. In the case that the
log hazard ratio for x1 varies with duration, the “partial residual effects” plot for x1
will reveal the functional form of the variation (including the location of any break
points) which should be similar to that revealed by the relevent smoothed Schoenfeld
residuals plot. By overlaying the estimated smooth intensity, ρ0(z, bˆ) exp(x1βˆ1(z)),
on the “partial residual effects” plot, we can see whether it fits reasonably well. The
“partial residual effects” plot is constructed separately for female data (xsex = 1),
rated data (xrated = 1), DP4 data (xdp4 = 1), DP13 data (xdp13 = 1), DP26 data
(xdp26 = 1) and DP52 data (xdp52 = 1).
The techniques described above are also extended to continuous covariates such as
age and year. To do so, age, year and sickness duration are categorised into discrete
bands as follows:
(i) Age band (9) : 17–24, 25–29, 30–34, 35–39, 40–44, 45–49, 50–54, 55–59, 60–65
(ii) Year band (7) : 1975–1978, 1979–1982, 1983-1986, 1987–1990, 1991–1994, 1995-
1998, 1999-2002
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(iii) sickness duration band (28) : 1–2, 2–3, 3–4, . . ., 10–11, 11–13, 13–15, 15–17,
17–21, 21–25, 25–30, 30–39, 39 weeks–1 year, 1–2, 2–3, . . ., 7–8, 8–12, 12–16,
16–20 years
We refer to the above partition of age, year and sickness duration as partitioning
system C. For each sickness duration band, we construct a “partial residual effects”
plot for age. The estimates are calculated using Equation (3.21) but with the effects
of sickness duration (i.e. the baseline intensity) and all other covariate effects apart
from age included in the exponential term of the denominator. From these plots,
we are able to view the shape of the hazard ratio as a function of the discrete age
bands and how this shape changes over the sickness duration bands. To see how well
the smooth intensity of age fitted the actual experience, we overlay on the “partial
residual effects” plot for themth sickness duration band (m = 1, 2, . . . , 28) the smooth
curve exp(
∑
i xageiβˆagei(zm)), where zm is the mid point of the mth sickness duration
band. The “partial residual effects” plot for year is constructed analogously.
The “residual effects” plot, in which all covariate effects are removed, is con-
structed separately using all the data, males data (xsex = 0), non-rated data
(xrated = 0) and DP1 data (xdp4 = xdp13 = xdp26 = xdp52 = 0). The estimates
are calculated by including all the covariate effects in the denominator of Equation
(3.21). The smooth baseline intensity, ρ0(z, bˆ), is then overlaid on these plots.
The confidence interval for the “partial residual effects” and “residual effects” can
be obtained on the basis of normal approximation by ensuring that the numbers of
recoveries used to calculate these estimates are sufficiently large, say greater than
8 through appropriate merger of discrete bands. Suppose we wish to calculate the
confidence interval for the “partial residual effects” of x1, ρ(zm, x1). Let d.m =
∑
l dlm
and R.m =
∑
l rlm exp(x2lβˆ2(z)). The 95% confidence interval for ρ(zm, x1) is
(
ρˆ(zm, x1)− zα
√
( ρˆ(zm,x1)
R.m
), ρˆ(zm, x1) + zα
√
( ρˆ(zm,x1)
R.m
)
)
(3.22)
where α = 0.025 and zα = 1.96. By putting ρˆ(zm, x1) = d.m/R.m, the interval (3.22)
becomes (
d.m−zα
√
d.m
R.m
, d.m+zα
√
d.m
R.m
)
(3.23)
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A more accurate confidence interval for ρ(zm, x1) can be provided by assuming that
the number of recoveries in the mth sickness duration band, d.m, follows a Poisson
distribution (see Forfar et al, 1988). If d.m = 0, the lower limit is 0; if d.m > 0, the
lower limit is the unique positive root of the equation
∑∞
k=d.m
e−µL µ
k
L
k! = α
or equivalently, ∑d.m−1
k=0 e
−µL µkL
k! = 1− α
 . (3.24)
The upper limit is the unique positive root of the equation
∑d.m
k=0 e
−µU µkU
k! = α
or equivalently, ∑∞
k=d.m+1
e−µU µ
k
U
k! = 1− α
 (3.25)
where µL = ρL(zm, x1)
∑
l rlm exp(x2lβˆ2(z)) and µU = ρU(zm, x1)
∑
l rlm exp(x2lβˆ2(z)).
We will then solve for ρL(zm, x1) and ρU(zm, x1) which, respectively, form the lower
and upper limits of the 95% confidence interval for ρ(zm, x1). Since calculating the
confidence interval based on the Poisson assumption is not computationally intensive,
we will use it for d.m ≤ 80 and only use Equation (3.23) for d.m > 80. Since the
relevant calculations are simple for a computer, we have chosen 80 as the cut-off point
even though 10 is usually sufficient for the normal approximation to hold.
Both confidence intervals, based on the Poisson or Normal assumption, are ob-
tained by ignoring the estimation of β. The true variability of the estimates is there-
fore higher than that given by these confidence intervals. These confidence intervals
are therefore used only as a rough indicator of the magnitude of the variability of the
estimates.
χ2 test
In addition to the “partial residual effects” and “residual effects” plots described
above, we wish to conduct a formal goodness-of-fit test on the model. For this pur-
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pose, sickness duration, age and year are discretised into 9, 7 and 28 bands as in
partitioning system C.
Using the same terminology as in CMI Report 15 (1996), the sickness experience
for each combination of covariate levels for sex, rating indictor, deferred period and
year band is referred to as a tableau. In each tableau, data are laid out in a two
dimensional array with age bands as rows and sickness duration bands as columns.
Two such arrays are constructed for each tableau, one containing the actual number
of recoveries (A) and the other the expected number of recoveries (E). In each cell
(the intersection of each distinct row and column), we will calculate z = D/
√
E,
incorporating continuity corrections to allow for the fact that the actual number of
recoveries is necessarily an integer, where:
D =

A− E − 0.5 if 0.5 < A− E
0.0 if − 0.5 ≤ A− E ≤ 0.5
A− E + 0.5 if A− E < −0.5 .
For each z to approximate a normal variate, its expected number of recoveries E
has to be greater than a certain number which is usually taken as 8 in CMI Report
15 (1996). Thus, cells with fewer than 8 expected recoveries have to be merged with
adjacent cells until at least 8 expected recoveries is obtained. We have a total of
2× 2× 5× 7 = 140 possible tableaux and the total number of expected recoveries in
each tableau has to exceed 8 before grouping of cells within the tableau can be carried
out. Details about the merger of tableaux and the subsequent grouping of cells within
each tableau can be found in Appendix E. The methodology used to group the cells
in a tableau is described elsewhere in Appendix A of CMI Report 15 (1996).
The sum of the squares of the z values, after necessary grouping is carried out, is
approximated by a χ2 distribution with the number of degrees of freedom equal to the
number of cells (after grouping) minus the number of parameters fitted in the model.
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Two-dimensional plot of deviance residuals
Apart from the χ2 statistic, the deviance statistic can be used to evaluate the goodness
of fit of a generalised linear model (see McCullagh and Nelder, 1989, for details). For
the Poisson model, the deviance statistic takes the following form:
Deviance = 2
∑
i
{
Ai log(
Ai
Ei
)− (Ai − Ei)
}
.
where Ai and Ei are respectively the actual and expected number of recoveries in
cell i.
The deviance residual measures the contribution of each cell i to the deviance and
is defined by
sign(A− E)
√
2
(
A log
A
E
− (A− E)
)
(3.26)
where sign(x) is a function that extracts the sign of x. Unlike in calculating χ2
statistics, there is no need to merge cells so that the expected number of recoveries in
each cell is greater than 8. An example of a two-dimensional plot of deviance residuals
is given in Figure 3.1. This plot is constructed with age bands as rows and sickness
duration bands as columns for each quadrennium arranged side by side. Positive and
negative deviance residuals are shown in red and blue rectangles respectively. Both
colours are represented by three different intensities, representing the different ranges
of values for the deviance residual. Cells with no exposed-to-risk, and therefore for
which deviance residuals cannot be calculated, are depicted in white. For each distinct
age band, there are 28 rectangles between two adjacent year bands, representing the
28 sickness duration intervals arranged in increasing order. For a good fit to the data,
the positive and negative deviance residuals of different ranges of values should be
randomly scattered.
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Figure 3.1: A two-dimensional plots of deviance residuals.
3.6 Estimation Results
There is a total of 70 causes of sickness and they are classified into 12 sickness cate-
gories as set out in Table 2.3 and reproduced here in Table 3.2.
Table 3.2: Grouping of the 70 causes of sickness into 12 categories.
Name Sickness Category ICD8 code for cause of sickness
G1 Infections & acute respiratory 01–19
G2 Neoplasms 20, 21
G3 Endocrine & Metabolic 22–26
G4 Mental Illness 27
G5 Nervous system & sensory organs 28–31
G6 Circulatory 32–38
G7 Respiratory 39–45
G8 Digestive (non-infectious) 47–51
G9 Genito-urinary 52–55
G10 Musculoskeletal 61, 62
G11 Injuries 66–70
G12 All other known causes 46, 56–60, 63–65
For the rest of this chapter, each cause of sickness will be represented by its ICD8
code prefixed by “cs”. For example, malignant neoplasm is represented by cs20.
For each sickness category, we wish to check whether its constituent causes of
sickness have broadly similar shape or level of recovery intensity. To do so, each cause
of sickness is coded by a binary indicator variable that is denoted by the symbol Icsi,
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where i is the ICD8 code for the cause of sickness. For example, cs20 is coded by
the binary indicator Ics20. These binary indicators, apart from the one representing
the reference cause of sickness, are estimated using the Cox model. We then rely on
the smoothed plot of the scaled Schoenfeld residuals (see Section 3.2) to establish
whether the recovery patterns for the causes of sickness in each sickness category are
proportional to each other. Causes of sickness with recovery patterns which are pro-
portional to each other will be modelled together by adding a set of binary indicators
representing these causes of sickness into the covariate vector. On the other hand,
causes of sickness which exhibit a disparate recovery pattern from the others will be
modelled separately.
The stages involved in the estimation of a fully parameterised recovery intensity
model for a cause of sickness are described in Sections 3.2, 3.3 and 3.4. In essence,
these stages can be represented by three different models: Model I, Model II and
Model III, where
(a) Model I is the Cox model in which the covariates are selected and estimated with-
out making any assumption about the baseline intensity. The PH assumption
for those covariates selected based on AIC criterion are assessed by examining
the smoothed plots of their scaled Schoenfeld residuals (see Section 3.2).
(b) Model II is Model I extended to include duration-varying coefficients of covari-
ates for which the PH assumption is not valid (see Section 3.2).
(c) Model III is Model II but with a parametric baseline intensity (see Section 3.3)
and all the parameters are estimated by maximum likelihood estimation (see
Section 3.4).
To avoid having a voluminous chapter, we will only present the estimation results
from the above three models for causes of sickness in sickness categories G2, G4,
G6 and G10. For the remaining sickness categories, only the estimation results from
Model III are presented in Appendix B.
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3.6.1 G2 Neoplasms
The causes of sickness in G2 Neoplasms alongside their ICD8 code, exposed to risk
in units of days and the number of recoveries are presented in Table 3.3.
Table 3.3: The causes of sickness in sickness category G2 Neoplasms.
ICD8 Cause of sickness Exposed to Recoveries
risk (days)
20 Malignant neoplasms, including neoplasms 1,919,924 1,621
of lymphatic and haematopoietic
21 Benign neoplasms and neoplasms 292,164 544
of unspecified nature
We first created a binary indicator for cs21, Ics21, and estimated it using the Cox
model. The proportionality between cs20 and cs21 is then assessed using the smoothed
plots of the scaled Schoenfeld residuals. Due to the discrete nature of the covariate
Ics21, the resulting unscaled Schoenfeld residual at event time zi (see Equation (3.8))
is rsi = 1 − aˆ(i) for Ics21 = 1 and rsi = 0 − aˆ(i) for Ics21 = 0, where aˆ(i) is given
by Equation (3.9). Therefore, the scaled version of these residuals (i.e. the scaled
Schoenfeld residuals as given in Equation (3.10)) appear as two horizontal bands of
black dots at the top and bottom of Figure 3.2. To facilitate interpretation of these
scaled Schoenfeld residuals, we use smoothing spline on the residuals. The solid line
in this graph denotes the smoothed scaled Schoenfeld residuals while the broken lines
represent a ± 2-standard-error band around the fit. Cox’s estimate for Ics21 (i.e. the
log hazard ratio between cs21 and cs20) is 0.848 and is represented by the broken red
line. As discussed in Section 3.2, the smoothed scaled Schoenfeld residuals indicate
the variation of the log hazard ratio with sickness duration. This plot indicates that
the recovery intensity for cs21 is higher than cs20 until both intensities converge (i.e.
β(z) = 0) somewhere between 200 to 500 days. This convergence in intensities may
be due to the fact that as time goes by there are more neoplasms of unspecified nature
left in the cs21 data which are in fact of malignant nature. Given the non-PH between
both intensities, we decided to estimate them separately.
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Figure 3.2: The smoothed plot of the Schoenfeld residuals, indicating the log hazard
ratio between cs21 and cs20.
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Recovery intensity model for cs20
For cs20, the estimation results from intermediate models (i.e. Model I and II) leading
up to a fully specified recovery intensity model (i.e. Model III) are presented in Table
3.4. The first column of Table 3.4 shows the notation representing different types
of regression coefficients as explained in Section 3.4. The second column of Table
3.4 shows the estimation results from Model I which is a Cox model that assumes
that the covariate effects are duration-fixed (i.e. the PH assumption holds). This
assumption is tested for each covariate by using the smoothed plot of the Schoenfeld
residuals. The covariate effects of xyear, xdp4 and xdp13 are found to be duration-
dependent because the smoothed plot of their respective scaled Schoenfeld residuals
as presented in Figure 3.3 suggest that
(i) The year effect has a concave shape until some point between 39 weeks to 1
year, from which it starts tailing off till the end, but with a wider confidence
interval. The falling trend at the right of the graph, observed also in the other
two graphs, is most likely due to the few residuals at the bottom right of the
graph. The functional form for βyear(z) is therefore specified as
βyear(z) = αyear+ζyear1(C1(t2.3(τyear))−C1(t2.3(z)))++ζyear2((C1(t2.3(τyear))−C1(t2.3(z)))+)2
where τyr = 319.5.
(ii) There is a ‘run-in’ period for DP4 and DP13, during which the recovery intensity
is lower, such that
βdp4(z) = αdp4 + γdp4(τdp4 − z)+
βdp13(z) = αdp13 + γdp13(τdp13 − z)+
where τdp4 = 58.5 and τdp13 = 185.5.
Model II is then obtained by extending Model I to include additional covariates
used to model the duration-varying effects of xyear, xdp4 and xdp13. The estimated
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Figure 3.3: The smoothed plots of the scaled Schoenfeld residuals for xyear, xdp4 and
xdp13 in cs20.
parameters in Model II are presented in column three of Table 3.4. Model II gives the
complete parameterisation of the relative risk component and as in Model I, all the
covariate effects are estimated without imposing any functional form on the baseline
intensity. Lastly, Model III retains all the parameters in Model II but with the baseline
intensity described by a exp(
∑3
i=0 biCi(t2.3(z))) formula. The estimated parameters
in this fully parameterised recovery intensity model are presented in column four of
Table 3.4. The standard error for each estimated parameters in these three models is
given by the value in bracket.
The goodness-of-fit of Model III is then assessed using a series of techniques pre-
sented in Section 3.5. The value of the χ2 statistic is 118.83. With a total of 125 cells
(after grouping) and 17 parameters fitted in the model, the probability value is 0.224
on 108 degrees of freedom, indicating a reasonably good fit to the data. The “residual
effects” and “partial residual effects” plots for the discrete covariates are presented in
Figure 3.4. The data upon which each plot is based is indicated by the caption of the
plot. Figures 3.5 and 3.6 show the “partial residual effects” plots for year and age,
respectively, for each sickness duration band. The red curve overlaid on each of the
plots in Figures 3.4–3.6 is the estimated smooth intensity according to Model III and
all of them have fitted the actual experience reasonably well.
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The two-dimensional plots of the deviance residuals for all data as well as its
subsets are shown in Figure 3.7. The positive and negative deviance residuals for
‘All’ and ‘Male & Not-rated’ data are roughly randomly scattered. For other subsets,
the plots are dominated by white and light blue cells because most of the cells have
either zero exposed to risk or no recoveries.
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Table 3.4: Parameters in the intermediate and final recovery intensity models for cs20.
Model I Model II Model III
k 2.3
b0 50.6322
(8.4196)
b1 -162.0055
(22.1178)
b2 48.1491
(8.2888)
b3 -46.6650
(6.3935)
αsex 0.2350 0.2356 0.2402
(0.0618) (0.0615) (0.0615)
αrated -0.2631 -0.2661 -0.2647
(0.0644) (0.0646) (0.06458)
αage -1.3901 -0.9967 -0.9899
(0.2201) (0.0925) (0.0926)
αyear -0.2352
(0.0557)
τyear 319.5 319.5
ζyear
1
-10.0621 -10.2329
(1.5267) (1.4919)
ζyear
2
43.7485 44.0975
(7.3581) (7.1534)
αdp4 -0.5241 -0.2498 -0.2776
(0.0827) (0.0914) (0.0879)
τdp4 58.5 58.5
γdp4 -0.0856 -0.0746
(0.0116) (0.0101)
αdp13 -0.6230 -0.2590 -0.3029
(0.0860) (0.1031) (0.1004)
τdp13 185.5 185.5
γdp13 -0.0073 -0.0068
(0.0022) (0.0019)
αdp26 -0.8360 -0.4804 -0.5885
(0.1021) (0.1137) (0.1080)
αdp52 -0.7502 -0.4794 -0.4977
(0.1733) (0.1789) (0.1760)
αsex:age 0.3870 0.3340 0.3381
(0.1676) (0.1677) (0.1677)
αdp4:age 0.4202 0.4465 0.4438
(0.1449) (0.1451) (0.1452)
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Figure 3.4: The “residual effects” and “partial residual effects” plots for the discrete
covariates – cs20.
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Figure 3.5: The “partial residual effects” plots for year – cs20.
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Figure 3.6: The “partial residual effects” plots for age – cs20.
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Figure 3.7: Two-dimensional plots of deviance residuals using cs20 data.
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Recovery intensity model for cs21
For cs21, Table 3.5 shows the estimated regression coefficients from intermediate mod-
els (i.e. Model I and II) leading up to the fully-specified recovery intensity model (i.e.
Model III), in columns two to four, respectively. Model I is a Cox model which as-
sumes that the covariate effects are duration-fixed. This assumption is not valid for
xyear, xdp4 and xdp13 because the smoothed plot of their respective scaled Schoenfeld
residuals in Figure 3.8 suggests that their respective coefficients can be parameterised
as
βsex(z) = αsex + γsex(τsex − z)+
βyear(z) = αyear + ζyear(C1(t2.3(τyear))− C1(t2.3(z)))+
βdp4(z) = αdp4 + γdp4(τdp4 − z)+
βdp13(z) = αdp13 + γdp13(τdp13 − z)+
where τsex = 74.5, τyear = 126.5, τdp4 = 52.5 and τdp13 = 165.5.
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Figure 3.8: The smoothed plots of the scaled Schoenfeld residuals for xsex, xyear, xdp4
and xdp13 for cs21.
Model II is then obtained by including in Model I the additional covariates created
to describe the duration-varying effects of xsex, xyear, xdp4 and xdp13. Lastly, Model
III is the fully parameterised recovery intensity model with the baseline intensity
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modelled by exp(
∑3
i=0 biCi(t2.3(z))). This final fitted model is then assessed for its
goodness-of-fit. The value of the χ2 statistic is 41.30. With 48 cells and 15 parameters
fitted in the model, the probability value is 0.152 on 33 degrees of freedom, indicating
a reasonably good fit to the data. The “residual effects” and “partial residual effects”
plots for the discrete covariates are presented in Figure 3.9. The data upon which
each plot is based is indicated by the caption of the plot. Figures 3.10 and 3.11 show
the “partial residual effects” plots for year and age, respectively, for each sickness
duration band. We only show the “partial residual effects” plot for age for the first
few sickness durations bands because of the small amount of data at longer sickness
durations bands. The red curves overlaid on the plots in Figures 3.9–3.11 are the
estimated smooth intensities according to Model III and they have represented the
actual experience reasonably well.
The two-dimensional plots of the deviance residuals for all data as well as its
subsets are shown in Figure 3.12. For ‘All’ and ‘Male & Not-rated’ data, the cells
belonging to longer sickness durations bands are mostly in blue or white because most
of the recoveries happen at shorter sickness duration, leaving very few recoveries or
exposed-to-risk at longer sickness durations bands. For other subsets, there are a
greater number of white and light blue cells because most of the cells have either zero
exposed-to-risk or no recoveries.
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Table 3.5: Parameters in the intermediate and final recovery intensity models for cs21.
Model I Model II Model III
k 2.3
b0 16.9710
(13.4547)
b1 -75.3337
(37.2265)
b2 13.3819
(13.3147)
b3 -20.4126
(11.0738)
αsex 0.0507 0.3743 0.3502
(0.104) (0.1387) (0.1381)
τsex 74.5 74.5
γsex -0.0132 -0.0123
(0.0039) (0.0039)
αage -0.6901 -0.7235 -0.7273
(0.131) (0.1318) (0.1319)
αyear -0.1860 -0.5655 -0.5433
(0.106) (0.1616) (0.1611)
τyear 126.5 126.5
ζyear 5.0649 4.8752
(1.592) (1.5980)
αdp4 -0.6424 -0.3106 -0.3993
(0.135) (0.1591) (0.1459)
τdp4 52.5 52.5
γdp4 -0.0848 -0.0805
(0.0180) (0.0158)
αdp13 -1.0603 -0.3705 -0.4018
(0.186) (0.2376) 0.2276
τdp13 165.5 165.5
γdp13 -0.0185 -0.0198
(0.0068) (0.0057)
αdp26 -0.9282 -0.4638 -0.4635
(0.267) (0.2891) (0.2800)
αsex:age 0.7290 0.7457 0.7415
(0.288) (0.2898) (0.2895)
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Figure 3.9: The “residual effects” and “partial residual effects” plots for the discrete
covariates – cs21.
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Figure 3.10: The “partial residual effects” plots for year – cs21.
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Figure 3.11: The “partial residual effects” plots for age – cs21.
87
17−24
25−29
30−34
35−39
40−44
45−49
50−54
55−59
60−65
75−78 79−82 83−86 87−90 91−94 95−98 99−02
All
17−24
25−29
30−34
35−39
40−44
45−49
50−54
55−59
60−65
75−78 79−82 83−86 87−90 91−94 95−98 99−02
Male & Not−rated (All deferred periods combined)
17−24
25−29
30−34
35−39
40−44
45−49
50−54
55−59
60−65
75−78 79−82 83−86 87−90 91−94 95−98 99−02
Male & Rated (All deferred periods combined)
17−24
25−29
30−34
35−39
40−44
45−49
50−54
55−59
60−65
75−78 79−82 83−86 87−90 91−94 95−98 99−02
Female & Not−rated (All deferred periods combined)
17−24
25−29
30−34
35−39
40−44
45−49
50−54
55−59
60−65
75−78 79−82 83−86 87−90 91−94 95−98 99−02
Female & Rated (All deferred periods combined)
>2
1−2
0.000001−1
<−2
−2  −  −1
−1  −  −0.000001
Figure 3.12: Two-dimensional plots of deviance residuals using cs21 data.
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3.6.2 G4 Mental Illness
There is only one cause of sickness in G4 Mental Illness. Its ICD8 code, exposed to
risk in units of days and the number of recoveries are presented in Table 3.6.
Table 3.6: The cause of sickness in sickness category G4 Mental Illness.
ICD8 Cause of sickness Exposed to Recoveries
risk (days)
27 Psychoses and non-psychotic mental disorders 8,845,266 5,287
Recovery intensity model for cs27
For cs27, Table 3.7 shows, in columns two to four, the estimated regression coefficient
from Models I, II and III, respectively. Model I assumes that all the covariate effects
are duration-fixed, an assumption which is not valid for xyear, xage, xdp4, xdp13 and xdp26
because the smoothed plots of their respective scaled Schoenfeld residuals shown in
Figure 3.13 suggest that their respective coefficients can be parameterised as
βyear(z) = αyear + γyear(τyear − z)+
βage(z) = αage + ζage1(C1(t2.3(τage))− C1(t2.3(z)))+ + ζage2((C1(t2.3(τage))− C1(t2.3(z)))+)2
βdp4(z) = αdp4 + γdp41(τdp41 − z)+ + γdp42(τdp42 − z)+
βdp13(z) = αdp13 + γdp13(τdp13 − z)+
βdp26(z) = αdp26 + γdp26(τdp26 − z)+
where τyear = 26.5, τage = 106.5, τdp41 = 45.5, τdp42 = 94.5, τdp13 = 198.5 and τdp26 =
250.5.
Model II is Model I but with the inclusion of additional covariates created to
describe the duration-varying effects of xyear, xage, xdp4, xdp13 and xdp26. Lastly, Model
III is the fully parameterised recovery intensity model with the baseline intensity
modelled by exp(
∑4
i=0 biCi(t2.3(z))) formula. This final fitted model is then assessed
for its goodness-of-fit. The value of the χ2 statistic is 383.3666. With 451 cells and
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Figure 3.13: The smoothed plots of the scaled Schoenfeld residuals for
xyear, xage, xdp4, xdp13 and xdp26 in cs27.
26 parameters fitted in the model, the probability value is 0.927088 on 425 degrees of
freedom, indicating a good fit to the data. The “residual effects” and “partial residual
effects” plots for the discrete covariates are presented in Figure 3.14. The data upon
which each plot is based is indicated by the caption of the plot. Figures 3.15 and
3.16 show the “partial residual effects” plots for year and age, respectively, for each
sickness duration band. The red curves overlaid on the plots in Figures 3.14–3.16 are
the estimated smooth intensities according to Model III, all of which have fitted the
actual experience well. The two-dimensional plots of the deviance residuals for all
data as well as its subsets are shown in Figure 3.17. Apart from ‘Female & rated’
for which the data is sparse, the positive and negative deviance residuals of different
ranges of values are roughly randomly scattered in other subsets of the data.
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Table 3.7: Parameters in the intermediate and final recovery intensity models for cs27.
Model I Model II Model III Model I Model II Model III
k 2.3 αdp4 -0.1241 0.1767 0.1729
b0 -418.8920 (0.0979) (0.0479) (0.0451)
(61.9760) τdp4
1
45.5 45.5
b1 521.1417 γdp4
1
-0.0251 -0.0379
(84.3994) (0.0119) (0.0103)
b2 -531.0750 τdp4
2
94.5 94.5
(77.3801) γdp4
2
-0.0181 -0.0159
b3 171.7831 (0.0021) (0.0018)
(27.0574) αdp13 -0.5820
b4 -110.0431 (0.0511)
(15.5167) τdp13 198.5 198.5
αsex 0.0338 0.0232 0.0228 γdp13 -0.0090 -0.0094
(0.0504) (0.0505) (0.0505) (0.0012) (0.0011)
αage -0.8362 -1.2531 -1.2484 αdp26 -0.7271 -0.2384 -0.2385
(0.0466) (0.06450) (0.0643) (0.0601) (0.0563) (0.0555)
τage 106.5 106.5 τdp26 250.5 250.5
ζage
1
25.9934 26.3914 γdp26 -0.0087 -0.0105
(2.8529) (2.8394) (0.0036) (0.0034)
ζage
2
-158.7982 -162.5144 αdp52 -1.0602 -0.6071 -0.5993
(21.3096) (21.2099) (0.0992) (0.0951) (0.0943)
αage2 -0.2495 -0.2733 -0.2703 αage:dp26 -0.8273 -0.4547 -0.4554
(0.0496) (0.04990) (0.0499) (0.1368) (0.1431) (0.1430)
αrated 0.0526 0.0365 0.0375 αage:dp52 -1.1170 -0.7453 -0.7442
(0.0440) (0.0434) (0.0434) (0.2866) (0.2900) (0.2899)
αyear -0.4182 -0.5215 -0.5211 αage:rated 0.1534 0.2516 0.2489
(0.0337) (0.0362) (0.0361) (0.1063) (0.1085) (0.1085)
τyear 26.5 26.5 αyear:rated -0.1820 -0.1440 -0.1474
γyear 0.0463 0.0460 (0.0731) (0.0738) (0.0738)
(0.0064) (0.0064) αsex:year2 -0.1623 -0.1647 -0.1631
αyear2 0.2786 0.1219 0.1221 (0.0684) (0.0684) (0.0684)
(0.0876) (0.0332) (0.0332) αsex:dp4 -0.1893 -0.1845 -0.1820
(0.0763) (0.0763) (0.0763)
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Figure 3.14: The “residual effects” and “partial residual effects” plots for the discrete
covariates – cs27.
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Figure 3.15: The “partial residual effects” plots for year – cs27.
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Figure 3.16: The “partial residual effects” plots for age – cs27.
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Figure 3.17: Two-dimensional plots of deviance residuals for cs27 data.
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3.6.3 G6 Circulatory
The causes of sickness in G6 Circulatory alongside their ICD8 code, exposed to risk
in units of days and the number of recoveries are presented in Table 3.8.
Table 3.8: The causes of sickness in sickness category G6 Circulatory.
ICD8 Cause of sickness Exposed to Recoveries
risk (days)
32 Active rheumatic fever 7,172 11
33 Chronic rheumatic heart disease 49,898 23
34 Hypertensive disease 657,927 566
35 Ischaemic heart disease 4,701,560 3,426
36 Cerebrovasular disease 1,503,893 389
37 Venous thrombosis and embolism 221,987 288
38 Other diseases of circulatory system 824,861 1,470
The reference cause of sickness is cs38. The binary indicators representing the re-
maining causes of sickness in this sickness category are estimated using the Cox model.
The proportionality of the recovery patterns for these causes of sickness are assessed
using the smoothed plots of the scaled Schoenfeld residuals which are presented in
Figure 3.18. The broken red lines overlaid on this plots are the Cox’s estimate. These
plots suggest that the log hazard ratio between cs38 and each of cs32, cs33, cs34, cs37
and cs38 stay reasonably constant at all sickness durations. On the other hand, the
log hazard ratio between cs35 and cs36 versus cs38 deviates from a horizontal line,
suggesting that their recovery patterns are not proportional to cs38. Therefore, we
will use a proportional hazard model incorporating cause of sickness as a factor to
describe the recovery intensities for cs32, cs33, cs34, cs37 and cs38. The recovery
intensity for cs35 and cs36 will be estimated separately.
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Figure 3.18: The smoothed plot of the Schoenfeld residuals for the causes of sickness
in G6.
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Recovery intensity model for cs32, cs33, cs34, cs37 and cs38
The recovery intensities for cs32, cs33, cs34, cs37 and cs38 are of different levels
but are proportional to each other. We therefore use a proportional hazards model
to describe their recovery intensities in which cs38 is the reference cause of sickness
while the remaining four causes of sickness are represented by their binary indicators
in the model. Table 3.9 shows, in columns two to four, the estimated parameters from
Models I, II and III, respectively. Model I assumes that all the covariate effects are
duration-fixed, an assumption which is not valid for xyear, xdp4 and xdp13 because the
smoothed plots of their respective scaled Schoenfeld residuals shown in Figure 3.13
suggests that their respective coefficients can be parameterised as
βyear(z) = αyear + θyearC1(t6.7(z))
βdp4(z) = αdp4 + γdp41(τdp41 − z)+ + γdp42(τdp42 − z)+
βdp13(z) = αdp13 + γdp13(τdp13 − z)+
where τdp41 = 37.5, τdp42 = 70.5 and τdp13 = 125.5.
Model II has all the parameters in Model I as well as additional covariates which are
created to describe the duration-varying effects of xyear, xdp4 and xdp13. Lastly, Model
III has all the parameters in Model II and a baseline intensity which is described by
a exp(
∑4
i=0 biCi(t6.7(z))) formula. The final fitted model, Model III, is then assessed
for its goodness-of-fit. The value of the χ2 statistic is 177.6417. With 195 cells and
26 parameters fitted in the model, the probability value is 0.3091 on 169 degrees of
freedom, indicating a reasonably good fit to the data.
The “residual effects” and “partial residual effects” plots for the discrete covariates
for cs34, cs37 and cs38 are presented in Figures 3.20 – 3.22, respectively. The data
upon which each plot is based is indicated by the caption of the plot. These plots are
not constructed for cs32 and cs33 because of the small amount of data in these causes
of sickness. The “partial residual effects” plots for age and year is only constructed
for cs38 due to its reasonably large amount of data and they are presented in Figures
3.23 and 3.24, respectively. The red curves overlaid on the plots in Figures 3.20
– 3.24 are the estimated smooth intensities according to Model III and they fitted
98
the actual experience reasonably well. The two-dimensional plots of the deviance
residuals for cs34, cs37 and cs38 as well as their subsets for are shown in Figures 3.25
– 3.27. In these figures, the positve and negative residuals do not seem to be randomly
scattered since cells for longer sickness duration bands are mostly in blue and white.
In particular, the cells for younger age range are dominantly white because there is
very small exposure to risk for these age ranges.
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Figure 3.19: The smoothed plots of the scaled Schoenfeld residuals for xyear, xdp4 and
xdp13 in the recovery intensity model for cs32, cs33, cs34, cs37 and cs38.
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Table 3.9: Parameters in the intermediate and final recovery intensity models for cs32,
cs33, cs34, cs37 and cs38.
Model I Model II Model III
k 6.7
b0 -49621.41
(6521.934)
b1 29804.68
(4072.891)
b2 -65398.31
(8597.399)
b3 9869.151
(1348.994)
b4 -15776.75
(2075.904)
Ics32 0.4101 0.5085 0.5272
(0.3184) (0.3185) (0.3184)
Ics33 -0.7315 -0.7352 -0.7275
(0.2114) (0.2114) (0.2114)
Ics34 -0.2115 -0.2070 -0.2093
(0.0582) (0.0581) (0.0581)
Ics37 -0.2560 -0.2791 -0.2787
(0.0711) (0.0726) (0.0725)
αage -0.6002 -0.6071 -0.6092
(0.0718) (0.0720) (0.0719)
αage2 -0.3072 -0.2817 -0.2881
(0.0707) (0.0707) (0.0707)
αrated -0.1461 -0.1255 -0.1257
(0.0603) (0.0606) (0.0605)
αrated × Ics32 -2.2613 -2.3477 -2.3618
(1.0507) (1.0507) (1.0506)
αyear -0.1054 0.5913 0.5774
(0.0457) (0.1005) (0.1004)
θyear -9.7122 -9.4564
(1.2198) (1.2166)
αdp4 -0.3318 0.2171 0.1347
(0.0709) (0.0964) (0.0896)
αdp4 × Ics34 -0.2034 -0.2497 -0.2384
(0.1109) (0.1114) (0.1113)
τdp4
1
37.5 37.5
γdp4
1
-0.1805 -0.2136
(0.0456) (0.0393)
γdp4
1
× Ics37 0.1331 0.1332
(0.0644) (0.0644)
τdp4
2
70.5 70.5
γdp4
2
-0.0258 -0.0197
(0.0051) (0.0039)
αdp13 -0.7313 -0.1734 -0.2037
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Figure 3.20: The “residual effects” and “partial residual effects” plots for the discrete
covariates – cs34.
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Figure 3.21: The “residual effects” and “partial residual effects” plots for the discrete
covariates – cs37.
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Figure 3.22: The “residual effects” and “partial residual effects” plots for the discrete
covariates – cs38.
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Figure 3.23: The “partial residual effects” plots for year – cs38.
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Figure 3.24: The “partial residual effects” plots for age – cs38.
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Figure 3.25: Two-dimensional plots of deviance residuals for cs34 data.
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Figure 3.26: Two-dimensional plots of deviance residuals for cs37 data.
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Figure 3.27: Two-dimensional plots of deviance residuals for cs38 data.
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Recovery intensity model for cs35
For cs35, Table 3.10 shows the estimated regression coefficients from intermediate
models (i.e. Models I and II) leading up to the fully-specified recovery intensity
model (i.e. Model III), in columns two to four, respectively. Model I is a Cox model
which assumes that all the covariate effects are duration-fixed, an assumption which
is not valid for xyear, xdp4, xdp13 and xdp26. This is because the smoothed plot of their
respective scaled Schoenfeld residuals in Figure 3.28 suggests that their respective
coefficients can be parameterised as
βyear(z) = αyear + γyear(τyear − z)+
βdp4(z) = αdp4 + γdp4(τdp4 − z)+
βdp13(z) = αdp13 + γdp13(τdp13 − z)+
βdp26(z) = αdp26 + γdp26(τdp26 − z)+
where τyear = 25.5, τdp4 = 72.5, τdp13 = 185.5 and τdp26 = 265.5.
Model II is obtained by including in Model I additional covariates created
to describe the duration-varying effects of xyear, xdp4, xdp13 and xdp26. Lastly,
Model III is Model II but with a parametric baseline intensity described by a
exp(
∑3
i=0 biCi(t6.7(z))) formula. The final fitted model, Model III, is then assessed
for its goodness-of-fit. The value of the χ2 statistic is 270.2829. With 289 cells and
18 parameters fitted in the model, the probability value is 0.5009 on 271 degrees of
freedom, indicating a good fit to the data. The “residual effects” and “partial residual
effects” plots for the discrete covariates are presented in Figure 3.29. The data upon
which each plot is based is indicated by the caption of the plot. Figures 3.30 and
3.31 show the “partial residual effects” plots for age and year, respectively, for each
sickness duration band. The red curves overlaid on the plots in Figures 3.29–3.31 are
the estimated smooth intensities according to Model III and they fitted the actual
experience reasonably well. The two-dimensional plots of the deviance residuals for all
data as well as its subsets are shown in Figure 3.32. The positve and negative resid-
uals are reasonably randomly scattered. However, the cells for younger age range are
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dominantly white because there is very small exposure to risk for these age ranges.
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Figure 3.28: The smoothed plots of the scaled Schoenfeld residuals for xyear, xdp4, xdp13
and xdp26 in cs35.
110
Table 3.10: Parameters in the intermediate and final recovery intensity models for
cs35.
Model I Model II Model III
k 6.7
b0 1128.687
(65.498)
b1 -8475.895
(388.616)
b2 1124.992
(65.292)
b3 -2777.223
(126.278)
αage 0.4939 0.4600 0.4602
(0.3809) (0.3791) (0.3787)
αage2 -0.7186 -0.7058 -0.6989
(0.2076) (0.2066) (0.2063)
αage3 0.3526 0.3403 0.3400
(0.1254) (0.1250) ( 0.1249)
αrated -0.5699 -0.5482 -0.5489
(0.1119) (0.1110) (0.1109)
αyear -0.2466 -0.3129 -0.3115
(0.0380) (0.0392) (0.0391)
τyear 25.5 25.5
γyear 0.0705 0.0648
(0.0107) (0.0103)
αyear2 0.0973 0.0944 0.0923
(0.0387) (0.0387) (0.0387)
αdp4 -0.1426
(0.0466)
τdp4 72.5 72.5
γdp4 -0.0261 -0.0295
(0.0036) (0.0031)
αdp13 -0.3174
(0.05596)
τdp13 185.5 185.5
γdp13 -0.0090 -0.0083
(0.0011) (0.0011)
αdp26 -0.1988 0.1521 0.1931
(0.1411) (0.1440) (0.1427)
τdp26 265.5 265.5
γdp26 -0.0117 -0.0137
(0.0037) (0.0035)
αdp52 -0.8835 -0.6690 -0.6343
(0.1836) (0.1816) (0.1806)
αage3:dp26 0.6104 0.6477 0.6477
(0.1716) (0.1716) (0.1707)
αage2:rated -0.4902 -0.4782 -0.4784
(0.1437) (0.1436) (0.1436)
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Figure 3.29: The “residual effects” and “partial residual effects” plots for the discrete
covariates – cs35.
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Figure 3.30: The “partial residual effects” plots for year – cs35.
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Figure 3.31: The “partial residual effects” plots for age – cs35.
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Figure 3.32: Two-dimensional plots of deviance residuals for cs35 data.
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Recovery intensity model for cs36
For cs36, Table 3.11 shows, in column two to four, the results from Models I, II and
III, respectively. Model I assumes that all the covariate effects are duration-fixed, an
assumption which is not valid for xdp4 and xdp13 are duration-dependent because the
smoothed plots of their scaled Schoenfeld residuals shown in Figure 3.33 suggests that
their respective coefficients can be parameterised as
βdp4(z) = αdp4 + γdp4(τdp4 − z)+
βdp13(z) = αdp13 + γdp13(τdp13 − z)+
where τdp4 = 81.5 and τdp13 = 180.5.
Model II is Model I but with the inclusion of additional covariates created to
describe the duration-varying effects of xdp4 and xdp13. Lastly, Model III is the
fully parameterised recovery intensity model with the baseline intensity described
by a exp(
∑3
i=0 biCi(t2.3(z))) formula. This final fitted model is then assessed for its
goodness-of-fit. The value of the χ2 statistic is 19.7367. With 31 cells and 14 param-
eters fitted in the model, the probability value is 0.2879 on 17 degrees of freedom,
indicating a reasonably good fit to the data. The “residual effects” and “partial resid-
ual effects” plots for the discrete covariates are presented in Figure 3.34. The red curve
overlaid on the plots in Figure 3.34 are the estimated smooth intensities according
to Model III and they seem to fit the actual experience rather well. The data upon
which each plot is based is indicated by the caption of the plot. We do not construct
the “partial residual effects” plots for age and year because the amount of data is not
sufficiently large to make such an exercise meaningful. The two-dimensional plots of
the deviance residuals for all data as well as its subsets are shown in Figure 3.35. Due
to the sparseness of the data, the plots appear mostly in blue and white.
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Figure 3.33: The smoothed plots of the scaled Schoenfeld residuals for xdp4 and xdp13
in cs36.
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Table 3.11: Parameters in the intermediate and final recovery intensity models for
cs36.
Model I Model II Model III
k 2.3
b0 32.1920
(14.8636)
b1 -107.9258
(38.2616)
b2 29.5602
(14.6404)
b3 -28.7525
(11.0018)
αsex -0.6698 -0.6302 -0.6349
(0.2785) (0.2786) (0.2787)
αage -0.7812 -0.7916 -0.8054
(0.1473) (0.1473) (0.1465)
αrated -0.3959 -0.3923 -0.3976
(0.1741) (0.1745) (0.1744)
αyear -0.4774 -0.4608 -0.4584
(0.1119) (0.1119) (0.1119)
αdp4 0.2023 0.3769 0.4191
(0.1412) (0.1568) (0.1487)
τdp4 81.5 81.5
γdp4 -0.0302 -0.0338
(0.0090) (0.0074)
αdp13 -0.0228 0.2609 0.3185
(0.1616) (0.1766) (0.1743)
τdp13 180.5 180.5
γdp13 -0.0140 -0.0141
(0.0054) (0.0046)
αdp52 -1.3888 -1.2462 -1.1757
(0.5904) (0.5922) (0.5913)
αrated:dp13 0.6790 0.6688 0.6679
(0.2751) (0.2754) (0.2753)
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Figure 3.34: The “residual effects” and “partial residual effects” plots for the discrete
covariates – cs36.
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Figure 3.35: Two-dimensional plots of deviance residuals for cs36 data.
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3.6.4 G10 Musculoskeletal
The causes of sickness in G10 Musculoskeletal alongside their ICD8 code, exposed to
risk in units of days and the number of recoveries are presented in Table 3.12.
Table 3.12: The causes of sickness in sickness category G10 Musculoskeletal.
ICD8 Cause of sickness Exposed to Recoveries
risk (days)
61 Arthritis and spondylitis 3,401,274 1,847
62 Other diseases of musculoskeletal 6,345,553 11,284
system and connective tissue
The reference cause of sickness is cs62. The proportionality between the recovery
patterns for cs61 and cs62 is assessed using the smoothed plot of the scaled Schoenfeld
residuals as presented in Figure 3.36. The broken red line overlaid on this plot is the
Cox’s estimate. This plot suggests that the log hazard ratio between cs61 and cs62
does not stay reasonably constant at all sickness durations. Given that both causes
of sickness have large amounts of data and their recovery patterns are not reasonably
proportional to each other, we will estimate their recovery intensities separately.
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Figure 3.36: The smoothed plot of the Schoenfeld residuals for the causes of sickness
in G10.
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Recovery intensity model for cs61
For cs61, Table 3.13 shows, in columns two to four, the results from Models I, II
and III, respectively. Model I is the Cox model which assumes that all covariate
effects stay constant for all sickness durations. This assumption is not valid for
xyear, xrated, xdp4, xdp13 and xdp26 because the smoothed plots of their scaled Schoen-
feld residuals in Figure 3.37 suggests that their respective coefficients are duration
dependent and can be parameterised as
βyear(z) = αyear + γyear(τyear − z)+ + θyearC(t1.3(z))
βrated(z) = αrated + θratedC(t1.3(z))
βdp4(z) = αdp4 + γdp41(τdp41 − z)+ + γdp42(τdp42 − z)+
βdp13(z) = αdp13 + γdp13(τdp13 − z)+
βdp26(z) = αdp26 + θdp261C1(t1.3(z)) + θdp262C2(t1.3(z))
where τyear = 32.5, τdp41 = 37.5, τdp42 = 73.5 and τdp13 = 135.5
Model II is obtaind by including in Model I additional covariates created to de-
scribe the duration-varying effects of xyear, xrated, xdp4, xdp13 and xdp26. Lastly, Model
III is the fully parameterised recovery intensity model with the baseline intensity de-
scribed by a exp(
∑1
i=0 biCi(t1.3(z))) formula. This final fitted model is then assessed
for its goodness-of-fit. The value of the χ2 statistic is 125.0230. With 151 cells and 25
parameters fitted in the model, the probability value is 0.5078 on 126 degrees of free-
dom, indicating a reasonably good fit to the data. The “residual effects” and “partial
residual effects” plots for the discrete covariates are presented in Figure 3.38. The
data upon which each plot is based is indicated by the caption of the plot. Figures 3.39
and 3.40 show the “partial residual effects” plots for age and year, respectively, for
each sickness duration band. The red curve overlaid on the plots in Figures 3.38–3.40
are the estimated smooth intensities according to Model III which fitted the actual
experience well. The two-dimensional plots of the deviance residuals for all data as
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well as its subsets are shown in Figure 3.41. The positive and negative deviance resid-
uals for ‘All’ and ‘Male & Not-rated’ data are roughly randomly scattered. For other
subsets, the plots are dominated by white and light blue cells because most of the
cells have either zero exposed to risk or no recoveries.
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Figure 3.37: The smoothed plots of the scaled Schoenfeld residuals for
xyear, xrated, xdp4, xdp13 and xdp26 in cs61.
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Table 3.13: Parameters in the intermediate and final recovery intensity models for
cs61.
Model I Model II Model III
k 1.3
s 2
b0 2.9727
(0.0604)
b1 -9.8003
(0.2229)
αsex -0.4220 -0.4390 -0.4411
(0.1310) (0.1307) (0.1307)
αage -1.5370 -0.9073 -0.9037
(0.2379) (0.0805) (0.0801)
αrated -0.2093 -0.6152 -0.6394
(0.0631) (0.1228) (0.1173)
θrated 1.4057 1.4858
(0.3484) (0.3290)
αyear -0.4380 -0.2200 -0.2287
(0.0551) (0.1073) (0.1075)
θyear -1.6028 -1.5693
(0.3472) (0.3470)
τyear 32.5 32.5
γyear 0.0228 0.0222
(0.0079) (0.0077)
αyear2 0.4846 0.2002 0.2026
(0.1905) (0.0549) (0.0549)
αdp4 -0.1788 0.3338 0.2852
(0.0705) (0.0907) (0.0765)
τdp4
1
37.5 37.5
γdp4
1
-0.1353 -0.1714
(0.0615) (0.0549)
τdp4
2
73.5 73.5
γdp4
2
-0.0358 -0.0296
(0.0056) (0.0041)
αdp13 -0.2145 0.3857 0.2760
(0.0952) (0.1138) (0.1016)
τdp13 135.5 135.5
γdp13 -0.0420 -0.0355
(0.0073) (0.0066)
αdp26 0.7912 -10.0812 -12.4658
(0.3780) (6.4941) (5.8057)
θdp26
1
15.3155 18.5551
(8.8839) (7.9450)
θdp26
2
-6.0138 -7.5355
(4.3446) (3.8761)
αdp52 -0.1716 0.3590 0.3218
(0.2856) (0.2933) (0.2914)
αsex:age 0.6913 0.6884 0.6884
(0.2023) (0.2017) (0.2018)
αsex:year2 -0.3321 -0.3113 -0.3165
(0.1670) (0.1671) (0.1671)
αsex:dp26 -0.8500 -0.7777 -0.7751
(0.3032) (0.3052) (0.3053)
αdp13:age -0.5591 -0.4783 -0.4698
(0.1713) (0.1719) (0.1713)
αdp26:age -1.4174 -1.2584 -1.2593
(0.2942) (0.2981) (0.2975)
αdp52:age -1.9150 -1.6638 -1.6507
(0.7653) (0.7753) (0.7769)
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Figure 3.38: The “residual effects” and “partial residual effects” plots for the discrete
covariates – cs61.
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Figure 3.39: The “partial residual effects” plots for year – cs61.
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Figure 3.40: The “partial residual effects” plots for age – cs61.
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Figure 3.41: Two-dimensional plots of deviance residuals for cs61 data.
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Recovery intensity model for cs62
For cs62, Table 3.14 shows, in columns two to four, the results from Models I, II
and III, respectively. Model I is the Cox model which assumes that all covariate
effects stay constant for all sickness durations. This assumption is not valid for
xyear, xrated, xdp4, xdp13 and xdp26 because the smoothed plots of their scaled Schoen-
feld residuals as shown in Figure 3.42 suggests that their respective coefficients are
duration dependent and can be parameterised as
βyear(z) = αyear + γyear(τyear − z)+ + θyearC1(t1.3(z))
βrated(z) = αrated + φrated1(C1(t1.3(z))− C1(t1.3(τrated)))+
+ φrated2(C1(t1.3(z))− C1(t1.3(τrated)))2+
βdp4(z) = αdp4 + γdp41(τdp41 − z)+ + γdp42(τdp42 − z)+
βdp13(z) = αdp13 + γdp13(τdp13 − z)+
βdp26(z) = αdp26 + γdp26(τdp26 − z)+
where τyear = 30.5, τrated = 206.5, τdp41 = 40.5, τdp42 = 72.5, τdp13 = 131.5 and τdp26 =
206.5
Model II is obtained by including in Model I additional covariates created to de-
scribe the duration-varying effects of xyear, xrated, xdp4, xdp13 and xdp26. Lastly, Model
III is the fully parameterised recovery intensity model with the baseline intensity de-
scribed by a exp(
∑3
i=0 biCi(t1.3(z))) formula. This final fitted model is then assessed
for its goodness-of-fit. The value of the χ2 statistic is 805.1444. With 866 cells and
31 parameters fitted in the model, the probability value is 0.7652 on 835 degrees of
freedom, indicating a reasonably good fit to the data. The “residual effects” and
“partial residual effects” plots for the discrete covariates are presented in Figure 3.43.
The data upon which each plot is based on is indicated by the caption of the plot.
Figures 3.44 and 3.45 show the “partial residual effects” plots for age and year, re-
spectively, for each sickness duration band. The red curves overlaid on the plots in
Figures 3.43–3.45 are the estimated smooth intensities according to Model III which
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have provided a good fit to the actual experience. The two-dimensional plots of the
deviance residuals for all data as well as its subset are shown in Figure 3.46. Apart
from ‘Female & Rated’ data for which the data is sparse, the positive and negative
deviance residuals for other subsets of data are roughly randomly scattered.
10 20 50 100 200 500 1000 2000 5000
−
10
−
5
0
5
10
Be
ta
(z)
 fo
r y
ea
r
Days
50 100 200 500 1000 2000 5000
−
4
−
2
0
2
4
Be
ta
(z)
 fo
r r
ate
d
Days
50 100 200 500 1000 2000 5000
−
15
−
10
−
5
0
5
Be
ta
(z)
 fo
r D
P4
Days
100 200 500 1000 2000 5000
−
5
0
5
10
Be
ta
(z)
 fo
r D
P1
3
Days
200 500 1000 2000 5000
−
10
−
5
0
5
10
Be
ta
(z)
 fo
r D
P2
6
Days
Figure 3.42: The smoothed plots of the scaled Schoenfeld residuals for
xyear, xrated, xdp4, xdp13 and xdp26 in cs62.
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Table 3.14: Parameters in the intermediate and final recovery intensity models for cs62.
Model I Model II Model III Model I Model II Model III
k 1.3 αdp4 -0.4200 0.1026 0.1096
b0 11.3558 (0.0340) (0.0337) (0.0307)
(1.2348) τdp4
1
40.5 40.5
b1 -24.7647 γdp4
1
-0.1028 -0.1021
(2.4823) (0.0129) (0.0106)
b2 7.7475 τdp4
2
72.5 72.5
(1.2102) γdp4
2
-0.0237 -0.0242
b3 -3.6943 (0.0023) (0.0016)
(0.6415) αdp13 -0.6116
αsex -0.2179 -0.2402 -0.2375 (0.0437)
(0.0352) (0.0352) (0.0352) τdp13 131.5 131.5
αage -0.2245 -0.2581 -0.2574 γdp13 -0.0358 -0.0362
(0.1100) (0.1102) (0.1100) (0.0036) (0.0033)
αage2 0.1137 0.0683 0.0704 αdp26 -0.7504 -0.1379 -0.1652
(0.0958) (0.0962) (0.0962) (0.0646) (0.0622) (0.0612)
αage3 0.1387 0.1477 0.1445 τdp26 206.5 206.5
(0.0556) (0.0559) (0.0558) γdp26 -0.0493 -0.0430
αage4 0.1560 0.1226 0.1231 (0.0168) (0.0163)
(0.0418) (0.0420) (0.0420) αdp52 -1.0478 -0.4310 -0.4208
αrated -0.2151 -0.2969 -0.2852 (0.1238) (0.1221) (0.1211)
(0.0349) (0.0382) (0.0379) αdp4:age -0.3991 -0.4090 -0.4048
τrated 206.5 206.5 (0.1722) (0.1724) (0.1723)
φrated1 5.9747 5.3474 αdp13:age -0.7739 -0.8002 -0.8077
(0.9070) (0.7839) (0.2271) (0.2279) (0.2288)
φrated2 -13.3007 -11.2222 αdp26:age -0.8927 -0.7682 -0.7695
(3.1531) (2.7736) (0.1497) (0.1485) (0.1483)
αyear -0.3237 -0.2868 -0.2713 αdp4:age3 -0.2303 -0.2626 -0.2575
(0.0783) (0.0467) (0.0466) (0.0867) (0.0870) (0.0869)
θyear -0.9224 -0.9608 αdp13:age3 -0.2362 -0.2988 -0.2956
(0.1758) (0.1753) (0.1175) (0.1180) (0.1185)
τyear 30.5 30.5 αdp52:age3 0.6734 0.5748 0.5760
γyear 0.0369 0.0345 (0.1677) (0.1675) (0.1675)
(0.0032) (0.0031) αsex:year 0.1232 0.1985 0.1988
αyear2 -0.0447 -0.0224 -0.0220 (0.0685) (0.0687) (0.0687)
(0.0271) (0.0273) (0.0273) αrated:year2 0.1041 0.1942 0.1940
(0.0429) (0.0441) (0.0441)
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Figure 3.43: The “residual effects” and “partial residual effects” plots for the discrete
covariates – cs62.
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Figure 3.44: The “partial residual effects” plots for year – cs62.
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Figure 3.45: The “partial residual effects” plots for age – cs62.
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Figure 3.46: Two-dimensional plots of deviance residuals for cs62 data.
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Chapter 4
Modelling of the Mortality
Intensity from Sick I: Base
Mortality Intensity
4.1 Introduction
This and the following chapter are dedicated to the modelling of the mortality intensity
among UK IPI claimants from sick. The modelling of the mortality intensity among
UK IPI claimants has been attempted before but on a smaller set of data than the
one we are using. Examples include CMI Report 12 (1991), Renshaw and Haberman
(1995, 2000) and CMI Working Paper 5 (2004). The latter two will be discussed in
greater detail because both these studies looked at sickness data from a longer period
of time and presented some interesting findings.
Renshaw and Haberman (2000) modelled the mortality intensity from sick among
IPI claimants using data from 1975 to 1994 inclusive for all causes of sickness com-
bined. They incorporated sex, sickness duration, age and calendar year as covariates
in their multiplicative mortality model and fitted the model using a GLM with Poisson
error structure and log link. The main results drawn from their mortality modelling
exercise are as follows:
(a) Sickness duration is the dominant explanatory variable, accounting for the
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biggest drop in the residual deviance. At the exploratory analysis phase, sick-
ness duration is discretised into 11 sickness duration intervals and included
in the model as categorical factors. Graphical examination of these duration-
dependent factors shows that the effect of sickness duration on the mortality
intensity follows a bell-shaped curve with the mortality intensity rising rapidly,
peaking at around 26 weeks and falling off until it shows a slight up-turn at
very long term sickness durations. However, the factors for these long term
sickness duration intervals are only of marginal statistical significance. In the
final model adopted, sickness duration is modelled as a continuous covariate by
using piecewise linear splines with 4 knots.
(b) Age is incorporated as a linear term in the model with a positive regression
coefficient, implying that the mortality intensity increases log linearly with age.
(c) Year is incorporated as a linear term in the model with a negative regression
coefficient, implying that the mortality intensity declines (or improves) over the
20 years from 1975 to 1994.
(d) Females experienced a lower mortality intensity than males.
(e) There are no interaction terms between any of the covariates.
CMI Working Paper 5 (2004) presented the graduation of the mortality experi-
ence for IPI male claimants from occupational class 1 from 1991 to 1998 inclusive.
Despite the data spanning eight years, the year effect is not included in the model
because preliminary investigation shows that the sickness experience from 1991 to
1998 as a whole was considered rather homogeneous. A multiplicative model with
attained age and sickness duration as explanatory variables was first investigated. As
in Renshaw and Haberman (2000), it is of interest to note that the duration-related
factors, examined when a multiplicative mortality intensity model was considered, has
a bell-curved shape, with intensity rising, peaking between 18 and 22 weeks, falling
off before showing an upturn at the very last interval representing sickness duration
exceeding 8 years. The authors attribute this eventual up-turn to a more dominant
ageing process taking effect. However, given a high χ2 test value that indicates a poor
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fit of this multiplicative model, it was abandoned in favour of an additive model. The
new proposed mortality intensity model consists of two additive components. The
first component is a Weibull formula, a hump-backed function of sickness duration
z, designed to capture the variation of the mortality intensity with sickness dura-
tion, capped at 5 years for practical reasons. The second component is a Gompertz
formula, a function of attained age alone. It was introduced in recognition of an
inevitable increase in the mortality intensity with increasing attained age, which is
not achievable with the first component alone. At a conceptual level, this mortality
model resembles the Pollard-Heligman model (Heligman & Pollard, 1980) which has
three components to deal with three phases of age-related mortality change. The final
graduation formula is presented in Appendix D.
Let x be a covariate vector consisting of sex, age, year, rating indicator and de-
ferred period. The notation representing these covariates and their coding are no
different to those in the recovery intensity model (see Section 3.2) with the exception
that the age in the mortality analysis is defined as attained age and not age at sickness
inception as in the case of the recovery intensity model. The mortality intensity from
sick of an individual (with covariates x) who has been ill or disabled with a specific
cause for duration z, λ(z,x), is therefore modelled as
λ(z,x) = λ∗(x) + ν(z,x) (4.1)
where λ∗(x) is a base intensity that varies by sex, attained age and calendar year while
ν(z,x) denotes the ‘excess’ mortality incurred from being sick with a specific cause
for duration z. This ‘excess’ mortality can be interpreted as the mortality in excess of
that experienced by a comparable population as a result of being sick for duration z.
The base mortality intensity in Equation (4.1), as with the Gompertz formula in CMI
Working Paper 5 (2004), provides a means to counteract the eventual fall in excess
mortality at long term sickness duration. In the case of IPI claimants, we regard the
UK assured lives population as a reasonably comparable group from which the base
mortality, an increasing function of age, can be estimated. Unlike in CMI Working
Paper 5 (2004), we do not derive this base mortality from the IPI data itself because
most recoveries or deaths occur within the first few years of sickness durations, leaving
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insufficient sickness data remaining at long term sickness durations at an individual
cause of sickness level to make the modelling of a monotonic increasing function of
age meaningful.
A mortality model that takes into account the mortality intensity of a comparable
population has widespread application in cancer research and is often referred to as
the ‘relative survival model’ in the medical statistics literature (see Dickman et al,
2004). There are two main classes of relative survival models. Apart from the addi-
tive mortality intensity model presented in Equation (4.1), there is the multiplicative
mortality intensity model where the intensity function is the product of the ‘standard’
mortality and a risk factor (relative mortality) due to a particular sickness (see Ander-
sen et al, 1985). Such a multiplicative model has been attempted in actuarial work.
Renshaw (1988) introduced a mortality model for impaired lives with hypertension in
which the impairment has a multiplicative effect on a standard mortality intensity ob-
tained by a suitable transformation of the A1967-70 standard table. Haberman and
Renshaw (1990) adopted similar approach in assessing the excess mortality among
insured lives who have peptic ulcer.
The advantage of using the additive mortality intensity model in Equation (4.1)
over the direct cause-specific mortality modelling in the context of cancer research
is discussed in Dickman et al (2004). They remarked that the modelling of a cause-
specific mortality intensity requires accurate information regarding the cause of death
and in cancer research, such information can be unreliable when a death is due to
cancer spreading to several body organs (metastasisation). With respect to IPI data,
unreliability in using cause of sickness as cause of death can occur. It is usually the
case that the cause of sickness recorded in the claim data remain unchanged even
if the claimant eventually dies from a sickness different from it. For example, an
IPI claimant who later dies from cerebrovascular disease even though the sickness
that gave rise to his/her IPI claim is mental illness. Thus, Equation (4.1) provides a
convenient tool to gauge the excess mortality of a sickness, regardless of whether the
death is directly or indirectly related to the sickness in question.
The IPI data that we are given covers the calendar years from 1975 to 2002 dur-
ing which considerable changes in the mortality of assured lives took place. In this
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chapter, we focus on the modelling of assured lives mortality intensities during these
years for males and females separately. In Section 4.2, we describe the assured lives
data set for males and females. In Section 4.3, we present a structured approach to
incorporate both age and calendar year effect in a mortality model. Such methodol-
ogy is then implemented on the male and female assured lives data sets separately,
the results of which are presented in Sections 4.4 and 4.5, respectively.
4.2 Data
The assured lives data set we used is provided by the CMI. The data is for all durations
(0, 1 and 2+) amalgamated together and is cross-classified by
• sex : male, female
• age nearest birthday (x) : 20, 21, 22,. . . , 90
• calendar year (y): 1975, 1976, . . . , 2003 for male
: 1983, 1984, . . . , 2003 for female
Based on this cross-classification, separately for males and females, we have values
for the number of deaths (dxy) at age x in calendar year y and its matching central
exposed-to-risk (rxy). Figures 4.1 and 4.2 present the crude mortality intensities for
males and females respectively plotted on the log scale against calendar year. These
graphs show a downward trend in both male and female mortality intensity at these
equally spaced ages but the slope with which the mortality intensities decline is not
uniform across these ages.
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Figure 4.1: Crude mortality intensities vs calendar year for male assured lives plotted
on a log scale for ages 30, 35, . . ., 90.
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Figure 4.2: Crude mortality intensities vs calendar year for female assured lives plotted
on a log scale for ages 30, 40, . . ., 90.
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4.3 Modelling Techniques
We will model the mortality intensity from sick for males and females separately. Let
λx,y denote the mortality intensity at age x in calendar year y. For computational
stability, we re-scale both age (x) and year (y) such that
x′ =
x− 55
35
, y′ =
y − 1989
14
.
We first propose a general model for λx,y as
λx,y = λ0(x
′) exp(
n∑
i=1
αi(x
′)Ci(y
′)) (4.2)
where λ0(x
′) is the baseline intensity that depends only on age, while exp(
∑n
i=1 αi(x
′)Ci(y
′))
is the relative risk for an individual in year y, when compared to the baseline intensity.
In this relative risk component, Ci(y
′) denotes the Chebycheff polymonial of degree i
while αi(x
′) is the age-dependent coefficient of the year effect. The downward trend in
the UK assured lives mortality intensity over the years is not uniform across all ages
and to take account of this variation in year trend, we incorporate an age-dependent
year coefficient, with the following structure:
αi(x
′) =
p∑
j=1
ψij(x
′)βij (4.3)
where ψij(x
′) denotes the age-related term and βij denotes its regression coefficient.
We will first make an assumption that the baseline mortality intensity between
integer age x and x + 1 is constant and is denoted by λx. The mortality intensity of
an individual whose age lies in [x, x+ 1) is
λxy = λx exp(
n∑
i=1
αi(x
′)Ci(y
′)) . (4.4)
Taking logs on both sides of Equation (4.4), we obtain the following additive
log-linear model
log(λxy) = log(λx) +
n∑
i=1
αi(x
′)Ci(y
′) . (4.5)
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Following this piece-wise constant baseline intensity assumption, the likelihood of
the data is given by
L =
∏
x,y
exp(−rxyλxy)λdxyxy . (4.6)
Taking logs on both sides of Equation (4.6), the log likelihood of the data is given
by
logL =
∑
x,y
(−rxyλxy + dxy log(λxy)) . (4.7)
Then Equation (4.7) can be combined with Equation (4.4) to give
logL =
∑
x,y
(−rxyλx exp(
n∑
i=1
αi(x
′)Ci(y
′))+dxy log(λx)+dxy
n∑
i
αi(x
′)Ci(y
′)) . (4.8)
Differentiating Equation (4.8) with respect to λx and setting it equal to zero gives
λˆx =
∑
y dxy∑
y rxy exp(
∑n
i=1 αi(x
′)Ci(y′))
(4.9)
which is the maximum likelihood estimate for λx and can be substituted into Equation
(4.8) to yield a likelihood that does not depend on the baseline intensity given by
logL =
∑
x
∑
y
dxy(
n∑
i=1
αi(x
′)Ci(y
′))−
∑
x
(
∑
y
dxy) log(
∑
y
rxy exp(
n∑
i=1
αi(x
′)Ci(y
′)))+C
(4.10)
where C is a term independent of any parameter of interest. By exponentiating
Equation (4.10), we obtain
L =
∏
x
∏
y
(
exp(
∑n
i=1 αi(x
′)Ci(y
′))∑
y rxy exp(
∑n
i=1 αi(x
′)Ci(y′))
)dxy
. (4.11)
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The likelihood given in Equation (4.11) is the grouped data version of Cox’s partial
likelihood as given in Equation (3.12). To estimate all the parameters in Equation
(4.4), we can obtain β̂ from maximising Equation (4.11) and then obtain λ̂x by
substituting β̂ into Equation (4.9).
Holford (1980) and Laird and Oliver (1981) show an alternative method to esti-
mate the parameters by noting that the piece-wise constant baseline intensity model
(Equation (4.4)) will produce the same estimates as the Poisson regression model be-
cause the likelihoods obtained from both approaches are proportional to each other.
As such, we treat the observed number of deaths dxy at age x in calendar year y as
the realisation of a Poisson random variable, Dxy, with mean and variance
E(Dxy) = µxy = rxyλxy, Var(Dxy) = µxy . (4.12)
Substituting Equation (4.4) into Equation (4.12) and taking logs on both sides of
the equation, we obtain
log(µxy) = log(rxy) + log(λx) +
n∑
i=1
αi(x
′)Ci(y
′) . (4.13)
We can estimate all the parameters in Equation (4.13) using a GLM, with a Poisson
error structure, log link and log(rxy) as an offset term. The advantage of using this
approach is that we can use the convenience of the GLM framework, which is available
in R, to do the estimation.
The use of GLMs in actuarial applications, including the modelling of mortality,
is not unusual (see Renshaw (1991), Haberman and Renshaw (1996)). In Renshaw
et al (1996), the mortality experience for male assured lives for duration 5 years and
over, from 1958 to 1990 inclusive, is analysed using a log linear Poisson regression
model in a GLM. In their approach, the multiplicative structures for both age and
calendar year are modelled simultaneously, followed by an age dependent trend ad-
justment through the inclusion of interaction terms between age and calendar year.
The approach described in this section provides an alternative way to utilise the
convenience of the GLM framework to estimate the mortality intensity model in a
structured manner. The general procedure is as follows:
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(i) By treating the baseline intensity as piece-wise constant so that parameterisa-
tion of the baseline intensity is not necessary, we can model and estimate the
parameters in the relative risk component of Equation (4.2). Any age dependent
trend adjustment is included at this stage.
(ii) We choose to use a GM(r, s) structure for the baseline intensity, which is defined
as follows:
GMr,sa,b(x) =
r∑
i=1
aix
i−1 + exp(
s∑
i=1
bix
i−1) . (4.14)
With a GM(r, s) formula imposed on the baseline intensity, the likelihood of
the data is maximised by fixing the regression coefficients in the relative risk
component at the values found in (i). The optimal GM(r, s) is then chosen by
examining the log likelihood values from fitting various GM(r, s) formulae.
(iii) Following (i) and (ii), we will have a complete structure for Equation (4.2).
Parameter values can be determined using maximum likelihood estimation.
The results of the implementation of such an approach on both male and female
assured lives data sets separately are presented in Sections 4.4 and 4.5.
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4.4 Mortality Model for Male Assured lives
In this section, we focus on the modelling of the mortality experience for male assured
lives aged between 20 and 90 from year 1975 to 2003 inclusive using the techniques
in Section 4.3. We take as our starting point the model structure
log λxy = hx +
n∑
i=1
(βi + βix)Ci(y
′), for x = 20, 21, . . . , 90 (4.15)
subject to the constraints
βi20 = 0, for i = 1, 2, . . . , n
where hx is a factor indicating the constant baseline intensity and the coefficients of
year-related terms are allowed to vary by every single age. In the same spirit as the
Lee-Carter model (Lee and Carter, 1992), hx is the average age-specific pattern of
mortality, Ci(y
′) (i = 1, . . . , n) captures the main year trend on the logarithmic scale
in mortality intensities at all ages while βix measures the age-specific deviation from
the main year trend.
Table 4.1 shows the order in which various sets of parameters in Equation (4.15)
are fitted sequentially (column one), the model deviances with additional parameter(s)
(column two), the number of degrees of freedom obtained after subtracting the number
of parameters fitted from 2059 (=29 × 71) (column three) and the AIC (Akaike, 1974)
value for each model (column four). Columns five and six of Table 4.1 are constructed
by calculating the differences in deviance and degrees of freedom respectively, as a
result of introducing additional parameter(s) sequentially into the model.
The model with the lowest AIC value is selected. As a result, both β5 and β5x
will be excluded from our model because inclusion of these parameters increases the
value of the AIC. Therefore, the model structure we have chosen is
log λxy = hx +
4∑
i=1
(βi + βix)Ci(y
′), for x = 20, 21, . . . , 90. (4.16)
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subject to the constraints
βi20 = 0, for i = 1, 2, 3, 4.
This model structure involves a total of 355 parameters, entailing the need for
a more parsimonious model. In the search for a suitable functional form for the
age-dependent year coefficients, we plotted each of the resulting sets of parameter
estimates {β1x}, {β2x}, {β3x}, {β4x} (Equation (4.16)) against x. These four plots are
produced in Figure 4.3. We will use a natural cubic spline basis, due to its flexibility,
to model the age-dependent year coefficient. Consider k fixed knots τ1, . . . , τk and let
(x′ − τj)+ =
 (x′ − τj) if x′ ≥ τj0 otherwise .
The age-dependent coefficient of Ci(y
′), αi(x
′), can be represented by
αi(x
′) = βi + γi1x
′ +
j=k−2∑
j=1
γijwj(x
′) (4.17)
where, as given by Devlin and Weeks (1986),
wj(x
′) = (x′ − τj)3+ − (x′ − τk−1)3+
(τk − τj)
(τk − τk−1) + (x
′ − τk)3+
(τk−1 − τj)
(τk − τk−1) . (4.18)
We explore the effect of using different numbers of knots and varying the placement
of knots. One method is to use a visual trial and error process. A less ad hoc method
is to use AIC values to select the optimal number of knots. The number of knots
that produced the lowest AIC is chosen. Generally, it is a standard practice to place
the knots at fixed quantiles in the data. However, we shall have occasion to resort to
using a visual trial and error process to guide the placement of knots.
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Table 4.1: Deviance profiles associated with sequential inclusion of parameters in
Equation (4.15).
Difference
Model terms Deviance D.f. AIC Deviance D.f.
hx 25760 1988 39932
20741.2 1
+ β1 5018.8 1987 19193
1527.2 70
+ β1x 3491.6 1917 17805
64.8 1
+ β2 3426.8 1916 17743
215.4 70
+ β2x 3211.4 1846 17667
12.5 1
+ β3 3198.9 1845 17657
193.9 70
+ β3x 3005.0 1775 17603
8.1 1
+ β4 2996.9 1774 17597
142.6 70
+ β4x 2854.3 1704 17594
0.4 1
+ β5 2853.9 1703 17596
121.2 70
+ β5x 2732.7 1633 17615
First, we fitted models with three to eight knots for α1(x
′) in turn. The quantiles
of the data where knots are placed are shown in Table 4.2. The AIC values for these
models are shown in the upper left corner of Table 4.3. The model with 6 knots for
α1(x
′) returns the lowest AIC value and is selected. The locations of the 6 knots are
23.5, 36.1, 48.7, 61.3, 73.9 and 86.5.
Following the inclusion of a 6-knots natural cubic spline basis for α1(x
′) in the
model, we introduce into our model sequentially three to eight knots for α2(x
′). The
resulting AIC value for each model is shown in the upper right corner of Table 4.3.
We settle on a 6-knot natural spline basis since its associated model returns the lowest
AIC value. The locations of the 6 knots are 23.5, 36.1, 48.7, 61.3, 73.9 and 86.5.
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Focusing on α3(x
′), a model with 8-knots for α3(x
′) returns the lowest AIC value.
However, we reckon that is too many parameters for α3(x
′). Hence, we endeavour
to achieve a similar reduction in the AIC by using a smaller number of knots placed
at locations other than quantiles. After a considerable trial and error process, it
transpires that we can use 6 knots located at 21.75, 50.25, 59.75, 69.25, 78.75 and
88.25 to achieve a similar fit.
As for α4(x
′), the value of the AIC increases with each additional knot until the
number of knots placed reaches 7. We felt that this sudden drop in the AIC is due
to additional knots being placed at a narrow cluster of points where a considerable
change of shape occurs. Again, we try to see whether we can use the same or fewer
number of knots placed at locations other than quantiles to achieve a similar reduction
in the AIC. We eventually settle on 6 knots located at 23.5, 45.5, 55, 65, 67.5 and
88.25.
Table 4.2: Location of knots for different numbers of knots.
k Quantiles
3 0.10 0.5 0.9
4 0.05 0.35 0.65 0.95
5 0.05 0.275 0.5 0.725 0.95
6 0.05 0.23 0.41 0.59 0.77 0.95
7 0.025 0.1833 0.3417 0.5 0.6583 0.8167 0.975
8 0.025 0.1607143 0.2964286 0.4321429 0.5678571 0.7035714 0.8392857 0.975
After the number of knots and the placement of knots are decided for αi(x
′),
i = 1, . . . , 4, Equation (4.16) is updated to read as follows:
log λxy = hx +
4∑
i=1
(βi + γi1x
′ +
j=5∑
j=2
γijwj(x
′))Ci(y
′) . (4.19)
Details of the parameter estimates are set out in Table 4.4.
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Figure 4.3: Age-varying year coefficients. The superimposed solid red line is obtained
from the estimated coefficients in Table 4.4 – piece-wise constant baseline intensity;
The superimposed solid green line is obtained from the estimated coefficients in Table
4.6 – GM(0,7) baseline intensity.
Table 4.3: AIC values for differing numbers of knots in each age-dependent year
coefficient.
α1(x
′) α2(x
′)
Number of knots AIC Number of knots AIC
3 17628 3 17612
4 17620 4 17587
5 17592 5 17586
6 17586 6 17566
7 17588 7 17569
8 17588 8 17569
α3(x
′) α4(x
′)
Number of knots AIC Number of knots AIC
3 17614 3 17588
4 17612 4 17590
5 17591 5 17589
6 17593 6 17590
7 17589 7 17573
8 17578 8 17587
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Table 4.4: Parameter estimates in Equation (4.19) with their standard errors.
Symbol Estimate Std. Error Symbol Estimate Std. Error
β1 −0.041694 0.102319 γ31 0.045130 0.055406
β2 0.114559 0.085673 γ32 0.045598 0.034499
β3 −0.005700 0.029220 γ33 −1.459982 0.329608
β4 0.124049 0.034187 γ34 4.293769 0.739948
γ11 0.047987 0.155690 γ35 −5.552429 0.961165
γ12 −1.550461 0.291322 γ41 0.200165 0.057682
γ13 4.816272 0.735973 γ42 −0.261402 0.059528
γ14 −4.822574 0.736087 γ43 2.168820 0.415472
γ15 1.325711 0.559288 γ44 −4.808512 0.877838
γ21 0.223883 0.129901 γ45 11.400437 2.309315
γ22 −0.124763 0.246787
γ23 −0.343810 0.631599
γ24 1.790896 0.649017
γ25 −2.352727 0.503456
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Having found a structure for the relative risk component, we focus on the gradu-
ation of the baseline intensity by using a GM(r, s) formula (see Equation (4.14)). By
using a GM(r, s) formula to graduate the piece-wise constant mortality intensity, the
log likelihood of the data is given by
logL =
∑
x
∑
y
−rxyλa,b(x) exp(
4∑
i=1
αi(x
′)Ci(y
′))+dxy log(λa,b(x))+dxy
4∑
i
αi(x
′)Ci(y
′)
(4.20)
where λa,b(x) is the smooth baseline intensity taking a GM(r, s) strcuture. We first
focus on finding a functional form for the baseline hazard by fixing the values of
β and γ in αi(x
′) for i = 1, 2, 3, 4 at the estimated regression coefficients shown
in Table 4.4. Thus, the only parameters left to estimate are the a and b in the
GM(r, s) formula. We fitted different GM(r, s) formulae in Equation (4.20). Table
4.5 gives twice the difference between the log likelihood from each model and the log
likelihood from GM(0,2). The log likelihood is calculated by ignoring the last term in
Equation (4.20). Additional parameter(s) are only worthwhile if twice the difference
in log likelihood when approximated to a χ2 distribution with the appropriate degrees
of freedom, is statistically significant. With this in mind, we settled on a GM(0,7)
formula for the baseline intensity.
Table 4.5: Twice the difference between the log likelihood from each each GM(r, s)
formula and the log likelihood from GM(0,2).
r s = 2 s = 3 s = 4 s = 5 s = 6 s = 7 s = 8
0 0 838 3115 3489 3588 3609 3610
1 2422 3340 3398 3557 3608 3609
2 3507 3521 3575 3578 3608
3 3508 3564 3575 3579
4 3555 3565 3598
5 3557 3565
6 3557
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With a GM(0,7) formula chosen for the baseline hazard, we can update Equation
(4.19) to give
log λxy =
6∑
i=0
biCi(x
′) +
4∑
i=1
(βi + γi1x
′ +
j=5∑
j=2
γijwj(x
′))Ci(y
′) . (4.21)
Note that with a GM(0,7) formula for baseline hazard, we can maintain the log-
linear property of Equation (4.21) and all the parameters can be estimated in the
GLM framework. The parameter estimates and their standard errors are set out in
Table 4.6. A comparison between the parameter estimates for β and γ in Table 4.6
and their corresponding values in Table 4.4 reveals no significant discrepancy.
Table 4.6: Parameter estimates in Equation (4.21) with their standard errors.
Symbol Estimate Std. Error Symbol Estimate Std. Error
b0 −5.008173 0.007158 γ21 0.167464 0.123156
b1 3.112883 0.013179 γ22 0.028993 0.227137
b2 0.449331 0.010706 γ23 −0.800877 0.573081
b3 −0.338143 0.008173 γ24 2.362281 0.580483
b4 0.092917 0.006055 γ25 −2.815544 0.462222
b5 −0.037030 0.004121 γ31 0.043105 0.055076
b6 −0.019695 0.003306 γ32 0.044698 0.034306
β1 −0.088583 0.097105 γ33 −1.420710 0.327058
β2 0.071923 0.080383 γ34 4.172928 0.732956
β3 −0.005599 0.029076 γ35 −5.386457 0.953359
β4 0.120374 0.034071 γ41 0.194873 0.057476
γ11 −0.016607 0.148566 γ42 −0.254007 0.059278
γ12 −1.390934 0.274117 γ43 2.108121 0.413333
γ13 4.361826 0.689810 γ44 −4.670528 0.873335
γ14 −4.299791 0.693569 γ45 11.037816 2.300782
γ15 0.963943 0.544455
Figures 4.4 – 4.8 depict the crude and graduated mortality intensities (on the log
scale) plotted against age for calendar year 1975 to 2003. Table 4.7 gives a summary
of some of the formal statistical tests of a graduation, applied separately to all 29
calendar years. These tests are carried out on the relative deviation after fitting
the model in Equation (4.21) to the data. The p-values for the sign test, run test,
Kolmogorov-Smirnov test, serial correlation test (with lag 1, 2, 3) are recorded in
column one to column six of Table 4.7. These statistical test are discussed in detail
in Forfar et al. (1988). Any p-value that is less than 5%, indicating failure of the test
concerned, is highlighted by an asterisk.
153
20 30 40 50 60 70 80 90
−
8
−
7
−
6
−
5
−
4
−
3
−
2
1975
20 30 40 50 60 70 80 90
−
8
−
7
−
6
−
5
−
4
−
3
−
2
1976
20 30 40 50 60 70 80 90
−
8
−
7
−
6
−
5
−
4
−
3
−
2
1977
20 30 40 50 60 70 80 90
−
8
−
7
−
6
−
5
−
4
−
3
−
2
1978
20 30 40 50 60 70 80 90
−
8
−
7
−
6
−
5
−
4
−
3
−
2
1979
20 30 40 50 60 70 80 90
−
8
−
7
−
6
−
5
−
4
−
3
−
2
1980
Figure 4.4: Log graduated and crude mortality intensities vs age for male assured
lives from 1975–1980. The vertical lines are the 95% confidence interval based on the
crude estimates.
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Figure 4.5: Log graduated and crude mortality intensities vs age for male assured
lives from 1981–1986. The vertical lines are the 95% confidence interval based on the
crude estimates.
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Figure 4.6: Log graduated and crude mortality intensities vs age for male assured
lives from 1987–1992. The vertical lines are the 95% confidence interval based on the
crude estimates.
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Figure 4.7: Log graduated and crude mortality intensities vs age for male assured
lives from 1993-1998. The vertical lines are the 95% confidence interval based on the
crude estimates.
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Figure 4.8: Log graduated and crude mortality intensities vs age for male assured
lives from 1999-2003. The vertical lines are the 95% confidence interval based on the
crude estimates.
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Table 4.7: Percentage p-value for graduation tests for each calendar year separately
on male assured lives.
Year Sign Run KS Serial Cor. Test
Test Test Test 1 2 3
1975 50.0 23.7 78.5 4.9* 23.6 69.8
1976 95.2 17.3 86.9 3.6* 88.4 85.3
1977 11.7 38.8 66.0 81.8 85.1 21.4
1978 23.8 18.9 81.5 21.0 45.8 40.4
1979 11.7 38.8 29.0 27.9 95.1 54.1
1980 50.0 11.6 96.2 61.3 95.1 13.5
1981 31.7 42.1 48.9 24.6 59.6 90.7
1982 50.0 83.1 39.8 77.0 14.1 39.7
1983 82.9 85.3 66.0 73.7 12.7 92.7
1984 4.8* 55.8 64.3 24.4 80.3 28.5
1985 59.4 83.1 26.4 71.2 63.0 34.4
1986 76.2 61.0 7.2 33.0 10.4 74.9
1987 7.7 41.9 6.5 50.8 2.9* 57.3
1988 40.6 32.2 48.8 12.4 12.9 97.2
1989 31.8 33.1 95.2 37.8 39.6 40.4
1990 99.2 55.0 75.3 28.6 19.5 77.3
1991 82.9 71.4 65.0 70.8 79.5 14.1
1992 50.0 76.3 98.0 36.8 88.9 91.4
1993 23.8 8.6 35.9 1.0* 60.4 41.4
1994 11.8 22.0 76.9 8.1 76.5 86.6
1995 0.8* 51.2 94.1 27.6 89.9 23.9
1996 7.7 99.9 30.9 48.2 96.4 63.6
1997 59.4 59.4 81.3 22.1 21.0 85.9
1998 97.2 87.6 44.4 69.8 27.3 62.1
1999 68.2 60.0 99.7 56.0 48.1 71.3
2000 31.8 1.7* 9.5 6.0 48.8 13.1
2001 7.7 61.4 98.4 83.5 68.7 83.0
2002 40.6 24.1 30.8 36.1 80.9 87.7
2003 76.2 12.3 87.1 17.0 9.7 94.1
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Figures 4.4- 4.8 show that the graduated values fitted the crude estimates ade-
quately. From these figures, the graduated values for 1986 seemingly fit the crude
estimates better than those for 1997 because the graduated values for 1997 fit poorly
the crude estimates at younger age range. However, the results from the Kolmogorov-
Smirnov test seem to indicate the opposite. The Kolmogorov-Smirnov test we use
considers the distribution of the maximum deviation between the distributions of ac-
tual and expected deaths and therefore more weight is given to older ages with a
lot of deaths than to younger ages does with few deaths. In other words, this test
tends to be more sensitive to ages with a lot of deaths (i.e. near the median of the
distribution) than to ages with few deaths (i.e. at the tail of the distribution). In
Table 4.7, of the 174 tests conducted, only 7 tests produced p-value which is less than
the 5% significance level.
For each distinct combination of age and calendar year, we will calculate its de-
viance residual (see Equation (3.26)). Figure 4.9 shows the two-dimensional plot of
the deviance residuals, with calendar years as rows and ages as columns. The red and
blue rectangles represent positive and negative deviance residuals, respectively. Each
colour is expressed in three different intensities, representing the different ranges of
values for the deviance residual (see legend of graph). There is a total of 2059 (29
× 71) deviance residuals, of which 983 are positive and 1076 are negative. Assum-
ing that the number of positive signs is binomially distributed as B(2059, 0.5), the
p-value is 2(1-0.97871)=0.043, suggesting the observed number of positive signs is
slightly less than expected. However, the positive and negative signs seems fairly
randomly scattered.
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Figure 4.9: A two-dimensional plot of deviance residuals for male assured lives aged
20 to 90 from calendar year 1975 to 2003.
4.5 Mortality Model for Female Assured lives
In this section, we focus on the modelling of the female assured lives mortality inten-
sity. The UK female assured lives data is available only from 1983 to 2003. Thus, we
need to make sure that the mortality model fitted to the 1983-2003 data will produce
sensible results when the mortality intensities are extrapolated back to 1975. In this
respect, we are guided by CMI Report 6 (1983) that produced a graduation formula
for the ultimate mortality probability, qx, based on female assured lives data from
1975-1978. For all ages x ≥ 0, the ultimate mortality probability qx is given by the
formula
qx =
exp(f(x))
1 + exp(f(x))
where
f(x) = a1 + a2t+ a3(2t
2 − 1) + a4(4t3 − 3t) + a5(8t4 − 8t3 + 1)
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t =
x− 70
50
a1 = −2.96537254
a2 = 6.23522259
a3 = 1.18884477
a4 = 0.39070030
a5 = 0.19540908 .
We can then obtain an estimate for µx(x = 20, 21, 22, . . . , 90) by using
µx = − ln(1− qx−1/2) . (4.22)
The mortality intensities from Equation (4.22) will be taken as the intensities at
1977, the mid point of the quadrennia 1975-1978. We denote this set of mortality
intensities as FA77 and aim to fit a female mortality model such that when the
mortality intensities are extrapolated back to 1977, the intensities produced will be
very close to FA77.
First, we take as our starting point the model structure
log λxy = hx + φy, forx = 20, 21, . . . , 90 (4.23)
where hx and φy are the factors representing age x and year y, respectively. We
estimated all the parameters by using a Poisson regression model and plotted hˆ45+ φˆy
against year y for y = 1983, 1984, . . . , 2003 in Figure 4.10. The triangle shape symbol
is the FA77 intensity at age 45. To make sure the mortality intensity varies linearly
by year outside the data range, we will use natural cubic splines to model the year
effect. Table 4.8 shows the AIC values obtained by replacing the {φy} with a natural
cubic spline with differing numbers of knots.
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Figure 4.10: Plotting of hˆ45 + φˆy against year y. The superimposed solid red line is
obtained from the estimated coefficients of year related terms in Equation (4.24). The
triangle symbol is the FA77 rate at age 45.
Table 4.8: AIC values for different numbers of knots to model the year effect in
Equation (4.23).
Number of knots Placement of knots AIC
4 1975, 1985, 1993, 2001 9620.0
5 1975, 1984, 1990, 1996, 2002 9623.9
6 1975, 1983.7, 1988.5, 1993.0, 1997.5, 2002 9619.5
7 1975, 1984, 1987, 1991, 1994, 1998, 2002 9622.8
8 1975, 1983.5, 1986.666, 1989.834, 9622.0
1993, 1996.166, 1999.334, 2002.5
We settled on 6-knot natural spline for the calendar year effect since it gives the
lowest AIC value. The estimated regression coefficients of the 6-knots spline basis are
given in the following equation.
log λxy = hx − 0.8509y′ + 0.5613w1(y′)− 2.7045w2(y′) + 4.4548w3(y′)− 3.6786w4(y′)
(4.24)
where w(y′) is a natural spline basis as defined in Equation (4.18). The fitted mortality
intensities at age 45 from 1975 to 2003, given in Equation (4.24), are overlaid in Figure
4.10. In this same graph, note that the extrapolated value at year 1977 is close to the
corresponding FA77 rate (triangle symbol).
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We will further refine our model by allowing for age-dependent year coefficients.
In the absence of data from 1975-1983, we felt that it is reasonable not to allow the
coefficients of y′ and w1(y
′), the two year terms that dictate the year trend between
1975 and 1983, to vary by age. With coefficients of w2(y
′), w3(y
′) and w4(y
′) varying
by every single age, the structure of our model then becomes
log λxy = hx + β1w1(y
′) + β2w2(y
′) +
5∑
i=3
90∑
x=21
(βi + βix)wi(y
′). (4.25)
We plotted the resulting sets of parameter estimates {β3x}, {β4x}, {β5x} (Equation
4.25) against x. These three plots are produced in Figure 4.11.
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Figure 4.11: Age-dependent year coefficients. The superimposed solid red line is
obtained from the estimated coefficients of year-related terms of Equation (4.26) in
Table 4.11.
Next, we denote by αi(x
′) the age-dependent coefficient of wi(y
′) for i = 3, 4, 5.
We use a natural cubic spline to model both α3(x
′) and α4(x
′) and a linear spline for
α5(x
′). After a lengthy trial-and-error process guided by the plots in Figure 4.11, the
number of knots chosen together with their locations are shown in Table 4.9.
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Table 4.9: Location of knots for the age-dependent year coefficients in Equation (4.26).
Number of knots Placement of knots
α3(x
′) 4 55, 68, 72, 86
α4(x
′) 4 50, 68, 75, 86
α5(x
′) 1 76
With a complete structure for αi(x
′) (i = 3, 4, 5), we can re-write Equation (4.25)
to give
log λxy = hx +
4∑
i=3
(βi + γi1x
′ +
3∑
j=2
γijwj(x
′))wi(y
′) (4.26)
+(β5 + γ51x
′ + γ52(x
′ − (76− 55)/35)+)w5(y′)
+β1w1(y
′) + β2w2(y
′).
Details of the parameter estimates and their standard errors are given in columns
two and three of Table 4.11. As for the male mortality intensity, we find a suitable
GM(r, s) formula to smooth the {hx} by fixing the values of β and γ in Equation
(4.26) at the estimated regression coefficients in column two of Table 4.11. We fitted
different GM(r, s) formulae and the log likelihood from each model is shown in Table
4.10.
Table 4.10: Twice the difference between the log likelihood from each each GM(r, s)
formula and the log likelihood from GM(0,2).
r s = 2 s = 3 s = 4 s = 5 s = 6 s = 7 s = 8 s = 9
0 0 190.5 238.3 284.6 304.4 310.9 319.8 320.8
1 102.7 206.5 297.2 299.5 305.4 311.4 321.3
2 130.5 282.9 297.9 300.3 310.5 318.0
3 271.5 289.7 297.9 311.3 317.3
4 302.6 303.1 307.8
5 303.3 319.7
6 306.7
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We settled on a GM(0,8) formula for the baseline intensity and update Equation
(4.26) to give
log λxy =
7∑
i=0
biCi(x
′) + β1w1(y
′) + β2w2(y
′) +
4∑
i=3
(βi + γi1x
′ +
3∑
j=2
γijwj(x
′))wi(y
′)
+(β5 + γ51x
′ + γ52(x
′ − (76− 55)/35)+)w5(y′).
The parameter estimates in Equation (4.27) and their standard errors are shown
in the fourth and fifth columns of Table 4.11.
Table 4.11: Parameter estimates in Equation (4.26) and (4.27) alongside their stan-
dard errors.
Piece-wise constant baseline GM(0,8) baseline
Symbol Estimate Std. Error Estimate Std. Error
b0 – – −5.939330 0.614450
b1 – – 3.367757 0.032079
b2 – – 0.309219 0.025177
b3 – – −0.061689 0.021643
b4 – – 0.111592 0.018500
b5 – – −0.078545 0.015911
b6 – – −0.005641 0.011097
b7 – – −0.028507 0.010097
β1 −0.7590 1.1666 −0.748567 1.166394
β2 0.5062 0.7566 0.496324 0.756464
β3 −2.4934 2.5506 −2.416903 2.550120
β4 3.9214 2.5417 3.758088 2.540982
β5 −2.7202 1.3849 −2.651587 1.384525
γ31 −0.7413 0.2627 −0.693227 0.259576
γ32 5.6975 1.1565 4.177638 1.009590
γ33 −67.3409 11.2553 −50.898874 9.424659
γ41 2.7578 1.0809 2.755805 1.069499
γ42 −5.3424 1.3588 −3.670702 1.209876
γ43 92.1564 17.6679 68.604318 15.027415
γ51 −2.8993 1.9056 −3.534043 1.879462
γ52 −19.7049 6.4042 −15.510799 5.744604
Figures 4.12 – 4.15 show the crude and graduated mortality intensities (on the log
scale) plotted against age from year 1983 to 2003 inclusive.
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Figure 4.12: Log graduated and crude mortality intensities vs age for female assured
lives from 1983-1988. The vertical lines are the 95% confidence interval based on the
crude estimates.
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Figure 4.13: Log graduated and crude mortality intensities vs age for female assured
lives from 1989-1994. The vertical lines are the 95% confidence interval based on the
crude estimates.
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Figure 4.14: Log graduated and crude mortality intensities vs age for female assured
lives from 1995-2000. The vertical lines are the 95% confidence interval based on the
crude estimates.
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Figure 4.15: Log graduated and crude mortality intensities vs age for female assured
lives from 2001-2003. The vertical lines are the 95% confidence interval based on the
crude estimates.
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We also show in Figures 4.16 and 4.17 the crude and graduated female mortality
intensities (on a log scale) for 5 yearly spaced ages, x = 30, 35, 40, . . . , 90 over the years
1975-2003. Included in these figures are the FA77 intensities at these ages. Such plots
provide a visual check on how close the extrapolated intensities from Equation (4.27)
are to their corresponding FA77 intensities. Table 4.12 gives a summary of some of
the formal statistical tests of a graduation, applied separately to all 21 calendar years.
The tests are carried out on the relative deviation after fitting the model in Equation
(4.27) to the data. The p-values expressed as percentages for the sign test, run test,
Kolmogorov-Smirnov, serial correlation test (with lag 1 to 3) are recorded in column
one to column six of Table 4.12. Any p-value that is less than 5% is highlighted by
an asterisk.
Table 4.12: Percentage p-value of graduation test for each calendar year separately
on female assured lives.
Year Sign Run KS Serial Cor. Test
Test Test Test 1 2 3
1983 40.6 60.0 93.0 57.5 63.8 4.8*
1984 7.7 11.7 78.9 16.2 33.9 41.1
1985 68.2 17.3 90.9 58.8 80.4 51.6
1986 11.8 48.5 78.5 68.9 74.7 73.7
1987 17.1 20.2 34.6 9.4 35.8 67.6
1988 59.4 88.4 99.4 92.1 47.9 71.8
1989 50.0 68.5 51.0 56.3 69.1 79.8
1990 40.6 95.5 77.2 50.3 20.3 29.1
1991 50.0 92.5 99.2 96.0 67.5 57.7
1992 76.2 95.8 82.7 66.8 32.7 95.0
1993 88.2 55.4 59.4 89.0 6.5 78.4
1994 7.7 85.1 87.3 70.0 75.6 35.9
1995 50.0 83.1 98.3 95.8 58.0 37.7
1996 68.2 7.8 65.6 6.4 95.8 90.2
1997 59.4 83.1 89.0 49.6 86.9 90.7
1998 4.8* 65.1 63.9 55.3 31.4 15.5
1999 11.8 29.9 93.2 50.4 66.4 90.6
2000 31.8 8.1 97.2 37.1 22.3 86.6
2001 7.7 70.6 99.9 84.6 46.8 65.4
2002 50.0 40.6 64.9 85.0 11.0 7.4
2003 59.4 59.4 96.9 96.0 44.3 98.8
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Figure 4.16: Log graduated and crude female mortality intensities vs calendar year,
ages 30, 40, 50, 60, 70, 80, 90. The red symbols are FA77 rates.
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Figure 4.17: Log graduated and crude mortality intensities vs calendar year, ages 35,
45, 55, 65, 75, 85. The red symbols are FA77 rates.
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Figures 4.12- 4.15 show that the graduated values fitted the crude estimates ade-
quately. Table 4.12 shows that of the 126 tests conducted, only 2 tests produced p−
value which are less than the 5% significance level. For each distinct combination of
age and calendar year, we calculate its deviance residual (see Equation (3.26)). Figure
4.18 shows the two-dimensional plot of the deviance residuals, with calendar years as
rows and ages as columns. There is a total of 1491 (21 × 71) deviance residuals, of
which 711 are positive and 780 are negative. Assuming that the number of positive
signs is binomially distributed as B(1491, 0.5), the p−value is 2(1-0.9609)=0.078, sug-
gesting the observed number of positive signs is not less than expected. The positive
and negative signs are fairly randomly scattered.
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Figure 4.18: A two-dimensional plot of deviance residuals for female assured lives
aged 20 to 90 from calendar year 1983 to 2003.
173
Chapter 5
Modelling of the Mortality
Intensity from Sick II: Excess
Mortality Intensity
5.1 Introduction
As mentioned in Chapter 4, the mortality intensity from sick is split into two additive
components. The first component is a base mortality that varies by sex, age and
calendar year while the second component is the excess mortality intensity entailed
with being sick with a specific cause. The mortality intensity at time z since sickness
inception for an individual with covariates x is λ(z,x), is
λ(z,x) = λ∗(x) + ν(z,x) (5.1)
in which λ∗(x) is the base mortality as discussed in Chapter 4 while ν(z,x) is the
excess mortality intensity that will be the focus of this chapter. In Section 5.2, we
will present the methodology to estimate the excess mortality intensity and describe
the transformation the data undergoes to make it compatible with the estimation
method. The results of the implementation of the methods described in Section 5.2
on IPI data by cause of sickness are presented in Section 5.3.
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5.2 Estimation Method
We consider the covariates x in the excess mortality component to act multiplicatively
on the baseline intensity, ν0(z), that depends only on sickness duration z. We re-write
Equation (5.1) to give
λ(z,x) = λ∗(x) + ν0(z) exp(xβ) (5.2)
where β denotes the regression coefficients. Further, we partition the sickness duration
into J discrete intervals with τj (j = 0, 1, . . . , J) as the interval end-points. We
then assume that the baseline intensity is constant in each discrete sickness duration
interval such that
ν0(z) = νj for z ∈ [τj−1, τj) . (5.3)
Following this assumption, the mortality intensity in sickness duration interval j,
zj, is written as
λ(zj,x) = λ
∗(x) + νj exp(xβ) . (5.4)
Este`ve et al. (1990) use a full likelihood approach based on individual level data
to estimate the parameters in Equation (5.4). The same likelihood can be obtained
using grouped data. In grouped data, we have a value for the central exposed-to-risk
(Rjl) and number of deaths (djl) for each distinct covariate pattern, indexed by l, in
sickness duration interval zj. The base mortality intensity, λ
∗(xl), is assumed constant
in each distinct covariate pattern l. The likelihood of the data is therefore given by
L =
∏
j,l
{exp[−Rjl(λ∗(xl) + νj exp(xlβ))](λ∗(xl) + νj exp(xlβ))djl} . (5.5)
Taking logs on both sides of Equation (5.5) and removing constant terms, we have
logL =
∑
j,l
{−Rjlνj exp(xlβ) + djl log[λ∗(xl) + νj exp(xlβ)]} . (5.6)
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Taking the derivative of Equation (5.6) with respect to νj and equating it to zero,
the MLE for νj, νˆj, can be found by solving the following equation iteratively
∑
l
djl exp(xlβ)
λ∗(xl) + νˆj exp(xlβ)
=
∑
l
Rjl exp(xlβ) . (5.7)
Dickman et al. (2004) show that we can use the convenience of GLMs to maximise
the likelihood in Equation (5.5). We do that by first assuming that the number of
deaths djl follows a Poisson distribution with mean
µjl = λ(zj, xl)Rjl . (5.8)
The kernel of the log-likelihood by treating djl as a Poisson observation with the
above mean is identical to the log-likelihood in Equation (5.6). Denoting d∗jl as the
expected number of deaths under model for base mortality intensity and substituting
Equation (5.4) into Equation (5.8), we obtain
µjl/Rjl = λ
∗(xl) + νj exp(xlβ)
= d∗jl/Rjl + νj exp(xlβ)
which, after some simple algebraic manipulation and let γj = log(νj), can be written
as
log(µjl − d∗jl) = log(Rjl) + log(νj) + xlβ (5.9)
= log(Rjl) + γj + xlβ .
The parameters in Equation (5.9) can be estimated by using a GLM with Poisson
error structure, outcome djl, link log(µjl − d∗jl) and logRjl as an offset term.
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The parameterisation of the excess mortality intensity can be split into two parts.
The first part is to graduate the piece-wise constant baseline intensities by incorpo-
rating a rich smooth parametric formula such as a GM(0, s) formula in the model and
let the data provide a smooth estimator. With a GM(0, s) formula for the baseline
intensity, the additive main effects model structure therefore takes the following form:
λ(z,x) = λ∗(x) + exp
(
s∑
i=1
bi(tk(z))
i−1
)
exp(xβ)) (5.10)
where the duration variable tk(z) is defined as tk(z) = z/(1 + kz). This du-
ration variable is used in CMI Working Paper 15 (2004) and in the modelling
of the recovery intensity (see Section 3.3). The covariate vector x consist of
{xsex, xrated, xage, xyear, xdp4, xdp13, xdp26, xdp52}. In the case that excess mortality in-
tensities for several causes of sickness are being modelled together, a set of binary
indicators representing these causes of sickness will be added to the covariate vector
x.
Substituting Equation (5.10) into Equation (5.8) and after some algebraic manip-
ulation, we obtain the following additive log linear model which, as in Equation (5.9),
can be estimated in the framework of a GLM
log(µjl − d∗jl) = log(Rjl) + b0 + b1tk(zj) + . . .+ bs(tk(zj))s + xlβ . (5.11)
The value of k used in the duration transformation is not pre-specified but will be
determined by the data. For each GM(0, s) formula (s = 1, 2, . . . , 6), we will try out a
range of k values (k = 0, 0.1, 0.2, . . . , 2.9, 3.0). The differences in the residual deviance
produced for two different GM(0, s) formulae is approximated by a χ2 distribution
with degrees-of-freedom equal to the difference in the number of parameters used.
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The second part of the parameterisation process is to select which covariates from
x to include in the model after keeping the chosen GM(0, s) formula and its optimal
k value in the model. The variable selection on the basis of AIC statistics is carried
out by using the ‘stepAIC’ function in the ‘R’ statistical package, which enables
the main effects and all possible two-way interaction terms to be explored and their
statistical significance assessed in an automated manner. Note that in this process,
the detection and fixing of non-proportional hazards is carried out at the same time
through the inclusion of time by covariate interaction term(s). We are aware that a
form of residual akin to the Schoenfeld residuals (Section 3.2), designed to check the
proportional hazard assumption in the Cox model, has been developed in the context
of additive relative survival models (see Stare et al., 2005). However, due to the
absence of evidence regarding a time varying effect for any covariate in the mortality
intensity among UK IPI claimants in the actuarial literature, we decided not to carry
out such tests in a separate exercise. Selection of variables is data-driven and not
guided by medical opinion or aimed to uncover hitherto unknown relationships. The
goodness-of-fit for the chosen model is then assessed by using the χ2 statistic and a
two-dimensional plot of the deviance residuals (see Section 3.5).
5.2.1 Data Preparation
The data we have from the CMI does not lend itself readily to GLM analysis as de-
scribed in Section 5.2. Thus, the format of the data needs to be suitably transformed.
First, we partitioned sickness duration into the following 41 intervals: 1–2 weeks,
2–3 weeks, . . . , 29–30 weeks, 30-39 weeks, 39 weeks – 1year, 1–2 years, 2–3 years, . . . ,
7–8 years, 8–12 years, 12–16 years and 16–20 years. These sickness duration intervals
are indexed by j. Then, each claim record is split into multiple observations, one
observation for each interval visited by the claimant. For each pseudo-observation
generated, we calculate the exposed-to-risk (R) and record the number of deaths (d).
Consider, for example, the claim record for an individual who died after being sick
for 38 days. This claim record will generate five pseudo-observations for which R = 7
days and d = 0 for the first four observations whereas R = 3 days and d = 1 for the
fifth observation. These pseudo-observations will be given the same covariate value
for sex, DP and rating indicator as the original observation. The covariates age and
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year are defined as the exact age and exact year at the start of the sickness duration
interval respectively. Note that this definition of age in the mortality intensity from
sick model is different to that in the recovery intensity model. Their values in these
pseudo-observations are calculated accordingly.
Next, the expected number of deaths, d∗, according to the assured lives mortality
intensity (see Chapter 4), is calculated for each pseudo-observation. Let xs and ys be
the age and year at the start of sickness duration interval j respectively. The expected
number of deaths, d∗, for each pseudo-observation is given by
d∗ =
∫ Rj
0
λ∗(xs + t, ys + t)dt (5.12)
where Rj is the exposed-to-risk in sickness duration interval j and λ
∗(x, y) is the as-
sured lives mortality intensity for a person aged x in year y as presented in Chapter 4.
Integration in the right-hand side of Equation (5.12) is calculated numerically.
First, age (17 to 65) and year (1975 to 2002) are discretised into intervals of 0.1 year.
Then, the assured lives mortality intensity is assumed constant in each age–year in-
terval and is taken as the intensity at the midpoint of the age–year interval. These
rates are then arranged in a two dimensional array with age as the row dimension
and year as the column dimension. Once the starting age–year interval for a person
is located, the assured lives mortality intensities applicable to the person move diag-
onally downwards as sickness duration advances. The expected number of deaths is
the sum of these assured lives mortality intensities multiplied by the corresponding
central exposed-to-risk in each age–year interval visited.
Generation of pseudo-observations for each original observation can substantially
increase the size of the data set and lead to increased computational time. To avoid
this, we sum the central exposed-to risk (R), number of deaths (d) and expected num-
ber of deaths (d∗) of the pseudo-observations within each distinct covariate pattern to
give only one observation for each distinct covariate pattern in each sickness duration
interval. The covariates are sex (2 levels), deferred period (5 levels), occupational
rating (2 levels), integer age last birthday (49 levels) and integer calendar year (28
levels) at the start of the sickness duration interval. The data is processed in a way
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such that the same age last birthday is applicable to the entire sickness duration in-
terval. These five covariates yield a maximum of 2× 5× 2× 49× 28 = 27,440 distinct
covariate patterns, indexed by l. For each covariate pattern l, we have Rjl, djl and
d∗jl denoting the exposed-to-risk, observed number of deaths and expected number of
deaths in sickness duration interval j, respectively.
5.3 Results
5.3.1 Grouping of Causes of sickness
There are 70 causes of sickness. The total number of deaths for all causes of sickness
is 3,498, of which 1,665 deaths are due to malignant neoplasm. Excluding malignant
neoplasm, only three causes of sickness have 200-300 deaths each while 41 causes
of sickness have less than ten deaths each. Given the low number of deaths in the
large majority of causes of sickness, separate modelling for each cause of sickness is
impractical. We therefore decided to classify the IPI data into fewer groups and use
amalgamated IPI data from each group in our analysis.
With the exception of cs61 Arthritis, any individual cause of sickness which has
more than 50 deaths is allowed to form its own group and there are six of them. De-
spite having 59 deaths, data from cs61 Arthritis is combined with cs62 Musculoskeletal
because it has as many as 50.079 expected deaths on the basis of the assured lives
mortality, leaving less than 10 deaths to be accounted for.
The other causes of sickness are bundled together in accordance to the grouping
of causes of sickness presented in Tables 2.3 and 3.2. In respect of the analysis of
mortality from sick, Table 5.1 shows the classification of IPI data into 15 different
sickness groups (column 1), the ICD8 codes of causes of sickness which constitute each
group (column 2), their respective numbers of deaths (column 3) and their respective
expected numbers of deaths according to the assured lives mortality intensity (column
4). The cause of sickness represented by each ICD8 code in column 2 is listed in
Appendix A.
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Table 5.1: Grouping of causes of sickness in the modelling of mortality intensity from
sick.
Name Sickness Group ICD8 code Deaths (d) Expected deaths (d∗)
H1 Infective 1–19 40 5.2021
H2 Malignant neoplasm 20 1665 21.9678
H3 Benign neoplasm 21 101 3.1365
H4 Endocrine & Metabolic 22–26 48 8.0040
H5 Mental illness 27 219 90.0761
H6 Nervous system & sense organs 28–31 220 49.3129
H7 Other circulatory diseases 32-34, 37-38 127 30.4939
H8 Ischaemic heart disease 35 289 85.8681
H9 Cerebrovascular disease 36 136 24.7038
H10 Respiratory 39–45 102 15.6277
H11 Digestive 47–51 114 12.2847
H12 Genito-urinary 52–55 58 5.9798
H13 Musculoskeletal 61, 62 144 107.7378
H14 Injuries 66–70 88 33.4236
H15 All Others 46, 56–60, 147 28.2141
63–65
All causes of sickness 3498 522.0329
We estimate the piece-wise constant baseline intensity, νj, for each sickness dura-
tion interval zj (j = 1, 2, . . . , 41) in the absence of covariates. The MLE for νj, νˆj,
can be obtained by solving the following equation iteratively
∑
l
djl
λ∗(xl) + νˆj
=
∑
l
Rjl . (5.13)
Note that the above equation is the same as Equation (5.7) but with exp(xβ) = 1.
We can also estimate νj using a Poisson regression model by creating a set of indicator
variables, fj, one for each sickness duration interval j (excluding the reference interval)
where fj = 1 for interval j and 0 otherwise. Both approaches will produce identical
estimates. There are no estimates for sickness duration intervals with no deaths.
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Figures 5.1–5.4 show the values of νˆj (j = 1, 2, . . . , 41) plotted against the mid-
point of the sickness duration intervals for each sickness group. Sickness groups which
exhibit the same mortality pattern are plotted together on the same graph. As far as
possible, we will attempt to relate some features of the excess mortality intensity to
any known medical opinion expressed in the medical literature. Some features present
in each figure are as follows:
(a) Figure 5.1: ‘H1 Infective’, ‘H3 Benign neoplasm’, ‘H4 Endocrine & Metabolic’,
‘H10 Respiratory’, ‘H11 Digestive’, ‘H12 Genito-urinary’ and ‘H14 Injuries’
(i) The mortality curves exhibit a hump-backed feature with a peak at around
200 days. A similar feature is reported in the mortality intensity for all
sicknesses combined (Renshaw and Haberman (2000), CMI Working Paper
5 (2005)).
(ii) The levels of the excess mortality intensity for ‘H3 Benign neoplasm’ and
‘H14 Injuries’ are noticeably higher and lower, respectively, than the rest.
(iii) Apart from ‘H1 Infective’, ‘H10 Respiratory’ and ‘H11 Digestive’, there are
no estimates for very short sickness durations.
(b) Figure 5.2: ‘H5 Mental illness’, ‘H6 Nervous system & sense organs’ and ‘H13
Musculoskeletal’
(i) The mortality curves exhibit a U -shaped relationship with sickness dura-
tion. The decline in the excess mortality intensity is followed by an up-turn
at around 3 years of sickness duration. In relation to ‘H5 Mental illness’,
the rise in excess mortality intensity after a few years of sickness may not
be surprising given that Stark et al. (2003), a study based on psychiatric
patients discharged from psychiatric hospitals in Scotland after a stay ex-
ceeding one year, reported that “...Deaths from respiratory disease were
four times higher than expected, and deaths from other causes, including
cardiovascular disease, were also elevated...”. They attributed this marked
increase in mortality rates to alcohol abuse, poor diet, smoking and possi-
bly antipsychotic drugs.
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(ii) The level of excess mortality intensity is highest in ‘H6 Nervous system &
sense organs’, followed by ‘H5 Mental illness’ and ‘H13 Musculoskeletal’.
(c) Figure 5.3: ‘H8 Ischaemic heart disease’, ‘H9 Cerebrovascular disease’ and ‘H7
Other circulatory diseases’
(i) The excess mortality intensity declines with increasing sickness duration
until it remains relatively constant at very long term sickness durations.
(ii) The level of excess mortality intensity for ‘H8 Ischaemic heart disease’ is
noticeably lower than the rest.
(d) Figure 5.4: ‘H2 Malignant neoplasm’
(i) The excess mortality intensity follows a bell-shaped curve with the intensity
rising, peaking at around 150 days and falling off before showing an up-turn
at the very last point. The striking similarity of this feature to that found
in CMI Working Paper 5 is expected given that deaths from malignant
neoplasm makes up the bulk of the total deaths reported.
(e) Figure 5.5: ‘H15 All others’
(i) Sicknesses with few deaths that are not readily classifiable into well-
recognised sickness groups are bundled into this sickness group.
(ii) The excess mortality intensity remains relatively constant until it starts to
decline at around 200 days.
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Figure 5.1: MLE, νˆj, for sickness groups: ‘H1 Infective’, ‘H3 Benign neoplasm’, ‘H4
Endocrine & Metabolic’, ‘H10 Respiratory’, ‘H11 Digestive’, ‘H12 Genito-urinary’ and
‘H14 Injuries’.
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Figure 5.2: MLE, νˆj, for sickness groups: ‘H5 Mental illness’, ‘H6 Nervous system &
sense organs’ and ‘H13 Musculoskeletal’.
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Figure 5.3: MLE, νˆj, for sickness groups: ‘H8 Ischaemic heart disease’, ‘H9 Cere-
brovascular disease’ and ‘H7 Other circulatory diseases’.
10 20 50 100 200 500 1000 2000 5000
−
3.
5
−
3.
0
−
2.
5
−
2.
0
−
1.
5
−
1.
0
−
0.
5
0.
0
lo
g(ν^
j)
day
H2 Malignant neoplasm
Figure 5.4: MLE, νˆj, for sickness group: ‘H2 Malignant neoplasm’.
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Figure 5.5: MLE, νˆj, for sickness group: ‘H15 All others’.
As shown in Figures 5.1 – 5.5, the mortality curves (on a log-log scale) for different
sickness groups in each graph have the same shape and are parallel to one another.
This observation points the way to a proportional hazard model incorporating cause
of sickness as a factor. The 15 sickness groups listed in Table 5.1 are further classified
into five separate sickness categories (MI to MV) as set out in Table 5.2. Sickness
groups belonging to the same category will be modelled together.
Table 5.2: The five sickness categories in the modelling of mortality intensity from
sick.
Sickness Category Sickness Group
MI H1 Infective, H3 Benign neoplasm, H4 Endocrine & metabolic,
H10 Respiratory, H11 Digestive, H12 Genito-urinary, H14 Injuries
MII H5 Mental illness, H6 Nervous system & sense organs,
H13 Musculoskeletal
MIII H7 Other circulatory disease, H8 Ischaemic heart disease,
H9 Cerebrovascular disease
MIV H2 Malignant Neoplasm
MV H15 All Others
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5.3.2 Sickness Category MI
The seven sickness groups in this sickness category MI are ‘H1 Infective’, ‘H3 Benign
neoplasm’, ‘H4 Endocrine & metabolic’, ‘H10 Respiratory’, ‘H11 Digestive’, ‘H12
Genito-urinary’ and ‘H14 Injuries’. There are a total of 551 deaths and 83.66 expected
deaths in this category. Apart from ‘H11 Digestive’ which is the reference sickness
group, the other sickness groups are coded using indicator variables and are added
as covariates in Equation (5.11). For example, ‘H12 Genito-urinary’ is represented
by IH12. The parameterisation and estimation of the excess mortality intensity are
described in Section 5.2. In respect of finding a suitable GM(0, s) formula to the
baseline intensity, we fitted Equation (5.11) to different GM(0, s) formula at a range
of k values (k = 0, 0.1, 0.2, 0.3, . . . , 2.9, 3.0). Table 5.3 shows the deviance profile of
fitting different GM(0, s) formula at selected k values.
Table 5.3: Deviance profile for k with different GM(0,s) as baseline intensity for
sickness category MI.
k 0.0 0.5 1.0 1.5 1.8 2.0 2.5 3.0
GM(0,3) 6249.4 6215.5 6187.5 6178.2 6177.2 6177.6 6180.6 6185.1
GM(0,4) 6247.1 6172.2 6173.5 6176.8 6177.2 6177.1 6176.4 6176.0
GM(0,5) 6239.8 6169.9 6169.6 6171.0 6172.6 6173.6 6175.3 6176.0
From Table 5.3, we note that the smallest residual deviance for GM(0,3) is pro-
duced at k = 1.8. The additional term in a GM(0,4) formula fitted at k = 0.5 is
marginally significant and is positive, meaning that the mortality curves show an up-
turn at very long sickness durations, a feature present in Figure 5.1. The difference
between the smallest residual deviance for GM(0,5) yielded at k = 1.0 and the small-
est residual deviance for GM(0,4) produced at k = 0.5 is not statistically significant.
Although GM(0,4) is the best formula statistically, we decided against using it and
opted for a GM(0,3) formula instead because we felt that there is no reason why the
mortality curves for these sickness groups should show an eventual mild upturn at
very long sickness durations.
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Thus, with a GM(0,3) formula and k = 1.8 as the baseline intensity, the excess
mortality model is
log(µjl−d∗jl) = log(Rjl)+b0+b1t1.8(zj)+b2(t1.8(zj))2+IH1+IH3+IH4+IH10+IH12+IH14+xlβ
(5.14)
where the covariate vector x consist of {xsex, xrated, xage, xyear, xdp4, xdp13, xdp26, xdp52}.
To select which covariates to include from the above model, we assess the statistical
significance of the main effects and all two-way interaction terms (including interaction
term between duration variable and covariates) using the AIC statistics. The model
after the AIC selection was applied is as follow:
log(µjl − d∗jl) = log(Rjl) + b0 + b1t1.8(zj) + b2(t1.8(zj))2 + IH3 + IH4 + IH10
+IH14 + βsexxsex + βagexage + βyearxyear + βsex:H4xsexIH4
+βsex:H10xsexIH10. (5.15)
All the estimated parameters in Equation (5.15) are set out in Table 5.4. We note
that
(i) Excess mortality intensity for ‘H1 Infective’ and ‘H12 Genito-urinary’ are not
statistically different from ‘H11 Digestive’, the reference sickness group.
(ii) Excess mortality intensity for ‘H3 Benign neoplasm’ is elevated by a factor of
4.313 (= exp(1.4617)) while the intensity for ‘H14 Injuries’ is reduced by a factor
of 0.144 (= exp(−1.9396)).
(iii) Female excess mortality intensity is 0.202 (= exp(−1.6018)) times the inten-
sity for males, but this factor is increased to 0.808 (= exp(−1.6018 + 1.3888))
and 0.878 (= exp(−1.6018 + 1.4720)) in ‘H4 Endocrine & Metabolic’ and ‘H10
Respiratory’, respectively.
(iv) A deterioration of the excess mortality intensity with an increase in age, given
a positive age coefficient. The excess mortality intensity increases by a factor
of 1.025 (= exp(0.6482/26)) with every increment in age. This means that the
age effect from the assured lives mortality alone does not account fully for the
variation of mortality intensity by age.
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(v) An improvement in the excess mortality intensity over the years, given a negative
year coefficient. The excess mortality intensity decreases by a factor of 0.948
(= exp(−0.7008/13)) with every passing year, in addition to the improvement
in assured lives mortality intensity.
Table 5.4: Parameters in the excess mortality intensity model for sickness
category MI.
Symbol Estimate Std.Error
b0 -4.8649 0.2884
b1 17.3217 1.9526
b2 -31.9593 3.0942
IH3 1.4617 0.1295
IH14 -1.9396 0.1878
IH4 -0.3329 0.2041
IH10 -0.1696 0.1462
βsex -1.6018 0.3287
βage 0.6482 0.1452
βyear -0.7008 0.1090
βsex:H4 1.3888 0.5698
βsex:H10 1.4720 0.5332
The mortality curve for the baseline profile (male, non-rated, DP1, aged 43, year
1988) for each sickness group is shown in Figure 5.6. The value of the χ2 statistic is
37.29565. With 47 cells, obtained in accordance to the grouping algorithm described
in Appendix E, and 12 parameters fitted in the model, the probability value is 0.364
on 35 degrees of freedom, indicating a good fit to the data. Figure 5.7 shows the
two-dimensional plot of the deviance residuals (as described in Section 3.6) for each
sickness group, using combined data from both sexes, rating indicators and all deferred
periods. These two-dimensional residuals plots are dominated by blue color because
most of the cells have zero deaths. The white space are due to cells with no exposed-
to-risk and for which deviance residuals cannot be calculated. The blocks of blue cells
seemingly give the impression of inadequate fit. However, we reckon that in order
for more meaningful conclusion to be drawn from these two-dimensional residuals
plots, the number of deaths have to be sufficiently large or the age, year and sickness
duration bands are partitioned in such a way that there are sufficient deaths in each
cell.
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Figure 5.6: Fitted excess mortality intensity (on log scale) for sickness groups in
sickness category MI using parameters in Table 5.4: male, non-rated, DP1, aged 43,
year 1988.
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Figure 5.7: A two-dimensional plot of deviance residuals for each sickness group in
sickness category MI.
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5.3.3 Sickness Category MII
There are three sickness groups in this category with a total of 583 deaths and 247.13
expected deaths. These sickness groups are ‘H5 Mental illness’, ‘H6 Nervous system
& sense organs’ and ‘H13 Musculoskeletal’. Apart from ‘H5 Mental illness’ which
is the reference sickness group, ‘H6 Nervous system & sense organs’ and ‘H13 Mus-
culoskeletal’ are coded using indicator variables IH6 and IH13, respectively, and are
added as covariates in Equation (5.11). For the parameterisation of the baseline
intensity, we fitted Equation (5.11) to different GM(0, s) formula at a range of k val-
ues (k = 0, 0.1, 0.2, 0.3, . . . , 2.9, 3.0). Table 5.5 shows the deviance profile of fitting
different GM(0, s) formula at selected k values.
Table 5.5: Deviance profile for k with different GM(0,s) as baseline intensity for
sickness category MII.
k 0.0 0.2 0.5 1.0 1.5
GM(0,3) 6539.0 6524.7 6530.4 6537.0 6539.8
GM(0,4) 6536.2 6523.7 6528.4 6536.0 6538.8
GM(0,5) 6535.3 6523.6 6527.8 6535.5 6537.3
From Table 5.5, we note that the smallest residual deviance for GM(0,3) is pro-
duced at k = 0.2 and other GM(0, s) functions of higher degree of varying k values do
not give a significantly better fit. With a GM(0,3) formula at k = 0.2 for the baseline
intensity, the excess mortality model is
log(µjl − d∗jl) = log(Rjl) + b0 + b1t0.2(zj) + b2(t0.2(zj))2 + IH6 + IH13 + xlβ (5.16)
where the covariate vector x consist of {xsex, xrated, xage, xyear, xdp4, xdp13, xdp26, xdp52}.
To select which covariates to include from the above model, we assess the statistical
significance of the main effects and all two-way interaction terms (including interaction
term between duration variable and covariates) using the AIC statistics. The model
after the AIC selection was applied is as follow:
log(µjl−d∗jl) = log(Rjl)+b0+b1t0.2(zj)+b2(t0.2(zj))2+IH6+IH13+βsexxsex+βyearxyear
(5.17)
191
All the estimated parameters in Equation (5.17) are set out in Table 5.6. We note
that
(i) The excess mortality intensity for ‘H6 Nervous system & sense organs’ and ‘H13
Musculoskeletal’, compared to ‘H5 Mental illness’, are multiplied by factors of
2.453 (= exp(0.89720)) and 0.278 (= exp(−1.27924)), respectively.
(ii) Female excess mortality intensity is 0.5086 (= exp(−0.67619)) times the male
intensity.
(iii) Year effect is significant and negative. The excess mortality intensity is reduced
by a factor of 0.9213 (= exp(−1.06559/13)) with every single increase in year.
(iv) Age is not included as an explanatory variable, indicating that much of the
age variation in the mortality intensity is already explained by the under-
lying assured lives mortality. This is not surprising given that over 42%
(247.13/583 = 0.424) of the observed deaths were expected on the basis of the
assured lives mortality.
Table 5.6: Parameters in the excess mortality intensity model for sickness
category MII.
Symbol Estimate Std.Error
b0 -4.09059 0.19514
b1 -0.94310 0.20655
b2 0.24153 0.04945
IH6 0.89720 0.13815
IH13 -1.27924 0.26424
βsex -0.67619 0.24625
βyear -1.06559 0.13509
The mortality curves for the baseline profile (male, non-rated, DP1, aged 43, year
1988) for all sickness groups are shown in Figure 5.8. The value of the χ2 statistic
is 48.33466. With 50 cells and 7 parameters fitted, the probability value is 0.266 on
43 degrees of freedom, indicating a good fit to the data. Figure 5.9 shows the two-
dimensional plot of the deviance residuals for each sickness group, using combined data
from both sexes, rating indicators and all deferred periods. These two-dimensional
residuals plots are dominated by blue because the majority of the cells have zero
deaths.
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Figure 5.8: Fitted excess mortality intensity (on log scale) for each sickness group in
sickness category MII using parameters in Table 5.6: male, non-rated, DP1, aged 43,
year 1988.
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Figure 5.9: A two-dimensional plot of deviance residuals for each sickness group in
sickness category MII.
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5.3.4 Sickness Category MIII
There are three sickness groups in this category with a total of 552 deaths and 141.07
expected deaths. These sickness groups are ‘H7 Other circulatory disease’, ‘H8 Is-
chaemic heart disease’ and ‘H9 Cerebrovascular disease’. Apart from ‘H7 Other cir-
culatory disease’ which is the reference sickness group, ‘H8 Ischaemic heart disease’
and ‘H9 Cerebrovascular disease’ are coded using indicator variables IH8 and IH9, re-
spectively, and are added as covariates in Equation (5.11). For the parameterisation
of the baseline intensity, we fitted Equation (5.11) to different GM(0, s) formula at
a range of k values (k = 0, 0.1, 0.2, 0.3, . . . , 2.9, 3.0). Table 5.7 shows the deviance
profile of fitting different GM(0, s) formula at selected k values.
Table 5.7: Deviance profile for k with different GM(0,s) as baseline intensity for
sickness category MIII.
k 0.0 0.5 1.0 1.5 1.8 2.0 2.5 3.0
GM(0,2) 5917.2 5897.7 5892.2 5890.2 5889.3 5889.5 5889.4 5889.6
GM(0,3) 5914.3 5888.3 5888.7 5889.2 5889.3 5889.3 5889.4 5889.3
GM(0,4) 5889.9 5888.2 5888.1 5888.2 5888.4 5888.5 5888.7 5888.9
From Table 5.7, we note that the smallest residual deviance for GM(0,2) is pro-
duced at k = 1.8 and no other GM(0, s) functions of higher degree of different k values
give a significantly better fit. Therefore, with a GM(0,2) formula at k = 1.8 as the
baseline intensity, the excess mortality model is
log(µjl − d∗jl) = log(Rjl) + b0 + b1t1.8(zj) + IH8 + IH9 + xlβ (5.18)
where the covariate vector x consist of {xsex, xrated, xage, xyear, xdp4, xdp13, xdp26, xdp52}.
To select which covariates to include from the above model, we assess the statistical
significance of the main effects and all two-way interaction terms (including interaction
term between duration variable and covariates) using the AIC statistics. The model
after the AIC selection was applied is as follow:
log(µjl − d∗jl) = log(Rjl) + b0 + b1t1.8(zj) + IH8 + IH9 + βsexxsex + βagexage
+βyearxyear + βyear:H8xyearIH8 + βyear:t(z)xyeart1.8(zj)
+βyear:agexyearxage. (5.19)
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All the estimated parameters in Equation (5.19) are set out in Table 5.8. We note
that
(i) Compared to the excess mortality intensity of ‘H7 Other circulatory diseases’,
the intensity for ‘H8 Ischaemic heart disease’ is reduced by a factor of 0.7756
(= exp(−0.2541)) while the intensity for ‘H9 Cerebrovascular disease’ is reduced
by a factor of 1.540 (= exp(0.4316)).
(ii) Female excess mortality intensity is 0.4398 (= exp(−0.8215)) times that of the
male intensity.
(iii) Age coefficient is dependent on year. The coefficient of xage is 0.5776+1.3444xyear,
resulting in an age factor ranging from 0.9709 = exp((0.5776 − 1.3444)/26) in
year 1975 to 1.0810 = exp((0.5776 + 1.3444× 1.077)/26) in year 2002.
(iv) Year coefficient for ‘H8 Ischaemic heart disease’ is −1.0110 (= −0.3745−0.6374).
(v) Year coefficient varies linearly with t1.8(z). In the case of ‘H7 Other circula-
tory diseases’ and ‘H9 Cerebrovascular disease’, the linear dependency is given
by −0.3745−2.5180t1.8(z). As sickness duration goes from 0 to the limit 1/1.8,
the year factor reduces from 0.9716 (= exp(−0.3745/13)) to 0.87248
(= exp((−0.3745− 2.5180× (1/1.8)))/13).
(vi) Year coefficient varies linearly with age according to the relationship
−0.3745 −1.3444xage. As age increases from 20 to 70, the year factor increases
from 0.8867 (= exp((−0.3745 + 1.3444× 0.8846)/13)) to 1.0818
(= exp((−0.3745 + 1.3444× 1.0385))/13).
The mortality curves for the baseline profile (male, non-rated, DP1, aged 43, year
1988) for all sickness groups are shown in Figure 5.10. The value of the χ2 statistic
is 27.17197. With 49 cells and 10 parameters fitted, the probability value is 0.923 on
39 degrees of freedom, indicating a good fit to the data. Figure 5.11 shows the two-
dimensional plot of the deviance residuals for each sickness group, using combined data
from both sexes, rating indicators and all deferred periods. These two-dimensional
residuals plots are dominated by blue because most of the cells have zero deaths.
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Table 5.8: Parameters in the excess mortality intensity model for sickness
category MIII.
Symbol Estimate Std.Error
b0 -2.6850 0.2032
b1 -3.3266 0.4181
IH8 -0.2541 0.1426
IH9 0.4316 0.1566
βsex -0.8215 0.4149
βage 0.5776 0.2255
βyear -0.3745 0.3968
βyear:H8 -0.6374 0.2448
βyear:t(z) -2.5180 0.8640
βyear:age 1.3444 0.4705
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Figure 5.10: Fitted excess mortality intensity (on log scale) for each sickness group
in sickness category MIII using parameters in Table 5.8: male, non-rated, DP1, aged
43, year 1988.
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Figure 5.11: A two-dimensional plot of deviance residuals for each sickness group in
sickness category MIII.
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5.3.5 Sickness Category MIV
The sickness group in this category is ‘H2 Malignant neoplasms’ which has 1665 deaths
and 21.97 expected deaths. With regards to the parameterisation of the baseline
intensity, we fitted Equation (5.11) to different GM(0, s) formula at a range of k
values (k = 0, 0.1, 0.2, 0.3, . . . , 2.9, 3.0). Table 5.9 shows the deviance profile of fitting
different GM(0, s) formula at selected k values.
Table 5.9: Deviance profile for k with different GM(0,s) as the baseline intensity for
sickness category MIV.
k 0.0 0.5 1.0 1.5 1.8 2.0 2.5
GM(0,3) 12077 12044 12040 12053 12063 12069 12085
GM(0,4) 12075 12037 12038 12040 12043 12046 12052
GM(0,5) 12052 12036 12038 12035 12033 12033 12033
GM(0,6) 12041 12032 12027 12030 12032 12032 12032
From Table 5.9, we note that GM(0,6) at k = 1.0 is the optimal fit for the baseline
intensity. The excess mortality model is therefore given by
log(µjl − d∗jl) = log(Rjl) +
5∑
i=0
bi(t1.8(zj))
i + xlβ (5.20)
where the covariate vector x consist of {xsex, xrated, xage, xyear, xdp4, xdp13, xdp26, xdp52}.
To select which covariates to include from the above model, we assess the statistical
significance of the main effects and all two-way interaction terms (including interaction
term between duration variable and covariates) using the AIC statistics. The model
after the AIC selection was applied is as follow:
log(µjl − d∗jl) = log(Rjl) +
5∑
i=0
bi(t1.8(zj))
i + βsexxsex + βagexage + βratedxrated
+βyearxyear + βage:t(z)xaget1.0(zj) + βyear:t(z)xyeart1.0(zj)
+βage:ratedxagexrated. (5.21)
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All the estimated parameters in Equation (5.21) are set out in Table 5.10. We
note that
(i) Female excess mortality intensity is reduced by a factor 0.6008 (= exp(−0.50942))
when compared to the male intensity.
(ii) Age coefficient varies linearly with t1.0(z), with the linear dependency described
by 0.63060−1.54019t1.0(z). The age coefficient will become negative once sick-
ness duration exceeds 253 days. A negative correlation between age coefficient
and follow-up time is found in Dickman et al. (2004) where the excess mor-
tality intensity for patients diagnosed with localised colon carcinoma and skin
melanoma are investigated. The reason given by the author is that cancer pa-
tients with the worst prognosis or those who are frail and elderly are likely to
die very soon after diagnosis while those who survive after a year will have a
higher chance of survival.
(iii) Rated coefficient varies linearly with age and the relationship is given by
−0.23475+0.51680xage. The coefficient ranges from −0.6919 to 0.3019 as age
increases from 20 to 70.
(iv) Year coefficient varies linearly with t1.0(z) according to−1.20784+1.08863t1.0(z),
giving rise to the year coefficient ranging from −1.20784 (t1.0(z) = 0) to
−0.11922 (t1.0(z) = 1).
(v) The up-turn in the excess mortality intensity (given a positive (t1.0(z))
5 term) is
probably due to heterogeneity in the type of cancer and the frailty of claimants.
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Table 5.10: Parameters in the excess mortality intensity model for sickness category
MIV.
Symbol H2 Malignant neoplasms Std. Error
b0 −2.78945 0.53791
b1 30.66597 8.03569
b2 −149.28489 42.94951
b3 351.54265 103.26848
b4 −392.05986 114.04745
b5 160.38971 46.99728
βsex −0.50942 0.07385
βage 0.63060 0.20648
βrated −0.23475 0.07832
βyear −1.20784 0.14423
βyear:t1.0(z) 1.08862 0.29414
βage:t1.0(z) −1.54019 0.40082
βage:rated 0.51680 0.17477
The mortality curves for the baseline profile (male, non-rated, DP1, aged 43, year
1988) are shown in Figure 5.12. The value of the χ2 statistic is 123.8620. With 130
cells and 12 parameters fitted, the probability value is 0.338 on 118 degrees of freedom,
indicating a good fit to the data. Figure 5.13 shows the two-dimensional plot of the
deviance residuals using amalgamated data from both sexes, rating indicators and all
deferred periods. The two-dimensional residuals plot for female is dominated by blue
because most of the cells have zero deaths. The two-dimensional plot of the deviance
residuals for males and females separately are produced in Figure 5.13.
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Figure 5.12: Fitted excess mortality intensity (on log scale) for ‘H2 Malignant neo-
plasm’ using parameters in Table 5.10: male, non-rated, DP1, aged 43, year 1988.
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Figure 5.13: A two-dimensional plot of deviance residuals for ‘H2 Malignant neo-
plasm’, separately for males and females.
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5.3.6 Sickness Category MV
The sickness group in this category is ‘H15 All others’ which has 147 deaths and 28.21
expected deaths. In respect to the baseline intensity, Table 5.11 shows the deviance
profile of fitting different GM(0, s) formulae to the baseline intensity at varying k
values in Equation (5.10).
Table 5.11: Deviance profile for k with different GM(0,s) as the baseline intensity for
sickness category MV.
k 0.0 0.2 0.5 1.0 1.5 2.0
GM(0,2 ) 1742.1 1740.4 1743.3 1748.7 1752.8 1755.9
GM(0,3) 1740.5 1740.1 1738.4 1737.9 1739.1 1740.9
GM(0,4) 1738.4 1736.9 1737.0 1737.6 1736.9 1736.6
GM(0,5) 1733.6 1735.8 1735.7 1735.0 1736.1 1736.6
With a GM(0,2) formula and k = 0.2 for the baseline intensity, the excess mortality
model is therefore given by
log(µjl − d∗jl) = log(Rjl) + b0 + b1(t0.2(zj)) + xlβ (5.22)
where the covariate vector x consist of {xsex, xrated, xage, xyear, xdp4, xdp13, xdp26, xdp52}.
To select which covariates to include from the above model, we assess the statistical
significance of the main effects and all two-way interaction terms (including interaction
term between duration variable and covariates) using the AIC statistics. The model
after the AIC selection was applied is as follow:
log(µjl − d∗jl) = log(Rjl) + b0 + b1(t0.2(zj)) + βsexxsex + βagexage + βyearxyear
(5.23)
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All the estimated parameters in Equation (5.23) are set out in Table 5.12. We
note that
(i) Female excess mortality intensity is 0.3311 (= exp(−1.1052)) times that of the
male intensity.
(ii) Age effect is significant and positive. Excess mortality intensity is elevated by
a factor of 1.0538 (= exp(1.3633/26)) with every increment in age.
(iii) Year effect is significant and negative. Excess mortality intensity is reduced by
a factor of 0.9333 (= exp(−0.8971/13)) with every single increase in year.
Table 5.12: Parameters in the excess mortality intensity model for sickness
category MV.
Symbol H15 All others Std. Error
b0 −3.0139 0.1834
b1 −0.8778 0.1393
βsex −1.1052 0.4181
βage 1.3633 0.2987
βyear −0.8971 0.2249
The mortality curves for the baseline profile (male, non-rated, DP1, aged 43, year
1988) are shown in Figure 5.14. The value of the χ2 statistic is 4.407133. With 13
cells and 5 parameters fitted, the probability value is 0.819 on 8 degrees of freedom,
indicating a good fit to the data. Figure 5.15 shows the two-dimensional plot of the
deviance residuals using combined data from both sexes, rating indicators and all
deferred periods. This two-dimensional residuals plot is dominated by blue because
most of the cells have zero deaths.
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Figure 5.14: Fitted excess mortality intensity (on log scale) for sickness group ‘H15
All Others’ using parameters in Table 5.12: male, non-rated, DP1, aged 43, year 1988.
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Figure 5.15: A two-dimensional plot of deviance residuals for sickness group ‘H15 All
Others’.
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Chapter 6
Some Applications
6.1 Introduction
In this chapter we present two applications of the recovery intensity and mortality
intensity from sick by cause of sickness, estimated in earlier chapters, in two aspects.
In Section 6.2 we present the expected present values of annuities by cause of sickness.
In Section 6.3 we derive the aggregate recovery and mortality intensities from sick and
compare them against their corresponding graduated intensities from CMI Working
Paper 5 (2004).
6.2 Expected Present Values of Annuities by Cause
of Sickness
Under an IPI policy the life office is obliged to pay the IPI claimant a regular income
(annuity) until he/she recovers, dies or reaches the retirement age of 60 (for females)
or 65 (for males), whichever happens earliest. The claim termination intensity is
therefore the sum of the recovery intensity and the mortality intensity from sick. For
most causes of sickness, the recovery intensity forms the bulk of the claim termination
intensity.
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For reserving purposes, we wish to calculate the expected present value of liability
for current claims. We consider the expected present value (EPV) of an annuity of
£1 per annum payable continuously to a person who is currently aged x (in years) in
year y and sick from cause of sickness i with duration of sickness z (in years). For a
male IPI claimant, the maximum period for the annuity payment is 65− x years. We
denote the EPV of this annuity by a¯SiSi
x,y,z : 65−x . The formula for a¯
SiSi
x,y,z : 65−x is given by
a¯SiSi
x,y,z : 65−x =
∫ 65−x
0
vttp
SiSi
x,y,zdt (6.1)
where v is the discounting factor and tp
SiSi
x,y,z represents the probability that an in-
dividual currently aged x in year y with exact sickness duration z will remain sick
continuously to exact sickness duration z + t.
To evaluate the above expression, we first need to calculate tp
SiSi
x,y,z, the formula for
which is given by
tp
SiSi
x,y,z = exp
{
−
∫ t
0
(ρ(i)x+s,y+s,z+s + λ(i)x+s,y+s,z+s)ds
}
(6.2)
where ρ(i) and λ(i) are the recovery intensity and mortality intensity from being sick
with cause of sickness i, respectively.
The above probability can be approximated by using a numerical method. For
this purpose, CMI Report 12 (1991), in Part D, presented the following recursive
approximate formula:
t+hp
SiSi
x,y,z ≈
tp
SiSi
x,z
{
1− h
2
(ρ(i)x+t,y+t,z+t + λ(i)x+t,y+t,z+t)
}{
1 + h
2
(ρ(i)x+t+h,y+t+h,z+t+h + λ(i)x+t+h,y+t+h,z+t+h)
} (6.3)
with 0p
SiSi
x,y,z = 1. The derivation of this recursive formula is given in Appendix C. We
then approximate the integral in Equation (6.1) by using Simpson’s rule for numerical
integration. Let t0 < t1 < t2 < . . . < tn and ti+1 − ti = h for i = 0, 1, 2, . . . , n − 1,
where ti and h are in unit of year and n = (65−x)/h. By using the repeated Simpson’s
rule, the approximation for the integral formula for the EPV of annuity in Equation
(6.1) is given by
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a¯SiSi
x,y,z : 65−x ≈
h
6
n−1∑
i=0
(
vti tip
SiSi
x,y,z + 4v
(ti+
h
2
)
ti+
h
2
pSiSix,y,z + v
ti+1
ti+1p
SiSi
x,y,z
)
(6.4)
We use the same step size h for both the approximations in Equations (6.3) and
(6.4). The initial step size for h is 1/5840 of a year. The desired accuracy for a¯SiSi
x,y,z : 65−x
is attained by halving the step size until successive approximations are within £10−6
(absolute error) of each other.
6.2.1 Results
In this section we present the results of using Equations (6.3) and (6.4) to approximate
the EPV of continuous annuity for each cause of sickness. One of the inputs in the
claim termination intensity model is “year”, which can be treated in two ways. We
can either allow the year to advance along with duration z, which is the case in Section
6.2, or let time stand still at the starting date of the annuity. The former case may
be more realistic for past periods, but for periods outside the range of the data, it
involves projecting the intensities outside the range of the data, which, depending
on the functional form of the year effect incorporated in the intensities models, may
produce implausible results. For example, if the recovery intensity model that includes
a non-linear year effect which is not a monotonic decreasing function (e.g. quadratic)
is projected to the future, we may eventually obtain increasing intensities with year, a
contrary to the falling year trend observed in the IPI data. Thus, the joint modelling
of year and duration that resulted in a non-linear year effect may not be reliable for
forecasting future intensities. All the results presented in this section are obtained by
letting time stand still at the starting date of the annuity which is fixed at 2002. The
current age increases along with duration z, but this is allowed for in the intensities
anyway.
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Tables 6.1 – 6.5 show the EPV of continuous annuities of £1000 per annum by
cause of sickness, payable to a person with a non-rated occupation immediately after
the end of deferred period for DP1, DP4, DP13, DP26 and DP52, respectively, with
the payment ceasing at recovery, death or age 65. The values are calculated for age
20, 40 and 60 at sickness inception, separately for males and females. We use the
same retirement age for both males and females so that a fair comparison can be
made between their EPV of annuities.
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Table 6.1: Expected present values of continuous annuities of £1000 per year payable to a DP1 IPI claimant with a non-rated
occupation who falls sick at exact age 20, 40 and 60, calculated separately for males and females using rate of interest 4%.
Males Females Males Females
Age Age Age Age
cs 20 40 60 20 40 60 cs 20 40 60 20 40 60
1 197.82 219.20 313.97 432.16 460.35 509.44 37 629.77 562.42 971.76 668.26 596.83 1007.32
2 313.81 334.91 410.00 646.17 664.95 640.05 38 230.79 217.27 615.52 242.88 228.82 637.09
3 7.75 18.73 132.66 11.71 41.16 240.69 39 8.36 18.01 60.62 9.41 23.42 79.48
4 309.93 1238.02 1246.69 312.08 1328.00 1338.96 40 6.74 10.05 20.88 9.06 16.32 40.67
5 353.14 1491.87 1375.71 355.99 1605.80 1479.03 41 25.14 41.81 95.34 25.14 41.84 95.91
6 45.67 55.54 126.64 111.53 131.91 230.98 42 8.58 36.51 196.11 9.69 51.09 246.72
7 45.67 55.54 126.64 111.53 131.91 230.98 43 10.04 26.80 89.21 11.66 36.68 116.12
8 45.67 55.54 126.64 111.53 131.91 230.98 44 21.61 94.22 221.89 29.16 132.82 277.24
9 1439.52 1343.62 969.72 2368.68 2168.92 1326.76 45 18.27 76.93 758.83 18.32 77.72 770.78
10 45.67 55.54 126.64 111.53 131.91 230.98 46 8.84 22.49 63.10 7.24 15.23 42.37
11 45.67 55.54 126.64 111.53 131.91 230.98 47 92.13 482.45 388.23 93.62 524.25 416.83
12 406.07 1447.14 897.68 422.69 1585.17 965.41 48 16.48 24.09 36.11 26.13 40.31 74.27
13 183.07 511.02 752.47 183.72 537.56 803.40 49 18.75 27.54 42.41 29.96 49.33 99.63
14 45.67 55.54 126.64 111.53 131.91 230.98 50 35.38 54.93 86.69 35.42 55.60 88.40
15 191.89 213.14 308.43 420.74 449.20 501.73 51 81.89 457.67 637.89 1199.55 884.77 339.89
16 45.67 55.54 126.64 111.53 131.91 230.98 52 4.41 51.83 398.06 4.41 54.17 423.39
17 45.67 55.54 126.64 111.53 131.91 230.98 53 2.98 27.50 121.80 2.99 29.25 129.21
18 45.67 55.54 126.64 111.53 131.91 230.98 54 239.01 222.01 152.73 247.67 232.91 157.49
19 45.67 55.54 126.64 111.53 131.91 230.98 55M 13.97 93.77 187.90 - - -
20 165.26 765.11 1216.99 214.57 695.06 966.29 55F - - - 39.78 170.56 740.39
21 24.40 145.80 330.23 294.45 243.74 134.57 56 - - - 392.55 1092.44 901.51
22 6718.59 2510.31 1098.92 6832.39 2559.33 1120.16 57 - - - 392.55 1092.44 901.51
23 1341.75 1307.04 1531.07 1361.56 1331.37 1561.37 58 - - - 392.55 1092.44 901.51
24 191.10 222.44 710.42 193.26 225.82 723.65 59 34.88 136.95 190.90 35.11 140.20 198.21
25 191.10 222.44 710.42 193.26 225.82 723.65 60 69.79 257.10 290.68 70.47 263.86 302.57
26 844.60 860.68 1282.01 856.49 876.14 1307.07 61 176.44 1403.80 1439.87 4841.50 4640.03 1711.56
27 953.35 1603.61 1813.03 1159.44 1869.38 1936.90 62 328.96 371.94 587.39 423.91 466.82 668.10
28 10.72 233.60 657.24 77.78 405.92 488.53 63 1658.15 2862.07 1562.92 1207.32 2358.79 1431.15
29 340.85 306.17 148.14 361.61 317.75 149.88 64 - - - 392.55 1092.44 901.51
30 5.48 63.21 344.50 18.17 123.00 231.86 65 606.49 1448.48 1039.81 392.55 1092.44 901.51
31 70.06 928.72 1251.62 469.24 1375.94 1033.27 66 122.14 237.79 255.78 196.42 379.53 354.30
32 29.35 30.36 181.37 29.81 30.89 186.57 67 52.79 203.38 319.12 44.54 170.34 286.14
33 2081.57 1749.50 1642.09 2223.88 1867.26 1704.54 68 1072.22 1176.83 1003.69 1747.50 1810.89 1296.10
34 499.94 451.85 876.61 529.64 478.81 908.41 69 258.41 334.48 480.29 505.76 610.80 690.62
35 11136.01 1110.18 1311.40 11490.31 1136.95 1334.99 70 64.52 90.79 208.44 131.52 181.03 331.61
36 2909.52 5309.38 2689.80 7358.61 8937.35 3453.91
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Table 6.2: Expected present values of continuous annuities of £1000 per year payable to a DP4 IPI claimant with a non-rated
occupation who falls sick at exact age 20, 40 and 60, calculated separately for males and females using rate of interest 4%.
Males Females Males Females
Age Age Age Age
cs 20 40 60 20 40 60 cs 20 40 60 20 40 60
1 968.79 1003.76 949.53 1614.14 1632.76 1282.43 37 2730.00 2353.82 1970.69 2897.98 2500.12 2041.41
2 3435.85 3112.19 1786.67 4852.77 4344.42 2202.22 38 1637.06 1464.59 1611.27 1728.63 1549.05 1667.54
3 1165.17 2080.10 1826.47 1900.52 3076.90 2243.76 39 2970.68 1609.57 1800.83 3444.74 1910.28 1946.10
4 394.06 1732.14 1691.69 397.20 1862.52 1820.71 40 2160.69 897.72 1298.79 3303.91 1516.36 1646.12
5 442.28 2034.40 1818.62 446.31 2194.28 1958.91 41 1196.43 1322.55 734.58 1207.26 1338.92 744.78
6 1435.11 1430.27 1160.42 2282.05 2225.85 1524.09 42 3066.61 2340.46 2322.77 3548.42 2709.91 2464.49
7 1435.11 1430.27 1160.42 2282.05 2225.85 1524.09 43 3628.18 2028.24 1969.86 4150.70 2371.07 2115.14
8 1435.11 1430.27 1160.42 2282.05 2225.85 1524.09 44 5555.49 3326.66 2380.26 6170.36 3759.59 2520.98
9 6485.61 5444.91 2426.21 8335.40 6984.85 2852.83 45 1004.89 2079.35 2301.30 1017.04 2111.58 2340.15
10 1435.11 1430.27 1160.42 2282.05 2225.85 1524.09 46 164.41 450.47 607.12 121.45 320.16 499.73
11 1435.11 1430.27 1160.42 2282.05 2225.85 1524.09 47 712.17 2785.17 1463.18 727.20 3040.22 1579.87
12 747.68 2718.06 1566.24 781.61 2984.11 1689.20 48 73.25 71.92 65.59 69.99 69.15 63.61
13 250.72 803.32 1165.70 251.82 848.80 1248.82 49 212.66 199.50 140.13 202.23 192.92 136.72
14 1435.11 1430.27 1160.42 2282.05 2225.85 1524.09 50 41.55 86.29 138.19 41.82 88.97 142.94
15 2784.97 2583.90 1612.69 4052.99 3706.11 2018.68 51 489.99 1445.08 1295.89 2986.15 2288.25 912.73
16 1435.11 1430.27 1160.42 2282.05 2225.85 1524.09 52 132.55 833.95 1120.69 136.11 900.48 1202.62
17 1435.11 1430.27 1160.42 2282.05 2225.85 1524.09 53 2468.80 2690.21 1249.02 2647.48 2946.24 1343.04
18 1435.11 1430.27 1160.42 2282.05 2225.85 1524.09 54 418.83 380.90 226.15 438.07 405.09 236.57
19 1435.11 1430.27 1160.42 2282.05 2225.85 1524.09 55M 929.57 1198.63 716.02 - - -
20 1060.02 1826.33 1544.93 1602.48 2079.58 1424.56 55F - - - 335.02 499.00 413.88
21 875.84 1994.76 1401.78 2636.66 2070.97 821.53 56 - - - 2627.55 4070.53 2146.58
22 8246.09 3734.21 1638.36 8380.18 3803.79 1669.53 57 - - - 2627.55 4070.53 2146.58
23 6871.61 5851.55 2952.33 6980.41 5966.67 3012.41 58 - - - 2627.55 4070.53 2146.58
24 3161.23 2969.67 2279.40 3205.47 3023.34 2324.54 59 1032.79 1950.93 1202.33 1045.56 2004.88 1253.82
25 3161.23 2969.67 2279.40 3205.47 3023.34 2324.54 60 1561.65 2608.24 1434.74 1582.16 2682.34 1497.41
26 5733.95 5000.04 2781.67 5822.30 5096.63 2837.94 61 1158.85 3735.76 2349.32 8626.47 7598.63 2596.16
27 1808.68 3276.77 2742.62 2949.09 4595.66 3068.26 62 916.27 2450.31 1755.76 1103.11 2758.36 1870.64
28 2140.63 3942.66 2178.27 4702.96 4853.40 1976.39 63 5518.57 6509.07 2678.96 4713.70 5991.74 2638.79
29 1575.86 1395.78 575.32 1682.80 1455.22 583.99 64 - - - 2627.55 4070.53 2146.58
30 1074.21 2546.05 1720.00 2929.14 3299.90 1501.27 65 3276.23 4625.36 2234.05 2627.55 4070.53 2146.58
31 4314.02 6088.50 2751.36 7542.58 7112.79 2595.52 66 525.33 881.37 650.24 815.51 1271.11 830.96
32 377.30 370.37 859.31 391.52 385.70 886.56 67 1126.08 1459.68 859.69 2005.66 2362.56 1197.41
33 5572.59 4583.13 2625.74 5948.83 4888.61 2722.60 68 2569.84 2602.10 1714.95 3622.65 3510.81 2024.94
34 3820.79 3226.53 2262.55 4065.88 3433.55 2344.75 69 786.41 925.00 965.24 1297.55 1440.90 1240.38
35 12894.84 2206.20 1863.54 13302.39 2260.49 1896.74 70 351.37 444.29 643.76 597.52 727.55 865.49
36 3686.21 6086.25 2951.84 8242.16 9573.47 3607.54
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Table 6.3: Expected present values of continuous annuities of £1000 per year payable to a DP13 IPI claimant with a non-rated
occupation who falls sick at exact age 20, 40 and 60, calculated separately for males and females using rate of interest 4%.
Males Females Males Females
Age Age Age Age
cs 20 40 60 20 40 60 cs 20 40 60 20 40 60
1 6868.09 5904.34 2620.46 8672.70 7425.71 3020.13 37 5701.14 4854.79 2756.13 6040.23 5147.78 2847.59
2 7628.88 6456.20 2734.27 9491.15 8014.30 3130.91 38 7186.94 5983.30 2982.54 7637.94 6358.09 3082.69
3 2025.52 3124.56 2273.95 2977.74 4290.94 2677.34 39 14166.80 7103.69 3409.97 14694.06 7590.26 3507.62
4 497.59 2698.48 2365.53 502.61 2911.17 2549.49 40 13422.66 5858.43 3208.54 14591.76 7043.08 3400.73
5 554.23 3067.53 2467.56 560.46 3317.28 2660.69 41 1171.94 2662.07 1887.68 1180.12 2694.85 1917.32
6 4774.41 4322.80 2255.99 6335.79 5683.08 2659.34 42 14242.63 8013.14 3573.02 14767.04 8489.19 3662.65
7 4774.41 4322.80 2255.99 6335.79 5683.08 2659.34 43 14648.76 7654.04 3466.80 15157.39 8135.24 3561.71
8 4774.41 4322.80 2255.99 6335.79 5683.08 2659.34 44 15716.49 8959.66 3588.99 16179.58 9416.37 3677.80
9 10696.35 8588.07 3128.60 12667.70 10215.05 3508.64 45 4168.37 5407.00 3085.48 4218.44 5490.04 3137.16
10 4774.41 4322.80 2255.99 6335.79 5683.08 2659.34 46 1246.48 2378.14 1703.75 942.84 1947.19 1580.25
11 4774.41 4322.80 2255.99 6335.79 5683.08 2659.34 47 1582.85 6172.92 2802.67 1618.93 6742.05 3029.71
12 1580.70 5441.50 2608.93 1663.48 5983.25 2818.07 48 332.93 865.66 1012.59 1156.98 2445.28 1798.54
13 327.01 1443.31 1899.75 329.07 1536.30 2042.19 49 473.19 1173.78 1194.25 1576.40 3049.39 2004.32
14 4774.41 4322.80 2255.99 6335.79 5683.08 2659.34 50 1014.28 1666.45 1061.13 1075.39 1810.33 1134.73
15 6820.06 5869.14 2613.00 8620.55 7387.86 3012.83 51 1793.26 3439.23 2015.09 6233.63 4773.74 1677.87
16 4774.41 4322.80 2255.99 6335.79 5683.08 2659.34 52 914.99 2772.66 2070.86 953.14 3003.44 2226.87
17 4774.41 4322.80 2255.99 6335.79 5683.08 2659.34 53 6194.99 5791.25 2287.18 6637.21 6338.04 2462.62
18 4774.41 4322.80 2255.99 6335.79 5683.08 2659.34 54 1978.81 1757.10 843.29 2088.61 1894.59 899.91
19 4774.41 4322.80 2255.99 6335.79 5683.08 2659.34 55M 3200.80 3417.69 1651.22 - - -
20 874.79 2094.16 1852.00 1266.39 2484.23 1916.44 55F - - - 4954.52 2595.88 634.02
21 3640.66 4594.75 2145.68 6763.44 5299.31 1909.04 56 - - - 6953.15 7848.56 3101.43
22 14549.12 9390.11 3192.00 14794.27 9575.05 3255.41 57 - - - 6953.15 7848.56 3101.43
23 9502.62 8041.91 3376.98 9646.12 8195.37 3444.70 58 7774.34 8265.62 3089.25 6953.15 7848.56 3101.43
24 5706.85 5261.54 2962.80 5781.48 5352.90 3020.91 59 2391.05 3648.99 1954.52 2416.33 3739.94 2031.34
25 5706.85 5261.54 2962.80 5781.48 5352.90 3020.91 60 6333.95 7056.22 2757.95 6417.36 7250.78 2871.94
26 8422.86 7282.80 3276.74 8545.96 7418.89 3342.12 61 2354.05 7403.89 3465.79 10664.04 10730.35 3604.16
27 3895.69 6177.86 3516.99 4381.74 6644.45 3598.16 62 2103.98 5902.19 3042.09 2421.00 6310.64 3132.32
28 4207.60 7366.80 3366.37 7178.86 8361.68 3299.34 63 10254.16 9827.19 3345.87 9495.80 9551.32 3396.81
29 6065.66 5332.09 1990.51 6493.06 5567.27 2022.33 64 - - - 6953.15 7848.56 3101.43
30 2707.00 5912.83 3120.12 5234.73 6877.66 3019.17 65 7774.34 8265.62 3089.25 6953.15 7848.56 3101.43
31 6664.72 9175.78 3627.94 9904.28 10157.57 3601.09 66 3817.84 4310.61 1920.57 4801.20 5164.44 2161.09
32 3870.91 3416.67 2409.70 4079.84 3609.13 2488.01 67 2427.45 3807.36 2026.30 2215.62 3607.24 1985.31
33 11632.12 9215.15 3504.69 12441.05 9833.93 3625.04 68 6387.58 5755.26 2627.74 7822.81 6858.42 2887.51
34 8552.48 6996.50 3162.85 9110.18 7446.42 3269.94 69 3562.71 3515.19 2065.56 4756.46 4511.82 2355.07
35 14787.13 4135.16 2486.41 15247.67 4239.38 2529.29 70 1819.13 1977.41 1551.86 2651.97 2746.75 1844.77
36 6878.93 8513.55 3387.31 11574.39 11439.10 3823.48
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Table 6.4: Expected present values of continuous annuities of £1000 per year payable to a DP26 IPI claimant with a non-rated
occupation who falls sick at exact age 20, 40 and 60, calculated separately for males and females using rate of interest 4%.
Males Females Males Females
Age Age Age Age
cs 20 40 60 20 40 60 cs 20 40 60 20 40 60
1 11222.85 9062.40 3159.69 13124.00 10617.06 3488.00 37 5039.62 8377.17 3638.39 5294.28 8899.31 3752.12
2 11858.04 9477.87 3218.81 13757.38 11030.02 3543.01 38 3466.36 7153.77 3555.82 3618.84 7584.13 3666.55
3 5794.87 6552.53 2969.22 7406.81 8045.01 3309.46 39 677.43 5102.56 3296.03 799.25 5552.02 3384.40
4 1345.58 6929.96 3205.55 1374.66 7544.84 3439.50 40 481.64 3914.07 3110.27 759.95 4997.57 3285.86
5 1515.52 7340.69 3249.12 1550.91 7998.69 3486.66 41 1061.03 2295.13 1943.54 1065.55 2315.75 1970.80
6 9259.37 7740.68 2958.87 11125.25 9280.46 3299.70 42 702.78 6051.94 3446.44 828.86 6515.73 3527.34
7 9259.37 7740.68 2958.87 11125.25 9280.46 3299.70 43 861.03 5668.91 3348.45 1012.82 6128.45 3434.28
8 9259.37 7740.68 2958.87 11125.25 9280.46 3299.70 44 1548.98 7112.19 3461.17 1796.94 7578.09 3541.32
9 14137.42 10926.94 3412.60 15984.65 12446.80 3722.08 45 12466.57 10785.78 3557.64 12632.42 10956.38 3614.66
10 9259.37 7740.68 2958.87 11125.25 9280.46 3299.70 46 885.76 3373.82 2621.94 697.20 2886.26 2575.44
11 9259.37 7740.68 2958.87 11125.25 9280.46 3299.70 47 1886.45 7823.71 3288.05 1926.46 8506.10 3529.35
12 6677.01 10335.63 3405.74 7136.89 11339.38 3657.14 48 1456.49 2687.36 1948.61 3436.43 5190.48 2675.40
13 820.72 5149.23 2986.29 833.22 5580.74 3202.19 49 1872.79 3241.95 2116.86 4176.92 5913.72 2820.17
14 9259.37 7740.68 2958.87 11125.25 9280.46 3299.70 50 1165.42 1890.27 1217.51 1223.68 2034.11 1293.14
15 11181.57 9035.21 3155.76 13082.63 10589.91 3484.33 51 6076.72 7225.08 2810.52 11672.03 8847.79 2683.31
16 9259.37 7740.68 2958.87 11125.25 9280.46 3299.70 52 1889.00 4266.20 2463.63 1975.67 4613.25 2635.43
17 9259.37 7740.68 2958.87 11125.25 9280.46 3299.70 53 8197.47 7331.32 2633.52 8762.85 7990.15 2819.26
18 9259.37 7740.68 2958.87 11125.25 9280.46 3299.70 54 4851.18 4281.70 1872.81 5117.05 4610.73 1996.30
19 9259.37 7740.68 2958.87 11125.25 9280.46 3299.70 55M 4988.25 4979.25 2113.52 - - -
20 1311.53 2823.13 2045.70 2082.57 3604.13 2211.88 55F - - - 253.01 2297.56 2233.89
21 5442.62 5856.30 2366.57 9124.11 7101.91 2355.15 56 - - - 5174.04 8824.26 3512.99
22 16606.98 11453.82 3469.04 16882.74 11675.01 3533.92 57 - - - 5174.04 8824.26 3512.99
23 13127.78 10556.12 3557.97 13330.52 10755.97 3624.82 58 - - - 5174.04 8824.26 3512.99
24 9856.51 8422.60 3354.44 9995.11 8573.15 3416.78 59 11352.11 10456.39 3341.64 11503.90 10733.69 3465.78
25 9856.51 8422.60 3354.44 9995.11 8573.15 3416.78 60 12333.50 11005.31 3416.28 12502.07 11299.91 3543.63
26 12274.04 10016.84 3510.16 12459.56 10204.03 3575.94 61 1564.22 9217.87 3819.89 13658.64 13697.69 3997.50
27 4187.59 8211.60 3728.16 4677.07 8689.71 3788.33 62 6033.27 8564.87 3550.86 6561.44 8953.71 3611.28
28 10467.77 11319.71 3765.75 13416.71 12203.25 3787.47 63 3114.89 6856.94 3192.33 2560.46 6351.84 3221.82
29 9620.92 8421.39 2958.42 10303.65 8792.50 3003.81 64 - - - 5174.04 8824.26 3512.99
30 8870.99 10509.71 3687.60 11951.39 11424.58 3695.57 65 5939.48 9175.52 3443.84 5174.04 8824.26 3512.99
31 12375.45 12182.20 3844.06 15062.92 13024.42 3879.92 66 1681.68 5685.97 3006.35 2291.99 6564.21 3175.63
32 1343.77 4621.97 3331.21 1382.23 4871.48 3433.84 67 5236.84 6414.37 2641.64 4953.87 6236.42 2627.26
33 7878.42 10033.75 3733.81 8340.26 10683.62 3851.01 68 8475.44 7363.46 2907.75 9913.10 8422.02 3116.62
34 4626.22 8084.81 3619.74 4852.97 8584.81 3732.79 69 5433.68 5092.40 2461.17 6794.30 6162.78 2707.58
35 16052.00 4688.90 3311.01 16541.57 4795.71 3365.90 70 3230.90 3291.58 2014.28 4342.90 4242.74 2284.29
36 10183.39 10401.71 3528.12 14352.81 12707.36 3817.72
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Table 6.5: Expected present values of continuous annuities of £1000 per year payable to a DP52 IPI claimant with a non-rated
occupation who falls sick at exact age 20, 40 and 60, calculated separately for males and females using rate of interest 4%.
Males Females Males Females
Age Age Age Age
cs 20 40 60 20 40 60 cs 20 40 60 20 40 60
1 8992.64 7756.10 2860.41 10706.97 9154.54 3107.59 37 15107.64 11736.67 3401.38 16128.83 12479.85 3491.92
2 9693.54 8234.71 2918.02 11433.61 9640.67 3160.47 38 14185.53 11155.91 3359.41 15120.42 11851.55 3448.59
3 3918.60 5100.33 2675.97 5088.12 6346.78 2936.91 39 10348.73 9986.73 3183.45 10917.19 10376.42 3247.12
4 705.87 5368.58 3018.02 712.71 5739.34 3181.14 40 9363.71 9086.28 3071.06 10772.69 9999.90 3188.18
5 787.05 5793.88 3052.43 795.38 6202.40 3217.72 41 2312.02 3895.50 2455.74 2321.62 3927.79 2485.75
6 6968.44 6306.47 2666.00 8550.37 7647.57 2927.62 42 10453.43 10599.16 3272.71 11021.20 10969.10 3331.49
7 6968.44 6306.47 2666.00 8550.37 7647.57 2927.62 43 11028.20 10361.33 3214.73 11590.64 10739.31 3276.70
8 6968.44 6306.47 2666.00 8550.37 7647.57 2927.62 44 12657.26 11203.80 3281.37 13191.22 11551.31 3339.66
9 12394.51 9987.90 3108.04 14154.02 11380.44 3333.48 45 10340.20 9786.06 3238.03 10456.30 9920.28 3281.05
10 6968.44 6306.47 2666.00 8550.37 7647.57 2927.62 46 4513.23 5954.42 2622.11 10504.90 10328.98 3222.47
11 6968.44 6306.47 2666.00 8550.37 7647.57 2927.62 47 1982.08 9023.28 3294.04 2014.67 9704.44 3474.76
12 4834.29 10698.26 3272.51 5086.27 11590.28 3452.18 48 954.30 1697.08 1685.74 2002.21 3342.27 2305.95
13 453.27 3659.37 2843.82 456.28 3884.13 2995.93 49 1175.10 2052.55 1838.64 2430.61 3914.48 2441.73
14 6968.44 6306.47 2666.00 8550.37 7647.57 2927.62 50 4369.62 5147.58 2204.97 4591.08 5512.26 2316.70
15 8947.87 7725.15 2856.58 10660.24 9122.93 3104.07 51 6820.61 7868.64 2793.20 12202.57 9368.20 2705.64
16 6968.44 6306.47 2666.00 8550.37 7647.57 2927.62 52 4277.09 6733.16 2831.08 4463.37 7216.61 2981.25
17 6968.44 6306.47 2666.00 8550.37 7647.57 2927.62 53 10987.42 9378.28 2921.03 11672.14 10112.26 3077.02
18 6968.44 6306.47 2666.00 8550.37 7647.57 2927.62 54 7212.54 6344.55 2471.47 7566.93 6770.38 2597.71
19 6968.44 6306.47 2666.00 8550.37 7647.57 2927.62 55M 7969.65 7400.49 2633.95 - - -
20 1834.32 3651.12 2207.87 2906.11 4631.86 2377.40 55F - - - 2144.84 6277.71 2958.34
21 6067.96 6525.77 2472.47 9511.91 7619.92 2484.41 56 - - - 16665.81 13470.60 3506.53
22 16292.69 11287.05 3237.81 16535.73 11477.63 3287.18 57 - - - 16665.81 13470.60 3506.53
23 12570.18 10366.09 3302.01 12738.12 10535.98 3352.61 58 12097.92 11043.40 3222.77 16665.81 13470.60 3506.53
24 9282.70 8226.04 3154.61 9390.52 8349.73 3202.39 59 10825.47 10313.35 3161.30 10947.76 10548.26 3253.41
25 9282.70 8226.04 3154.61 9390.52 8349.73 3202.39 60 11795.87 10854.90 3212.70 11933.82 11105.81 3306.66
26 11691.99 9818.59 3267.53 11843.23 9976.40 3317.47 61 2679.00 11385.03 3566.54 10383.81 13211.62 3607.74
27 6648.30 10678.26 3527.12 7262.60 11126.40 3569.65 62 15211.82 11207.56 3464.74 15703.49 11521.35 3504.23
28 8246.78 10159.08 3377.64 11179.86 11041.87 3388.22 63 6188.76 7336.36 2817.47 12292.07 11327.53 3319.52
29 11377.18 9891.98 3129.31 12190.90 10325.34 3172.44 64 - - - 16665.81 13470.60 3506.53
30 6620.36 9151.42 3302.88 9488.25 10052.32 3300.58 65 12097.92 11043.40 3222.77 16665.81 13470.60 3506.53
31 10416.07 11283.66 3452.80 13250.81 12130.57 3476.73 66 10553.59 9467.06 2918.04 11638.65 10208.56 3043.34
32 11906.99 9674.75 3242.93 12636.29 10251.62 3328.30 67 11801.61 10854.60 3192.28 11621.75 10835.99 3215.70
33 16233.42 12432.67 3449.31 17362.14 13233.45 3541.43 68 15895.31 12341.06 3364.05 16795.36 12951.51 3453.43
34 14895.20 11603.76 3391.94 15896.36 12336.01 3482.17 69 13943.04 11127.77 3236.21 15042.95 11873.65 3343.08
35 18442.43 11146.21 3350.00 19010.04 11443.77 3399.61 70 11892.51 9808.52 3086.13 13154.16 10677.40 3212.48
36 16261.47 13007.51 3479.74 18494.88 14244.77 3599.96
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We first examine the variation of the EPV of annuities by cause of sickness. We
present in Figure 6.1 the claim termination intensity for cs35 (Ischaemic heart disease),
cs61 (Arthritis & spondylitis) and cs62 (Musculoskeletal), separately for males and
females, with respect to a DP1 IPI policyholder aged 40 at sickness inception and has
a non-rated occupation. Given an inverse relationship between the claim termination
intensity and the probability of remaining sick, it is expected that the higher the claim
termination intensity, the lower the probability of remaining sick, which in turn leads
to a lower EPV of annuity. It is shown in Figure 6.1 that cs39 has the highest level
of claim termination intensity, followed by cs62 and cs61. This is also the order in
which their corresponding EPV of annuities in Table 6.1 are arranged from lowest to
highest.
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Figure 6.1: The claim termination intensity for cs39, cs61 and cs62, separately for
males and females, with respect to a DP1 IPI policyholder aged 40 at sickness incep-
tion holding a non-rated occupation.
We also examine the variation of EPV of annuities by age at sickness inception.
We present in Figure 6.2 the claim termination intensity for up to 5 years of sickness
durations for a male DP1 IPI policyholder with a non-rated occupation who falls sick
at ages 20, 40 and 60, separately for cs20 (Malignant neoplasms), cs35 (Ischaemic
heart disease) and cs36 (Cerebrovascular disease). In general, the recovery intensity
decreases with age while the mortality intensity from sick increases with age. Since
the recovery intensity is the major component in the claim termination intensity, the
variation of the claim termination intensity by age, at least for the initial period
of sickness durations, is usually dictated by the age effect included in the recovery
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intensity model. For cs20 and cs36, due to a negative linear age effect included in
their recovery intensity models, their claim termination intensities decrease as age at
sickness inception increases. For cs35, due to a non-linear age effect that follows a
humpbacked shape, the claim termination intensity for age 20 is lowest, followed by
that for ages 60 and then 40. We also observe that the claim termination intensities
for cs35 and cs36 at age 60 show an upturn at longer sickness durations, which is most
likely due to the ageing process (which is modelled by the ‘base’ mortality component
of the mortality intensity from sick model) taking effect. The maximum durations of
payment for a person falling sick at exact age 20, 40 and 60 are 45, 20 and 5 years
less 7 days, respectively. To make a fair comparison between the EPV of annuities
for these different ages, we decided to restrict the payment period to at most 5 years
less 7 days. Table 6.6 shows the EPV of such annuities for different ages at sickness
inception, separately for cs20, cs35 and cs36. As expected, for each cause of sickness,
the order in which the values are arranged from lowest to highest is opposite to the
order in which the level of their corresponding claim termination intensity in Figure
6.2 are arranged from lowest to highest.
Table 6.6: Expected present values of continuous annuities of £1000 per year lasting
for at most 5 years less 7 days for male DP1 policyholder with a non-rated occupation
who falls sick at exact age 20, 40 and 60, separately for cs20, cs35 and cs36. rate of
interest 4%.
Age 20 40 60
cs20 157.05 562.17 1216.99
cs35 2790.01 510.90 1311.40
cs36 955.13 1888.93 2689.80
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6.2.1: cs20 (Malignant neoplasms)
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6.2.2: cs35 (Ischaemic heart disease)
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6.2.3: cs36 (Cerebrovascular disease)
Figure 6.2: The claim termination intensity for male DP1 policyholder with non-rated
occupation falling sick at ages 20, 40 and 60, separately for cs20, cs35 and cs36.
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Finally, we examine the variation of EPV of annuities by deferred period. In
Table 6.7, we present the EPV of continuous annuities payable to a male IPI claimant
aged 40 at sickness inception holding a non-rated occupation and with the payment
starting at 1, 4, 13, 26 and 52 weeks of sickness duration and ceasing at age 65
for different deferred periods, separately for cs35 (Ischaemic heart disease) and cs39
(Acute respiratory infections). The claim termination intensities by deferred period
for both cs35 and cs39, upon which the values in Table 6.7 are calculated, are presented
in Figure 6.3. From Table 6.7, we see that for both causes of sickness, the longer the
sickness duration at which the payment starts for each deferred period, the higher
the annuity value because the claim termination intensity generally decreases with
sickness duration.
For cs35, apart from the ‘run-in’ period for DP4 and DP13, the termination in-
tensities for DP4 and DP13 thereafter are the same as DP1. As a result, the EPV
of annuities for DP4 with payment starting after the ‘run-in period’ are the same as
their corresponding DP1 values. For annuity payment starting at 26 weeks of sickness
duration, DP13 has a slightly different EPV of annuity than DP1 because the ‘run-in’
period for DP13 lasted until 185 days while DP26 has the lowest EPV of annuity
because it has higher claim termination intensity than other deferred periods.
Focusing on cs39, for all sickness durations at which annuity payments start, DP1
has a lower EPV of annuity than those from higher deferred periods because the DP1
claim termination intensity lies above all other deferred periods. We also note that the
EPV of annuities for DP1 payable immediately after the end of 1 week and 4 weeks
are much lower than the values for a different starting duration from DP1 or the same
starting duration from higher deferred periods. This is most likely because the vast
majority of the recoveries for cs39 are from DP1 and they are concentrated in the
first few weeks of sickness duration, leaving relatively few recoveries at longer sickness
durations. As a result, after the initial few weeks of very high recovery intensity, the
shape of the curve thereafter is very much guided by the presence of a few recoveries
at very long sickness durations, resulting in an intensity curve that is extrapolated
downwards quickly.
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Table 6.7: Expected present values of continuous annuities of £1000 per year payable
to a male aged 40 at sickness inception holding a non-rated occupation and with
the payment starting at selected sickness duration and ceasing at age 65 for different
deferred periods, separately for cs35 and cs39. rate of interest 4%.
cs35
Sickness duration DP1 DP4 DP13 DP26 DP52
(weeks)
1 1110.18
4 1814.24 2206.20
13 3291.79 3291.79 4135.16
26 6072.87 6072.87 6074.24 4688.90
52 8830.26 8830.26 8830.26 6921.29 11146.21
cs39
Sickness duration DP1 DP4 DP13 DP26 DP52
(weeks)
1 18.01
4 191.22 1609.57
13 1936.54 4099.73 7103.69
26 4062.94 6469.04 9124.22 5102.56
52 5904.83 8148.81 10363.37 6911.17 9986.73
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6.3.2: cs39
Figure 6.3: The claim termination intensities by deferred period, separately for cs35
and cs39, for a male IPI claimant aged 40 at sickness inception holding a non-rated
occupation.
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6.3 Aggregate Recovery and Mortality Intensities
from Sick
The graduated recovery and mortality intensities for IPI claimant presented in CMI
Working Paper 5 (2004) are obtained by using all the sickness data regardless of the
cause of sickness. The full graduation formulae for the recovery and mortality intensi-
ties in CMI Working Paper 5 (2004) are presented in Appendix D. In this section, we
wish to compare these graduated intensities and their corresponding aggregate inten-
sities obtained from using the cause-specific recovery and mortality intensities. We let
the aggregate recovery and mortality intensities from sick for a portfolio of sicknesses
consisting of different causes of sickness be represented by ρA and λA respectively.
Denote cause of sickness by i, i = 1, 2, . . . I. We assume that at sickness duration z0,
which is the starting point of annuity payment, the cause of sickness i is included in
the portfolio with proportion r(z0, i), with
∑
i r(z0, i) = 1. The aggregate recovery
and mortality intensities from sick at the starting point z0 are
ρAx,y,z0 =
I∑
i=1
r(z0, i)ρ(i)x,y,z0
and
λAx,y,z0 =
I∑
i=1
r(z0, i)λ(i)x,y,z0 .
The probability of sickness surviving to duration z (=z0 + t), conditional on sickness
existing at the starting duration z0, is given by tpx,y,z0 where
tpx,y,z0 =
I∑
i=1
r(z0, i)tp
SiSi
x,y,z0
and the proportionate distribution of causes at sickness duration z is given by
r(z, i) =
r(z0, i)tp
SiSi
x,y,z0
tpx,y,z0
.
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Thus, the aggregate recovery intensity and mortality intensity form sick at sickness
duration z are given by
ρAx,y,z =
I∑
i=1
r(z, i)ρ(i)x,y,z
and
λAx,y,z =
I∑
i=1
r(z, i)λ(i)x,y,z.
For the purposes of example, we will calculate the aggregate recovery and mortality
intensities for a male aged 40 at sickness inception with a non-rated occupation,
separately for each deferred period. In order to compare them against that in CMI
Working Paper 5 (2004), the year at which these aggregate intensities are calculated
is 1995, i.e the midpoint between 1991 and 1998. As in Section 6.2.1, we let the year
stand still at the start of the annuity payment.
Apart from having cause-specific termination assumptions, we also need to know
the proportion with which each cause of sickness is included in the portfolio of sickness
belonging to male aged 40 at sickness inception with a non-rated occupation at the
start of the annuity payment, i.e. at the end of deferred period. These proportions
are taken as the proportion of claim inceptions by cause of sickness for each deferred
period in the IPI male occupational class 1 data belonging to ages 37 to 43 from years
1991 to 1998, results of which are shown in Table 6.8.
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Table 6.8: The proportion in percentage with which each cause of sickness is included
in the portfolio belonging to male aged 40 at sickness inception with a non-rated
occupation at the start of annuity payment for DP1, DP4, DP13, DP26 and DP52.
cs DP1 DP4 DP13 DP26 DP52 cs DP1 DP4 DP13 DP26 DP52
1 0.639 0.463 0.000 0.000 0.000 34 0.246 1.389 0.000 1.250 1.389
2 0.000 0.000 0.000 0.000 0.000 35 0.344 3.935 3.376 3.750 1.389
3 3.291 0.463 0.000 0.000 1.389 36 0.049 1.157 0.844 1.250 2.778
4 0.000 0.231 0.000 0.000 0.000 37 0.246 0.231 0.422 0.000 0.000
5 0.000 0.000 0.000 0.000 0.000 38 1.179 1.389 0.844 0.000 1.389
6 0.000 0.000 0.000 0.000 0.000 39 7.613 1.620 0.000 1.250 0.000
7 0.000 0.000 0.000 0.000 0.000 40 17.976 0.000 0.000 0.000 0.000
8 0.000 0.000 0.000 0.000 0.000 41 0.835 0.926 0.000 0.000 0.000
9 0.049 0.231 0.000 0.000 0.000 42 0.982 0.000 0.422 0.625 0.000
10 0.049 0.000 0.000 0.000 0.000 43 2.652 0.000 0.422 0.000 0.000
11 0.049 0.000 0.000 0.000 0.000 44 0.098 0.000 0.000 0.000 0.000
12 0.098 0.000 0.422 0.625 0.000 45 0.688 0.000 0.422 0.000 0.000
13 0.147 0.463 0.000 0.000 0.000 46 0.344 0.000 0.000 0.000 0.000
14 0.000 0.000 0.000 0.000 0.000 47 0.147 0.694 0.000 0.000 0.000
15 0.049 0.000 0.000 0.000 0.000 48 0.344 0.231 0.000 0.000 0.000
16 0.000 0.000 0.000 0.000 0.000 49 1.572 2.778 0.844 1.250 0.000
17 0.000 0.000 0.000 0.000 0.000 50 0.098 0.694 0.000 0.000 0.000
18 0.000 0.000 0.422 0.000 0.000 51 0.933 2.083 2.532 0.625 0.000
19 7.466 1.157 1.266 0.000 0.000 52 0.393 0.231 0.000 0.000 0.000
20 0.786 6.019 10.127 12.500 15.278 53 0.049 0.000 0.000 0.000 0.000
21 0.295 0.694 0.844 0.625 1.389 54 0.000 0.000 0.000 0.000 0.000
22 0.000 0.231 0.422 0.000 0.000 55M 1.916 1.157 0.000 0.000 0.000
23 0.000 0.231 0.000 0.000 0.000 59 1.523 0.463 0.000 0.000 0.000
24 0.000 0.000 0.000 0.000 0.000 60 1.277 0.694 0.422 0.000 1.389
25 0.295 0.694 0.422 1.250 0.000 61 0.835 1.157 0.844 1.875 1.389
26 0.000 0.000 0.000 0.000 0.000 62 21.906 20.833 16.878 10.625 11.111
27 5.501 20.370 29.958 35.625 40.278 65 1.130 4.398 3.797 9.375 8.333
28 1.081 0.231 0.844 1.250 0.000 66 5.157 9.259 8.439 6.250 2.778
29 0.098 0.000 0.000 0.000 0.000 67 2.603 7.176 8.017 2.500 2.778
30 0.000 0.000 0.000 0.000 1.389 68 0.196 0.000 0.000 0.625 0.000
31 4.224 3.472 5.063 6.250 4.167 69 0.000 0.463 0.000 0.000 0.000
32 0.000 0.000 0.000 0.000 0.000 70 2.554 2.083 1.688 0.625 0.000
33 0.000 0.000 0.000 0.000 1.389
Recovery intensity
With respect to the recovery intensity, Figures 6.4–6.8 show the aggregate recov-
ery intensities for a male DP1 IPI policyholder aged 40 at sickness inception with a
non-rated occupation for DP1, DP4, DP13, DP26 and DP52, respectively. We also
overlaid on these graphs the graduated recovery intensities from CMI Working Paper
5 (2004). From these figures, we note that the aggregate recovery intensities for DP1,
DP4 and DP13 are rather close to their corresponding intensities from CMI Work-
ing Paper 5 (2004). For DP26 and DP52, the difference between both set of intensities
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are greater, most likely due to fewer number of recoveries underlying both set of
intensities. The number of recoveries belonging to male aged 40 at sickness inception
for DP1, DP4, DP13, DP26 and DP52 are 1365, 807, 275, 93 and 20, respectively.
For DP4, each cause of sickness has a different break point and for the majority of
them, the breakpoint occurs between 40 to 50 days, resulting in a ‘smooth’ curve in
the aggregate recovery intensity that occurs before the distinct break point at 56 days
(8 weeks) from CMI Working Paper 5 (2004). For DP13, we also observe a ‘smooth’
curve in the aggregate recovery intensity as opposed to a distinct break point and the
location of the ‘smooth’ curve is close to the distinct break point at 119 days from
CMI Working Paper 5 (2004) because the break point for each individual cause of
sickness is close to 119 days.
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Figure 6.4: A comparison between the aggregate recovery intensities obtained given
cause-specific recovery intensities and those from CMI Working Paper 5 (2004) with
respect to a male DP1 IPI policyholder aged 40 at sickness inception with a non-rated
occupation.
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Figure 6.5: A comparison between the aggregate recovery intensities obtained given
cause-specific recovery intensities and those from CMI Working Paper 5 (2004) with
respect to a male DP4 IPI policyholder aged 40 at sickness inception with a non-rated
occupation.
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Figure 6.6: A comparison between the aggregate recovery intensities obtained given
cause-specific recovery intensities and those from CMI Working Paper 5 (2004) with
respect to a male DP13 IPI policyholder aged 40 at sickness inception with a non-rated
occupation.
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Figure 6.7: A comparison between the aggregate recovery intensities obtained given
cause-specific recovery intensities and those from CMI Working Paper 5 (2004) with
respect to a male DP26 IPI policyholder aged 40 at sickness inception with a non-rated
occupation.
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Figure 6.8: A comparison between the aggregate recovery intensities obtained given
cause-specific recovery intensities and those from CMI Working Paper 5 (2004) with
respect to a male DP52 IPI policyholder aged 40 at sickness inception with a non-rated
occupation.
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Mortality intensity from sick
With respect to the mortality intensity from sick, Figures 6.9–6.13 show the aggregate
mortality intensities for up to 25 years of sickness duration in relation to a male IPI
claimant aged 40 at sickness inception with a non-rated occupation for DP1, DP4,
DP13, DP26 and DP52 respectively. We also overlaid on these graphs the graduated
mortality intensities from CMI Working Paper 5 (2004). For DP1, although both set
of intensities follow a hump-backed shape, the intensities from CMI Working Paper 5
(2004) are higher than the aggregate intensities for most sickness durations, with the
difference being most marked in the region near the peak value at around 22 weeks of
sickness duration. For both DP4 and DP13, the intensities from CMI Working Paper
5 (2004) lie above the aggregate intensities until both intensities become very close
to each other after around 1 year of sickness duration. For both DP26 and DP52,
the aggregate intensities are generally higher than the intensities from CMI Working
Paper 5 (2004). The eventual upturn in both sets of intensities for all deferred periods
is due to the more dominant ageing process taking effect.
In general, for all deferred periods, both sets of mortality intensities are more sim-
ilar at the later sickness durations, during which most of the deaths are concentrated,
than at the initial sickness durations when relatively few deaths occur. Nevertheless,
for all deferred periods, the difference between both sets of mortality intensities is
more significant than the difference between their counterparts for recovery intensi-
ties. This is likely due to a small number of deaths, particularly at younger ages,
underlying both sets of mortality intensities. Therefore, these estimated mortality
intensities may not be as ‘reliable’ as their corresponding recovery intensities which
are estimated based on a large number of recoveries. In the IPI data used by CMI
Working Paper 5 (2004), the number of deaths (recoveries) belonging to those un-
der age 40 at sickness inception for DP1, DP4, DP13, DP26 and DP52 are 7(2366),
14(568), 13(130), 9(55) and 4(11), respectively.
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Figure 6.9: A comparison between the aggregate mortality intensities obtained given
cause-specific recovery intensities and those from CMI Working Paper 5 (2004) with
respect to a male DP1 IPI policyholder aged 40 at sickness inception with a non-rated
occupation.
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Figure 6.10: A comparison between the aggregate mortality intensities obtained given
cause-specific recovery intensities and those from CMI Working Paper 5 (2004) with
respect to a male DP4 IPI policyholder aged 40 at sickness inception with a non-rated
occupation.
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Figure 6.11: A comparison between the aggregate mortality intensities obtained given
cause-specific recovery intensities and those from CMI Working Paper 5 (2004) with
respect to a male DP13 IPI policyholder aged 40 at sickness inception with a non-rated
occupation.
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Figure 6.12: A comparison between the aggregate mortality intensities obtained given
cause-specific recovery intensities and those from CMI Working Paper 5 (2004) with
respect to a male DP26 IPI policyholder aged 40 at sickness inception with a non-rated
occupation.
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Figure 6.13: A comparison between the aggregate mortality intensities obtained given
cause-specific recovery intensities and those from CMI Working Paper 5 (2004) with
respect to a male DP52 IPI policyholder aged 40 at sickness inception with a non-rated
occupation.
Comparison at age 60
In the IPI data used by CMI Working Paper 5 (2004), the number of deaths belonging
to those over age 60 at sickness inception for DP1, DP4, DP13, DP26 and DP52 are
19, 20, 18, 20 and 10, respectively. Since there are relatively more deaths at higher
ages, we carry out the same comparison in relation to a male IPI claimant aged 60
at sickness inception. The distribution of sicknesses at the start of annuity payment
for each deferred period is taken as the proportion of claim inceptions by cause of
sickness, separately for each deferred period, in the IPI male occupational class 1
data from years 1991 to 1998 belonging to ages 57 to 63, results of which are shown
in Table 6.9.
229
Table 6.9: The proportion in percentage with which each cause of sickness is included
in the portfolio belonging to male aged 60 at sickness inception with a non-rated
occupation at the start of annuity payment for DP1, DP4, DP13, DP26 and DP52.
cs DP1 DP4 DP13 DP26 DP52 cs DP1 DP4 DP13 DP26 DP52
1 0.138 0.175 0.000 0.000 0.000 34 1.866 1.573 1.509 3.738 5.455
2 0.069 0.000 0.000 0.000 0.000 35 9.053 19.755 21.983 23.598 16.970
3 1.244 0.000 0.000 0.000 0.000 36 1.106 3.497 5.819 5.841 4.848
4 0.069 0.000 0.000 0.467 0.000 37 0.415 1.224 0.647 0.701 0.606
5 0.000 0.000 0.216 0.000 0.000 38 2.695 1.573 2.802 0.701 0.606
6 0.000 0.000 0.000 0.000 0.000 39 5.045 0.350 0.216 0.701 0.606
7 0.000 0.000 0.000 0.000 0.000 40 7.187 0.000 0.000 0.000 0.000
8 0.000 0.000 0.000 0.000 0.000 41 0.691 0.175 0.216 0.234 1.212
9 0.000 0.000 0.000 0.000 0.000 42 2.695 0.524 1.293 2.804 3.636
10 0.000 0.000 0.000 0.000 0.000 43 0.484 0.000 0.000 0.000 0.000
11 0.000 0.000 0.000 0.000 0.000 44 0.000 0.000 0.000 0.000 0.000
12 0.000 0.000 0.431 0.000 0.000 45 0.622 0.350 0.647 0.467 0.000
13 0.069 0.350 0.216 0.467 0.606 46 0.207 0.175 0.000 0.000 0.000
14 0.000 0.000 0.000 0.000 0.000 47 0.346 0.175 0.000 0.000 0.000
15 0.207 0.000 0.216 0.000 0.000 48 0.138 0.000 0.000 0.000 0.000
16 0.000 0.000 0.000 0.000 0.000 49 3.317 3.147 1.078 0.234 0.000
17 0.000 0.000 0.000 0.000 0.000 50 0.691 0.350 0.216 0.000 0.000
18 0.000 0.000 0.000 0.000 0.000 51 1.797 1.399 0.862 1.168 3.030
19 3.870 0.874 0.431 0.000 0.606 52 0.553 0.000 0.216 0.000 0.000
20 3.179 10.315 14.224 11.682 9.697 53 0.000 0.175 0.000 0.000 0.000
21 0.415 1.399 1.724 0.467 0.606 54 0.346 0.000 0.000 0.000 0.000
22 0.138 0.175 0.216 0.467 0.000 55M 5.598 2.622 1.078 1.168 1.212
23 0.276 0.524 0.647 0.000 1.212 59 1.106 0.699 0.431 0.000 0.606
24 0.069 0.000 0.000 0.000 0.000 60 1.589 0.350 0.431 0.234 1.818
25 0.691 0.000 0.000 0.467 0.000 61 5.252 10.839 7.543 7.477 7.273
26 0.138 0.175 0.431 0.234 0.606 62 16.517 10.490 8.190 7.009 10.909
27 5.045 11.538 13.362 13.084 15.152 65 1.451 2.273 2.586 2.570 3.030
28 0.968 0.699 0.647 0.234 0.606 66 3.525 3.322 1.724 0.467 0.000
29 2.972 1.573 0.216 0.467 0.000 67 1.175 2.448 1.293 0.701 0.606
30 0.000 0.000 0.000 0.000 0.000 68 0.069 0.000 0.000 0.000 0.000
31 4.216 4.371 5.172 11.916 7.879 69 0.000 0.000 0.000 0.000 0.000
32 0.000 0.000 0.000 0.000 0.000 70 0.691 0.350 1.078 0.000 0.606
33 0.000 0.000 0.000 0.234 0.000
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There are notable differences between the distribution of sicknesses at the start of
annuity payment for male IPI claimants aged 60 and those for aged 40 as tabulated in
Table 6.8. For example, the proportions for cs34–cs38 (heart-related diseases), cs55M
(genito-urinary related diseases) and cs61 (arthritis) are higher for age 60 than for
age 40 for all deferred periods. On the other hand, the proportions for cs27 (mental
illness), cs40 (influenza) and cs66 (road transport accident) are higher for age 40 than
for age 60 for all deferred periods.
Figures 6.14 – 6.18 give a visual comparison between both sets of intensities for up
to 12 years of sickness durations for DP1, DP4, DP13, DP26 and DP52, respectively.
For DP1, the aggregate intensities lie above the corresponding intensities from
CMI Working Paper 5 (2004), with the gap between them narrowing with increasing
sickness duration until about 5 year of sickness duration, from which the intensities
from CMI Working Paper 5 (2004) become increasingly higher than the aggregate
intensities.
For DP4, DP13 and DP52, the same pattern as in DP1 is observed but the sickness
duration at which their respective intensities from CMI Working Paper 5 (2004) cross
over and become increasingly higher than their respective aggregate intensities are
0.90 year, 2.28 years and 1.73 years. For DP26, the intensities from CMI Working
Paper 5 (2004) are higher than their corresponding aggregate intensities and the gap
between them remains relatively constant until it starts to widen from around 2 years
of sickness duration.
We note that, for each deferred period, the difference between both sets of mor-
tality intensities in the region near the peak value is smaller for age 60 than for age
40 as the estimates for age 60 are based on greater numbers of deaths. On the other
hand, for each deferred period, the difference between both sets of intensities at the
longer period of sickness durations (i.e. during the upturn of the intensity) is greater
for age 60 than for age 40.
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For a male age 60 at sickness inception, the mortality intensities during the upturn
apply to a male with attained age over 65. For the aggregate intensities, this upturn
is described by the ‘base’ mortality intensity derived from assured lives data set and
therefore gives a more realistic set of intensities outside the age range of the data than
the extrapolated values from the Gompertz formula of CMI Working Paper 5 (2004).
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Figure 6.14: A comparison between the aggregate mortality intensities obtained given
cause-specific recovery intensities and those from CMI Working Paper 5 (2004) with
respect to a male DP1 IPI policyholder aged 60 at sickness inception with a non-rated
occupation.
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Figure 6.15: A comparison between the aggregate mortality intensities obtained given
cause-specific recovery intensities and those from CMI Working Paper 5 (2004) with
respect to a male DP4 IPI policyholder aged 60 at sickness inception with a non-rated
occupation.
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Figure 6.16: A comparison between the aggregate mortality intensities obtained given
cause-specific recovery intensities and those from CMI Working Paper 5 (2004) with
respect to a male DP13 IPI policyholder aged 60 at sickness inception with a non-rated
occupation.
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Figure 6.17: A comparison between the aggregate mortality intensities obtained given
cause-specific recovery intensities and those from CMI Working Paper 5 (2004) with
respect to a male DP26 IPI policyholder aged 60 at sickness inception with a non-rated
occupation.
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Figure 6.18: A comparison between the aggregate mortality intensities obtained given
cause-specific recovery intensities and those from CMI Working Paper 5 (2004) with
respect to a male DP52 IPI policyholder aged 60 at sickness inception with a non-rated
occupation.
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Chapter 7
Contributions and Ideas for
Further Research
The purpose of this chapter is to provide an overview of the main research findings
of this thesis as well as some avenues for further research.
Contributions
The main contribution of this thesis is the estimation of the recovery and mortality
intensities from sick by cause of sickness as well as highlighting the role a number of
well known statistical techniques such as the Cox model, generalised linear models
and relative survival models have to play in the analysis of IPI data.
In terms of methodology, the CMI’s usual approach to analysing IP data with
covariates is to split the data into homogeneous subgroups and compare the sickness
experience for each subgroup to the standard experience presented in CMI Report 12
(1991) or CMI Working Paper 5 (2004) by using the Actual/Expected ratios. Such
comparisons are usually one-way analyses which do not give a complete picture of
how the covariates jointly relate to the recovery and mortality intensities from sick.
In this thesis, we incorporate covariates in the regression model for the recovery and
mortality intensities from sick and estimate the covariate effects in a structured man-
ner. The covariates we consider are sex, rating indicator, deferred period, calendar
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year, age at sickness inception (for recovery intensity), attained age (for mortality
intensity from sick) and sickness duration. Of all these covariates, sickness duration
has the most impact on both recovery and mortality intensities from sick and the
variation of these intensities with sickness duration is very often rapid (for the initial
period of sickness duration) and irregular.
Apart from introducing a regression-type model, we use the Cox model heavily in
the parameterisation of the recovery intensity model. In particular, we show in Chap-
ter 3 that by modelling the variation of sickness duration in the baseline intensity,
we are able to avoid specifying its precise functional form and estimate the remaining
covariate effects by using the partial likelihood of the Cox model. In addition, the phe-
nomenon of a ‘run-in’ period for DP4, DP13 and DP26 and the duration-dependent
year effect, found in the IP related literature, are similarly revealed by using a standard
diagnostic tool associated with the Cox model. These duration-dependent covariate
effects are estimated using a generalised linear model with Poisson error structure
which is shown to be somewhat equivalent to the Cox model. For the baseline in-
tensity, the irregularity in the variation for sickness duration is reduced by using the
transformed sickness duration variable (see Section 3.3).
We use an additive relative survival model in the modelling of the mortality inten-
sity from sick. As far as we are aware, this form of modelling has not been attempted
before in insurance modelling and is an attractive alternative to the usual direct cause-
specific modelling or the multiplicative relative survival model for reasons stated in
Section 4.1.
In terms of estimation results, the recovery intensity model by cause of sickness is
presented in Section 3.6 and Appendix B. From these results, we note that causes of
sickness which belong to the same sickness category do not necessarily have the same
recovery patterns with sickness duration. In sickness category G5 Nervous system,
cs29 (Cataract) has a quadratic-shaped recovery pattern while cs28 (Inflammatory
diseases of eye), cs30 (Otitis media and mastoiditis) and cs31 (Other diseases of ner-
vous system and sense organs) have recovery patterns which vary linearly with the
transformed duration variable. The difference in recovery pattern can probably be
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explained by the dissimilar treatment for these causes of sickness. For cs29 (Cataract),
surgery is normally involved and therefore hospitalisation and waiting time for surgery
are required. This may explain the recovery intensity for cs29, in the case of DP1,
that increases with sickness duration until it starts to decrease from around 4 weeks
of sickness duration. Similar quadratic-shaped recovery patterns are also observed for
both cs48 (Appendicitis) and cs49 (Hernia) from sickness category G8 Digestive as
well as cs54 (Hyperplasia of prostate) from sickness category G9 Genito-urinary, all
of which involve surgery as part of their treatment.
We also note that most of the causes of sickness have recovery pattern which vary
linearly with the transformed duration variable. Examples are all causes of sickness
in G3 Endocrine & Metabolic, 5 out of the 7 causes of sickness in G7 Respiratory and
3 out of the 4 causes of sickness in G5 Nervous system & sensory organs. We note
that these causes of sickness are normally treated with medication.
For cs35 (Ischaemic heart disease), the recovery pattern for DP1 decreases before
becoming relatively constant between 4 weeks and 13 weeks of sickness duration and
falling of thereafter (see Figure 3.29). This peculiar recovery pattern may be due
to treatment varying with the seriousness of the disease. For example, for people
who receive medication to treat angina, their recovery pattern may be a decreasing
function of sickness duration. For people with a more serious heart condition who
are in need of surgery, their recovery pattern may be quadratic-shaped. Thus, a
combination of both types of people receiving different treatments may result in the
peculiar recovery pattern we see in Figure 3.29. A similar recovery pattern as in cs35
is also observed in cs55F (Other diseases of genito-urinary system (female)). This is
also likely to be due to the different types of female genito-urinary disease in cs55F
that involve either surgery, such as hysterectomy, or medication.
It is therefore reasonable to say that the recovery pattern for a cause of sickness,
to a certain extent, is influenced by the type of medical treatment a person receives.
In view of this, it is essential for IPI underwriters or actuaries to be aware of any
changes in medical treatment that could affect the recovery pattern.
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For the mortality intensity from sick by cause of sickness, although it consists of
the sum of the ‘base’ mortality and ‘excess mortality’ intensities, its overall shape is
very likely to follow that of the ‘excess mortality’ at least for the initial period of
sickness duration during which sickness duration is the more dominant explanatory
variable. As described in Section 5.3, in modelling the ‘excess mortality’ intensity, the
causes of sickness are classified into five sickness categories, i.e. MI to MV, depending
on the shape of their mortality curves. For causes of sickness in sickness categories MI
and MIV, their mortality curves have a hump-backed feature. For causes of sickness
in sickness categories MIII and MV, their mortality curves decrease linearly with
transformed sickness duration. For cause of sickness in sickness category MII (cs20
Malignant neoplasm), the mortality curves follow a U-shape. No easy explanation
can be given as to the shape of the mortality curve in each sickness category.
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In general, sickness duration has a more dominant effect on mortality intensity
to begin with, but its effect wears off over time until attained age becomes more
important . Given that deaths from cs20 Malignant neoplasm constitute almost half
of the total deaths, the aggregate mortality intensity for DP1, given cause-specific
mortality intensity, (see Figure 6.9 and 6.14) follows the same hump-backed shape as
cs20.
Ideas for Further Research
Actuaries are required to assess the magnitude, timing and duration of future claim
payments associated with IPI so that sufficient reserves are set aside to cover these
future cash outflows. In respect of reserving more reliably for claims in payment, we
have produced in this thesis the estimated recovery and mortality intensities by cause
of sickness which will enable an actuary to calculate a more reliable reserve for a port-
folio of claims resulting from different causes of sickness. In respect of reserving more
reliably for future claims, apart from having cause-specific termination assumptions,
it is useful to know the sickness inception intensity by cause of sickness, although in
computing reserves a breakdown of sickness inception by cause will produce the same
result as one calculated without the breakdown. However, the modelling of sickness
inception by cause of sickness with year trend incorporated will shed light on the rela-
tive importance of different cause of sickness over the years. These sickness inception
intensities are defined in the multiple state model by cause of sickness in Chapter 1
(i.e. transitions from Healthy to each of the Sick states). Thus, a natural extension
of this thesis is to estimate these sickness inception intensities using IPI in-force data
so that the multiple state model by cause of sickness can become fully operational for
IPI business.
We calculated the expected present values of annuities by cause of sickness for
claims in payment and presented the results in Chapter 6. Another important quantity
worth investigating is the average duration of a claim by cause of sickness which is
important for the underwriting and claim control stages of IPI business. It is also
possible to construct confidence interval for the aggregate recovery and mortality
intensities which are derived using cause-specific intensities by using bootstrapping.
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The graduation formulae for recovery and mortality intensities from sick presented
in CMI Report 12 (1991) and CMI Working Paper 5 (2004) assume homogeneity in
that all IP claimants, regardless of their cause of sickness, are subject to the same
recovery and mortality intensities. In this thesis, we have relaxed this assumption by
introducing an observed source of heterogeneity, cause of sickness, into our model. It
would be interesting to incorporate into the model unobserved sources of heterogeneity
(frailty) that are not readily captured by covariates. The idea is that an individual
frailty will influence the occurrence of recovery, death or sickness.
Finally, the impact of economic variables, such as the level of interest rates and
unemployment in particular, on the recovery intensity could also be investigated.
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Appendix A
ICD8 Code for Causes of Sickness
The list below shows the causes of sickness, grouping within each of the 12 sickness
categories as presented in Table 2.3 as well as their codes according to Abbreviated List
C in the Eight Revision of the Manual of the International Statistical Classification
of Diseases, Injuries and Causes of Death (ICD8).
G1 Infections & acute respiratory
ICD8 code Cause of sickness
1 Typhoid, paratyphoid fever, other salmonella infections
2 Bacillary dysentery and amoebiasis
3 Enteritis and Other diarrhoeal diseases
4 Tuberculosis of respiratory system
5 Other tuberculosis, including late effect
6 Brucellosis
7 Diphteria
8 Whooping cough
9 Streptococcal sore throat and scarlet fever
10 Small pox
11 Measles
12 Viral encephalitis
13 Infectious hepatitis
14 Typhus and other rickettsioses
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ICD8 code Cause of sickness
15 Malaria
16 Syphilis and its sequelae
17 Gonnococcal infections
18 Helminthiases
19 All other infective and parasitic diseases
G2 Neoplasms
ICD8 code Cause of sickness
20 Maglinant neoplasm, including neoplasms of lymphatic
and haematopoietic tissue
21 Benign neoplasms and neoplasms of unspecified nature
G3 Endocrine & Metabolic
ICD8 code Cause of sickness
22 Thyrotoxicosis with or without goitre
23 Diabetes Mellitus
24 Avitaminoses and other nutritional deficiency
25 Other endocrine and metabolic diseases
26 Anaemias
G4 Mental Illness
ICD8 code Cause of sickness
27 Psychoses and non psychotic mental disorders
G5 Nervous system & sensory organs
ICD8 code Cause of sickness
28 Inflammatory diseases of eye
29 Cataract
30 Otitis media and mastoiditis
31 Other diseases of nervous system and sense organs
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G6 Circulatory
ICD8 code Cause of sickness
32 Active rheumatic fever
33 Chronic rheumatic heart disease
34 Hypertensive disease
35 Ischaemic heart disease
36 Cerebrovascular disease
37 Venous thrombosis and embolism
38 Other diseases of respiratory system
G7 Respiratory
ICD8 code Cause of sickness
39 Acute respiratory infections
40 Influenza
41 Pneumonia
42 Bronchitis, emphysema and astham
43 Hypertrophy of tonsils and adenoids
44 Pneumoconioses and related diseases
45 Other diseases of respiratory system
G8 Digestive
ICD8 code Cause of sickness
47 Peptic Ulcer
48 Appendicitis
49 Intestinal obstruction and hernia
50 Cholelithiasis and cholecystitis
51 Other diseases of digestive system
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G9 Genito-Urinary
ICD8 code Cause of sickness
52 Nephritis and nephrosis
53 Calculus of urinary system
54 Hyperplasia of prostate
55 Other diseases of genito-urinary system
G10 Musculoskeletal
ICD8 code Cause of sickness
61 Arthritis and spondylitis
62 Other diseases of musculoskeletal system and connective tissue
G11 Injuries
ICD8 code Cause of sickness
66 Road transport accident
67 All other accidents
68 Attempted suicide and self-inflicted injuries
69 Attempted homicide and injury purposely inflicted by other
persons; legal intervention
70 All other external causes
G12 All other known causes
ICD8 code Cause of sickness
46 Diseases of teeth and supporting structures
56 Abortion
57 Other complications of pregnancy, childbirth and the puerperium
58 Delivery without mention of complication
59 Infections of skin and subcutaneous tissue
60 Other diseases of skin and subcutaneous tissue
63 Congenital anomalies
64 Certain causes of perinatal morbidity
65 Other specified and ill-defined diseases
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Appendix B
The Recovery Intensity Models for
Other Sickness Categories
In this Appendix we present the estimated recovery intensity models for causes of
sickness in Sickness Categories ‘G1 Infections & acute respiratory’, ‘G3 Endocrine
& Metabolic’, ‘G5 Nervous system & sensory organs’, ‘G7 Respiratory’, ‘G8 Diges-
tive’, ‘G9 Genito-urinary’, ‘G11 Injuries’ and ‘G12 All other known causes’. For each
recovery intensity model, the parameters for the baseline intensity are first given,
followed by those for the duration-fixed covariates, the interaction terms between
duration-fixed covariates, and the duration-dependent covariates. In terms of the
goodness-of-fit for each recovery intensity model, the χ2 statistic is given. The rele-
vant “partial residual effects” plot,‘residual effects” plot and two-dimensional plot of
deviance residuals (constructed wheneve the data is sufficiently large), can be found
in Ling (2008).
G1 Infections & acute respiratory
There are 19 causes of sickness in sickness category G1 Infections & acute respi-
ratory and they are cs1 – cs19. The data belonging to cs7, cs14, cs16, cs17 and
cs18 are amalgamated with cs19 data because their exposed-to-risk in days (num-
ber of recoveries) are 195(1), 329(4), 2,558(3), 57(3) and 769(3), respectively. Of
the remaining causes of sickness, those with recovery intensities which are propor-
tional to each other are modelled together using a proportional hazards model with
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cause of sickness as a factor. As such, the 14 causes of sickness can be split into two
groups, G1sub1 and G1sub2, and a separate recovery intensity model is fitted to each
group. The causes of sickness in each group are as follows:
G1sub1: cs4, cs5, cs12 and cs13
G1sub2: cs1, cs2, cs3, cs6, cs8, cs9, cs10, cs11, cs15 and cs19
For G1sub1, the χ2 statistic for the fitted recovery intensity model is 80.4461.
With 39 cells and 14 parameters fitted in the model, the probability value is 0.8992
on 25 degrees of freedom. For G1sub2, the χ2 statistic for the fitted recovery intensity
model is 80.4461. With 233 cells and 23 parameters fitted in the model, the probability
value is 0.2329 on 210 degrees of freedom. Table B.1 and B.2 show the exposed-to-risk
in days, the number of recoveries and the parameters in the recovery intensity model
for each cause of sickness in G1sub1 and G1sub2, respectively.
Table B.1: Parameters in the recovery intensity models for causes of sickness in
G1sub1.
cs4 cs5 cs12 cs13
Exposed to risk (days) 36,361 17,198 73,977 78,112
Number of recoveries 66 30 59 330
k 0.5 0.5 0.5 0.5
b0 1.8335 1.7434 2.4943 2.2079
b1 -3.0257 -3.0257 -4.9218 -3.0257
αrated -0.3231 -0.3231 -0.3231 -0.3231
αdp26 -0.7099 -0.7099 -0.7099 -0.7099
αyear -0.4472 -0.4472 -0.4472 -0.4472
αage -0.1061 -0.1061 -0.1061 -0.1061
τdp4 50.5 50.5 50.5 50.5
γdp4 -0.0329 -0.0329 -0.0329 -0.0329
τdp13 122.5 122.5 122.5 122.5
γdp13 -0.0549 -0.0549 -0.0549 -0.0549
τyear 27.5 27.5 27.5 27.5
γyear 0.0403 0.0403 0.0403 0.0403
τage 27.5 27.5 27.5 27.5
φage -2.0455 -2.0455 -2.0455 -2.0455
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Table B.2: Parameters in recovery intensity models for causes of sickness in G1sub2.
cs1 cs2 cs3 cs6 cs8 cs9 cs10 cs11 cs15 cs19
Exposed to risk (days) 14,183 11,683 30,668 4,155 385 1,905 753 3,175 2,240 262,666
Number of recoveries 106 48 947 21 12 58 12 30 29 3,135
k 2.3 2.3 2.3 2.3 2.3 2.3 2.3 2.3 2.3 2.3
b0 29.9825 29.8673 30.5319 30.3101 30.3101 30.3101 30.3101 30.3101 29.9898 30.3101
b1 -89.6762 -89.6762 -89.6762 -89.6762 -89.6762 -89.6762 -89.6762 -89.6762 -89.6762 -89.6762
b2 25.9040 25.9040 25.9040 25.9040 25.9040 25.9040 25.9040 25.9040 25.9040 25.9040
b3 -22.0979 -22.0979 -22.0979 -22.0979 -22.0979 -22.0979 -22.0979 -22.0979 -22.0979 -22.0979
αsex -0.1842 -0.1842 -0.1842 -0.1842 -0.1842 -0.1842 -0.1842 -0.1842 -0.1842 -0.1842
αrated -0.2666 -0.2666 -0.2666 -0.2666 -0.2666 -0.2666 -0.2666 -0.2666 -0.2666 -0.2666
αdp4 0.3488 -0.1372 -0.5933 -0.1372 -0.1372 -0.1372 -0.1372 -0.1372 -0.1372 -0.1372
αdp13 -0.3030 -0.3030 -0.3030 -0.3030 -0.3030 -0.3030 -0.3030 -0.3030 -0.3030 -0.3030
αdp26 -0.7125 -0.7125 -0.7125 -0.7125 -0.7125 -0.7125 -0.7125 -0.7125 -0.7125 -0.7125
αyear -0.5801 -0.5801 -0.5801 -0.5801 -0.5801 -1.6387 -0.5801 -0.5801 -0.5801 -0.5801
αage -0.3495 -0.3495 -0.7117 -0.3495 -0.3495 -0.3495 -0.3495 -0.3495 -0.3495 -0.3495
αage2 -0.1331 -0.1331 -0.1331 -0.1331 -0.1331 -0.1331 -0.1331 -0.1331 -0.1331 -0.1331
τdp4 47.5 47.5 47.5 47.5 47.5 47.5 47.5 47.5 47.5 47.5
γdp4 -0.0800 -0.0800 -0.0800 -0.0800 -0.0800 -0.0800 -0.0800 -0.0800 -0.0800 -0.0800
τdp13 119.5 119.5 119.5 119.5 119.5 119.5 119.5 119.5 119.5 119.5
γdp13 -0.0421 -0.0421 -0.0421 -0.0421 -0.0421 -0.0421 -0.0421 -0.0421 -0.0421 -0.0421
τyear 47.5 47.5 47.5 47.5 47.5 47.5 47.5 47.5 47.5 47.5
γyear 0.0247 0.0247 0.0247 0.0247 0.0247 0.0247 0.0247 0.0247 0.0247 0.0247
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G3 Endocrine & Metabolic
There are 5 causes of sickness in sickness category G3 Endocrine & Metabolic and they
are cs22 – cs26. The recovery intensities for these 5 causes of sickness are modelled
together using a proportional hazards model with cause of sickness as a factor because
they are found to be proportional to each other. Table B.3 shows for each cause of
sickness in G3 Endocrine & Metabolic the exposed-to-risk in days, the number of
recoveries and the parameters in the recovery intensity model. The χ2 statistic for
the fitted model is 43.9113. With 50 cells and 16 parameters fitted in the model, the
probability value is 0.1188 on 34 degrees of freedom.
Table B.3: Parameters in the recovery intensity models for causes of sickness in G3
Endocrine & Metabolic.
cs22 cs23 cs24 cs25 cs26
Exposed-to-risk (days) 209,164 246,938 6,044 137,380 51,597
Number of recoveries 91 137 9 292 67
k 2.3 2.3 2.3 2.3 2.3
b0 2.7287 2.9605 3.5392 3.5392 3.1256
b1 -14.5645 -14.5645 -14.5645 -14.5645 -14.5645
αdp4 0.4594 -0.2807 -0.2807 -0.2807 -0.2807
αdp26 -0.3933 -0.3933 -0.3933 -0.3933 -0.3933
αyear 0.0339 0.0339 0.0339 0.0339 0.0339
αage 0.1178 -0.6799 -0.6799 -0.6799 -0.6799
αage2 -0.2940 -0.2940 -0.2940 -0.2940 -0.2940
τdp4 52.5 52.5 52.5 52.5 52.5
γdp4 -0.0569 -0.0569 -0.0569 -0.0569 -0.0569
τdp13 140.5 140.5 140.5 140.5 140.5
γdp13 -0.0372 -0.0372 -0.0372 -0.0372 -0.0372
τyear 20.5 20.5 20.5 20.5 20.5
γyear 0.0453 0.0453 0.0453 0.0453 0.0453
θyear -3.0624 -3.0624 -3.0624 -3.0624 -3.0624
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G5 Nervous system & sensory organs
There are 4 causes of sickness in sickness category G5 Nervous system & sensory organs
and they are cs28 – cs31. The recovery intensities for cs28, cs30 and cs31 are modelled
together because they are found to be proportional to each other. The χ2 statistic for
the fitted recovery intensity model for these 3 causes of sickness is 203.3780. With
204 cells and 17 parameters fitted in the model, the probability value is 0.1956 on 187
degrees of freedom. The recovery intensity for cs29 is modelled separately and the
fitted model has a χ2 statistic of 11.4250. With 23 cells and 6 parameters fitted in
the model, the probability value is 0.8336 on 17 degrees of freedom. Table B.4 shows
for each cause of sickness in G5 Nervous system & sensory organs the exposed-to-risk
in days, the number of recoveries and the parameters in the recovery intensity model.
Table B.4: Parameters in the recovery intensity models for causes of sickness in G5
Nervous system & sensory organs.
cs28 cs29 cs30 cs31
Exposed-to-risk(days) 235,093 92,897 44,719 3,587,559
Number of recoveries 424 285 148 2,008
k 2.3 6.7 2.3 2.3
b0 4.1016 -308.3070 4.4025 3.6802
b1 -18.0868 63.1057 -18.0868 -18.0868
b2 -309.1824
αsex -0.0937 -0.0937 -0.0937
αrated 0.1686 0.1686 0.1686
αdp4 -0.1120 -0.1120 -0.1120
αdp26 -0.3538 -0.3538 -0.3538
αyear -0.6030 1.2748 -0.6030 -0.6030
αage -0.9358 -0.9358 -0.9358
αsex:age 0.3825 0.3825 0.3825
αdp4:age 0.3385 0.3385 0.3385
αdp26:year -0.4569 -0.4569 -0.4569
τrated 68.5 68.5 68.5
γrated -0.0245 -0.0245 -0.0245
τdp4 46.5 56.5 46.5 46.5
γdp4 -0.0698 -0.0342 -0.0698 -0.0698
τdp13 121.5 121.5 121.5
γdp13 -0.0541 -0.0541 -0.0541
τyear 45.5 45.5 45.5
γyear 0.0302 0.0302 0.0302
θyear -12.7439
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G7 Respiratory
There are 7 causes of sickness in sickness category G7 Respiratory and they are
cs39 – cs45. The recovery intensities for cs39, cs40, cs42, cs43 and cs44 are modelled
together because they are found to be proportional to each other. The χ2 statistic for
the fitted recovery intensity model for these 5 causes of sickness is 283.0298. With
291 cells and 25 parameters fitted in the model, the probability value is 0.2261 on 266
degrees of freedom. The recovery intensities for cs41 and cs45 are fitted separately.
For cs41, the fitted recovery intensity model has a χ2 statistic of 30.8606. With 53
cells and 11 parameters fitted in the model, the probability value is 0.8977 on 42
degrees of freedom. For cs45, the fitted recovery intensity model has a χ2 statistic of
66.8385. With 65 cells and 13 parameters fitted in the model, the probability value
is 0.0808 on 52 degrees of freedom. Table B.5 shows for each cause of sickness in G7
Respiratory the exposed-to-risk in days, the number of recoveries and the parameters
in the recovery intensity model.
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Table B.5: Parameters in the recovery intensity models for causes of sickness in G7
Respiratory.
cs39 cs40 cs41 cs42 cs43 cs44 cs45
Exposed-to 127,930 41,123 67,836 505,352 14,379 7,373 210,108
-risk(day)
Number of 2,639 4,504 630 1,419 329 38 881
recoveries
k 2.3 2.3 6.7 2.3 2.3 2.3 2.3
b0 4.5644 4.8340 -302.4215 4.3385 4.4458 4.1399 29.1540
b1 -17.7844 -17.7844 61.1308 -17.7844 -17.7844 -17.7844 -103.2332
b2 -304.1462 25.1611
b3 -27.5685
αsex -0.0796 -0.2212 -0.0796 -0.0796 -0.0796
αrated -0.4901
αdp4 -0.5160 -0.5160 -0.1596 -0.5160 -0.5160 -0.5160 -0.4317
αdp13 -1.1482 -1.1482 -0.6582 -1.1482 -1.1482 -1.1482
αdp26 -0.3686 -0.3686 -0.3686 -0.3686 -0.3686 -1.0302
αdp52 -1.0029 -1.0029 -1.0029 -1.0029 -1.0029
αyear -0.0206 -0.0206 0.1820 -0.0206 -0.0206 -0.0206 -0.0037
αage -0.5603 -0.4438 -0.6164 -0.7953 -0.5603 -0.5603 -0.7969
αage2 -0.0347 -0.0347 -0.0347 -0.0347 -0.0347 -0.2947
αdp4:age 0.4928
αdp26:age -1.2614 -1.2614 -1.2614 -1.2614 -1.2614
αdp4:year -0.4343 -0.4343 -0.7182 -0.4343 -0.4343 -0.4343
αdp13:year -0.9366 -0.9366 -0.9366 -0.9366 -0.9366
αdp4:age2 -0.3969 -0.3969 -0.3969 -0.3969 -0.3969
αdp13:age2 -0.8687 -0.8687 -0.8687 -0.8687 -0.8687
αyear:age -0.3893
τdp41 40.5 40.5 59.5 40.5 40.5 40.5 42.5
γdp41 -0.1001 -0.1001 -0.0496 -0.1001 -0.1001 -0.1001 -0.1187
τdp42 70.5 70.5 70.5 70.5 70.5
γdp42 -0.0156 -0.0156 -0.0156 -0.0156 -0.0156
τdp13 220.5
γdp13 -0.0111
τyearγ 35.5 35.5 35.5 35.5 35.5
γyear 0.0114 0.0114 0.0114 0.0114 0.0114
τyearφ 20.5
φyear -3.2097
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G8 Digestive
There are 5 causes of sickness in sickness category G8 Digestive and they are
cs47 – cs51. The recovery intensities for cs48 and cs49 are modelled together be-
cause they are found to be proportional to each other. The χ2 statistic for the fitted
recovery intensity model for both causes of sickness is 255.0009. With 282 cells and
22 parameters fitted in the model, the probability value is 0.5759 on 260 degrees of
freedom. The recovery intensities for cs47, cs50 and cs51 are fitted separately. For
cs47, the fitted recovery intensity model has a χ2 statistic of 23.7274. With 30 cells
and 9 parameters fitted in the model, the probability value is 0.3064533 on 21 de-
grees of freedom. For cs50, the fitted recovery intensity model has a χ2 statistic of
32.1172. With 49 cells and 11 parameters fitted in the model, the probability value
is 0.7375 on 38 degrees of freedom. For cs51, the fitted recovery intensity model has
a χ2 statistic of 107.4741. With 128 cells and 15 parameters fitted in the model, the
probability value is 0.6289974 on 113 degrees of freedom. Table B.6 shows for each
cause of sickness in G8 Digestive the exposed-to-risk in days, the number of recoveries
and the parameters in the recovery intensity model.
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Table B.6: Parameters in the recovery intensity models for causes of sickness in G8
Digestive.
cs47 cs48 cs49 cs50 cs51
Exposed-to-risk (days) 91,916 24,189 268,100 70,661 583,935
Number of recoveries 350 608 2,618 612 1,565
k 1.3 6.7 6.7 2.3 2.3
b0 3.0712 -375.3728 -375.5133 -28.1944 55.5717
b1 -8.0560 93.3918 93.3918 13.0201 -177.4550
b2 -375.9880 -375.9880 -30.1205 51.8543
b3 -50.4236
αsex -0.4958 -0.4958 -0.1155
αrated -0.3572 -0.0171 -0.0171 -0.5489 -0.2075
αdp4 -0.2369 -0.4718 0.1674
αdp13 -0.0213 -0.0213 -0.5161
αdp26 -0.8313 -0.8313 -0.4412
αyear -1.4777 0.2038 0.2038 -0.5034 -0.4041
αyear2 0.1512 0.1512 0.2684
αage -6.8031 -0.5330 -0.5330 -0.3858 -0.6502
αsex:age 0.6943
αdp4:age 0.5364 0.5364
αdp4:year -0.3284 -0.3284
αdp13:year -0.7464 -0.7464
αrated:age -0.2655 -0.2655
αsex:dp4 0.5211 0.5211
τrated 75.5 75.5
γrated -0.0269 -0.0269
τdp41 49.5 40.5 40.5 42.5
γdp41 -0.0620 -0.0912 -0.0912 -0.1707 -0.1064
τdp42 90.5
γdp42 -0.0091
τdp13 128.5 128.5 119.5
γdp13 -0.0329 -0.0329 -0.0469
τyearγ 26.5 26.5 32.5
γyear 0.0667 0.0667 0.0351
τyearζ 135.5 52.5
ζyear1 9.7968 49.9025
ζyear2 -460.9677
θage1 4.1772
θage2 -6.3111
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G9 Genito-urinary
There are 4 causes of sickness in sickness category G8 Digestive and they are
cs52 – cs55. For cs55, the recovery intensity for males and females are fitted sep-
arately because their recovery pattern are very dissimilar to each other. We refer to
cs55 for males and females as cs55M and cs55F, respectively.
The recovery intensities for cs52, cs53 and cs55M are modelled together because
they are found to be proportional to each other. The χ2 statistic for the fitted re-
covery intensity model for these causes of sickness is 80.4461. With 125 cells and
16 parameters fitted in the model, the probability value is 0.9816 on 109 degrees of
freedom.
The recovery intensities for cs54 and cs55F are estimated separately. For cs47,
the fitted recovery intensity model has a χ2 statistic of 10.8174. With 21 cells and
4 parameters fitted in the model, the probability value is 0.8659 on 17 degrees of
freedom. For cs55F, the fitted recovery intensity model has a χ2 statistic of 46.8785.
With 60 cells and 13 parameters fitted in the model, the probability value is 0.4775
on 47 degrees of freedom. Table B.7 shows for each cause of sickness in G9 Genito-
urinary, the exposed-to-risk in days, the number of recoveries and the parameters in
the recovery intensity model.
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Table B.7: Parameters in the recovery intensity models for causes of sickness in G9
Genito-urinary.
cs52 cs53 cs54 cs55M cs55F
Exposed-to-risk(days) 102,633 30,929 23,737 211,813 157,067
Number of recoveries 155 163 259 1,211 818
k 1.3 1.3 6.7 1.3 6.7
b0 3.1425 3.5696 -404.5940 3.6364 1690.9520
b1 -9.5505 -9.5505 103.1949 -9.5505 -12041.2100
b2 -404.0155 1684.5420
b3 -3940.3580
αrated -0.2545 -0.2545 -0.2545 -0.8554
αdp4 -0.1718 -0.1718 -0.1718 -0.1288
αdp13 -0.5375
αyear 0.3411 -0.8032 -0.3135 -0.3416
αage -0.8187 -0.2099 -0.2099 -1.1964
αdp4:age 0.9581
αdp13:age 1.5520
αrated:year 0.5599
τdp4 43.5 43.5 47.5 43.5 49.5
γdp4 -0.1051 -0.1051 -0.0659 -0.1051 -0.0787
τdp13 155.5 155.5 155.5
γdp13 -0.0218 -0.0218 -0.0218
τyear 50.5 50.5 50.5
γyear 0.0168 0.0571 0.0168
τage 38.5 38.5 38.5
γage -0.0330 -0.0330 -0.0330
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G11 Injuries
There are 5 causes of sickness in sickness category G11 Injuries and they are
cs66 – cs70.
The recovery intensities for cs68, cs69 and cs70 are modelled together because they
are found to be proportional to each other. The χ2 statistic for the fitted recovery
intensity model for these causes of sickness is 118.6597. With 165 cells and 21 param-
eters fitted in the model, the probability value is 0.9396 on 144 degrees of freedom.
Table B.8 shows for each cause of sickness in G9 Genito-urinary, the exposed-to-risk
in days, the number of recoveries and the parameters in the recovery intensity model.
The recovery intensities for cs66 and cs67 are estimated separately. For cs66,
the fitted recovery intensity model has a χ2 statistic of 293.528. With 332 cells and
20 parameters fitted in the model, the probability value is 0.7666 on 312 degrees of
freedom. For cs66, the fitted recovery intensity model has a χ2 statistic of 571.7478.
With 645 cells and 19 parameters fitted in the model, the probability value is 0.9407
on 626 degrees of freedom.
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Table B.8: Parameters in the recovery intensity models for causes of sickness in G11
Injuries.
cs66 cs67 cs68 cs69 cs70
Exposed-to-risk (days) 1,458,667 2,383,238 18,158 39,193 476,814
Number of recoveries 3,893 7,695 60 117 1,993
k 2.3 2.3 2.3 2.3 2.3
b0 -220.4817 26.8452 -449.0517 -448.6254 -448.2689
b1 250.2069 -102.6865 550.8088 550.8088 550.8088
b2 -280.6401 23.4335 -570.4026 -570.4026 -570.4026
b3 81.8599 -29.3062 181.6597 181.6597 181.6597
b4 -57.7592 -118.9095 -118.9095 -118.9095
αsex -0.1429 0.0511 -0.1819 -0.1819 -0.1819
αrated -0.2727 -0.1240 -0.2593 -0.2593 -0.2593
αdp4 -0.1762 -0.1896 0.2256 0.2256 0.2256
αdp13 -0.2107 -0.2924
αdp26 -0.4365 -0.4144
αdp52 -0.5208 -0.8429 -0.8803 -0.8803 -0.8803
αyear 0.2242 -0.1959 -0.3274 -0.3274 -0.3274
αyear2 0.1159 0.1697 0.1697 0.1697
αage -0.3068 -0.5003 -0.4127 -0.4127 -0.4127
αage2 -0.1332 -0.1332 -0.1332
αdp4:age 0.2699
αdp26:age -0.8826
αdp13:year -0.3122
αrated:year -0.3346
αsex:dp4 -0.2848
τdp41 47.5 47.5 44.5 44.5 44.5
γdp41 -0.0803 -0.0869 -0.0775 0.0248 -0.0775
τdp42 92.5 92.5 92.5
γdp42 -0.0157 -0.0157 -0.0157
τdp13 119.5 128.5 115.5 115.5 115.5
γdp13 -0.0579 -0.0325 -0.0878 -0.0878 -0.0878
τyearγ 28.5 28.5 24.5 24.5 24.5
γyear -0.0163 0.0316 0.0280 0.0280 0.0280
τyearφ 67.5
φyear -3.0723
θyear -1.2328
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G12 All other known causes
There are 9 causes of sickness in sickness category G11 Injuries and they are
cs46, cs56 – cs60 and cs63 – cs65.
The recovery intensities for cs46, cs56, cs57, cs58, cs63, cs64 and cs65 are modelled
together because they are found to be proportional to each other. The χ2 statistic
for the fitted recovery intensity model for these causes of sickness is 242.1508. With
279 cells and 27 parameters fitted in the model, the probability value is 0.6608 on 252
degrees of freedom.
The recovery intensity for cs59 and cs60 are estimated together since they are found
to be proportional to each other. The χ2 statistic for the fitted recovery intensity
model for these causes of sickness is 77.6994. With 97 cells and 11 parameters fitted
in the model, the probability value is 0.7268 on 86 degrees of freedom.
The recovery intensities for cs66 and cs67 are estimated separately. For cs66,
the fitted recovery intensity model has a χ2 statistic of 293.528. With 332 cells and
20 parameters fitted in the model, the probability value is 0.7666 on 312 degrees of
freedom. For cs66, the fitted recovery intensity model has a χ2 statistic of 571.7478.
With 645 cells and 19 parameters fitted in the model, the probability value is 0.9407
on 626 degrees of freedom.
Table B.9 shows for each cause of sickness in G9 Genito-urinary, the exposed-to-
risk in days, the number of recoveries and the parameters in the recovery intensity
model.
259
Table B.9: Parameters in the recovery intensity models for causes of sickness in G12 All other known causes.
cs46 cs56 cs57 cs58 cs59 cs60 cs63 cs64 cs65
Exposed-to-risk (days) 7,763 1,965 14,971 1,233 126,352 194,363 89,725 36,664 2,452,853
Number of recoveries 201 18 108 2 701 642 102 140 3177
k 2.3 2.3 2.3 2.3 2.3 2.3 2.3 2.3 2.3
b0 29.8043 28.8907 28.8907 28.8907 4.1147 3.9567 28.5392 28.8907 28.8907
b1 -89.4239 -89.4239 -89.4239 -89.4239 -16.4267 -16.4267 -89.4239 -89.4239 -89.4239
b2 25.1623 25.1623 25.1623 25.1623 25.1623 25.1623 25.1623
b3 -22.5471 -22.5471 -22.5471 -22.5471 -22.5471 -22.5471 -22.5471
αsex -0.0563 -0.0563 -0.0563 -0.0563 -0.0563 -0.0563 -0.0563
αrated -1.2448 -0.0209 -0.0209 -0.0209 -0.0209 -0.0209 -0.0209
αdp4 -0.0552 -0.0552 -0.0552 -0.0552 -0.0552 -0.0552 -0.0552
αdp13 0.0118 0.0118 0.0118 0.0118 0.5062 0.0120 0.0118 0.0118 0.0118
αdp26 -0.2239 -0.2239 -0.2239 -0.2239 -0.4631 -0.4631 0.6170 -0.2239 -0.2239
αdp52 -0.3710 -0.3710 -0.3710 -0.3710 0.8936 -0.3710 -0.3710
αyear -0.4669 -0.7892 -0.7892 -0.7892 0.1197 0.1197 -0.7892 -0.7892 -0.7892
αage -0.4937 -0.4937 -0.4937 -0.4937 -0.4512 -0.4512 -0.4937 -0.4937 -0.4937
αdp26:age -0.5812 -0.5812 -0.5812 -0.5812 -0.5812 -0.5812 -0.5812
αdp13:year -0.3462 -0.3462 -0.3462 -0.3462 -0.3462 -0.3462 -0.3462
αrated:year 0.2946 0.2946 0.2946 0.2946 0.2946 0.2946 0.2946
αsex:year 0.2106 0.2106 0.2106 0.2106 0.2106 0.2106 0.2106
αsex:dp52 -1.0490 -1.0490 -1.0490 -1.0490 -1.0490 -1.0490 -1.0490
τdp4 47.5 47.5 47.5 47.5 63.5 63.5 47.5 47.5 47.5
γdp4 -0.1016 -0.1016 -0.1016 -0.1016 -0.0396 -0.0396 -0.1016 -0.1016 -0.1016
τdp13 121.5 121.5 121.5 121.5 119.5 119.5 121.5 121.5 121.5
γdp13 -0.0572 -0.0572 -0.0572 -0.0572 -0.0773 -0.0773 -0.0572 -0.0572 -0.0572
τdp26 220.5 220.5 220.5 220.5 220.5 220.5 220.5
γdp26 -0.0512 -0.0512 -0.0512 -0.0512 -0.0512 -0.0512 -0.0512
τyearγ 34.5 34.5 34.5 34.5 34.5 34.5 34.5
γyear 0.0313 0.0313 0.0313 0.0313 0.0313 0.0313 0.0313
τyearφ 32.5 32.5
φyear -4.1303 -4.1303
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Appendix C
The Derivation of the Recursive
Formula for tp
SiSi
x,y,z
In this Appendix we present the deriviation of the recurrence relations for the evalu-
ation of tp
SiSi
x,y,z in Equation (6.3).
The Kolmogorov forward equation for tp
SiSi
x,y,z is given by
∂
∂t
tp
SiSi
x,y,z = −tpSiSix,y,z(ρ(i)x+t,y+t,z+t + ν(i)x+t,y+t,z+t)
and similarly,
∂
∂t
t+hp
SiSi
x,y,z = −t+hpSiSix,y,z(ρ(i)x+t+h,y+t+h,z+t+h + ν(i)x+t+h,y+t+h,z+t+h)
We then take the “average” value of the derivative over (t, t+ h) as
{
∂
∂t
tp
SiSi
x,y,z +
∂
∂t
t+hp
SiSi
x,y,z
}
/2
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and put, approximately:
{
t+hp
SiSi
x,y,z − tpSiSix,y,z
}
/h
=
{
∂
∂t
tp
SiSi
x,y,z +
∂
∂t
t+hp
SiSi
x,y,z
}
/2
=
{
−tpSiSix,y,z(ρ(i)x+t,y+t,z+t + ν(i)x+t,y+t,z+t)
}
/2
+
{
−t+hpSiSix,y,z(ρ(i)x+t+h,y+t+h,z+t+h + ν(i)x+t+h,y+t+h,z+t+h)
}
/2
After some algebraic manipulation, we get
t+hp
SiSi
x,y,z
{
1 +
h
2
(ρ(i)x+t+h,y+t+h,z+t+h + ν(i)x+t+h,y+t+h,z+t+h)
}
= tp
SiSi
x,y,z
{
1− h
2
(ρ(i)x+t,y+t,z+t + ν(i)x+t,y+t,z+t)
}
and obtain the following recursive formula:
t+hp
SiSi
x,y,z =
tp
SiSi
x,y,z
{
1− h
2
(ρ(i)x+t,y+t,z+t + ν(i)x+t,y+t,z+t)
}{
1 + h
2
(ρ(i)x+t+h,y+t+h,z+t+h + ν(i)x+t+h,y+t+h,z+t+h)
}
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Appendix D
The Graduation Formulae for the
Recovery and Mortality Intensities
from Sick in CMI Working Paper 5
(2005)
In this Appendix we present the graduation formula for recovery and mortality inten-
sitiies from sick as reported in CMI Working Paper 5 (2005). The general functional
form for the recovery intensity is discussed in Sections 1.5 while that for the mortality
intensity from sick is discussed in Section 4.1. Both sets of graduated intensities are
used to compare against the aggregate intensities in Section 6.3.
Graduation formula for the recovery intensity
The graduation formula for the recovery intensity is represented by the following
symbolic form:
log(ρ(d, y, z)) = sd + gz + qz + fyz + hyz
where z is the exact sickness duration in years, such that
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Z =
 z for z ≤ 55 for z > 5
where y is the exact age (in years) at the date of falling sick, such that
Y =
 y − 50 for z ≤ 5y − 55 + z for z > 5
w = (365/7)Z i.e. Z is translated into units of weeks
t(Z) = w/(1 + kw)
The full details of the component terms in the above graduation formula are as
follows:
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sd = s(d) and d ∈ {DP1, DP4, DP13, DP26, DP52}
gz =
 −b1t(Z) for w ≤ 26−b1t(26)− b2{t(Z)− t(26)} for w > 26
qz =
 −r1(16− w)/8 for DP4 if 8 ≤ w < 160 otherwise
rz =

−r2(8− w)/4− r1 for DP4 if 4 ≤ w < 8
−r3(17− w)/4 for DP13 if 13 ≤ w < 17
0 otherwise
fyz = a1(Y/100) + a2(Y/100)
2 + a3(Y/100)
3 + a4(Y/100)t(Z)
hyz =
 {t(4)− t(Z)}{h0 + h1Y/100 + h2t(Z)} for w < 40 for w > 4
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The parameter values in the above graduation formula are as follows:
s(1) = 3.036467 s(2) = 3.316474 s(3) = 3.025743 s(4) = 2.856549
s(5) = 2.511347 k = 0.016000 a1 = −3.080944 a2 = −6.419924
a3 = 20.048953 a4 = −0.113352 b1 = 0.195291 b2 = 0.108662
h0 = 0.198289 h1 = −0.724805 h2 = 0.047682 r10.622543
r2 = 1.197880 r3 = 1.830356
Graduation formula for the mortality intensity from sick
The graduation formula for the mortality intensity from sick is given by
ν(y + z, z) =
(
a exp{−b/(Z + c)}
(Z + c)2
+ (r/100) exp{s(Y + Z)}
)
q(d)
where z is the exact sickness duration in years, such that
Z =
 z for z ≤ 55 for z > 5
where y is the exact age (in years) at the date of falling sick, such that
Y =
 y − 50 for z ≤ 5y − 55 + z for z > 5
where q(d) =
 q for DP11 for other deferred periods
The parameter values in the above graduation formula are as follows:
a = 0.188906 b = 1.081708 c = 0.132474
r = 0.257331 s = 0.149466 q = 0.744739
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Appendix E
The Grouping Algorithm
It was explained in Section 3.5 that in order to carry out the χ2 test when the data
is sparse, it was desirable to group cells in a systematic and reasonable way so that
the number of events in each cell is sufficiently large. The purpose of this appendix
is to present the grouping algorithm used in the merger of cells.
In a tableau, data is arranged with columns representing sickness duration bands
and rows representing age bands. Let kcolumn, krow and kcell be integers representing
the minimum numbers of expected events for any column, row and cell in the final
compressed tableau, respectively. As in CMI Report 15 (1996), we choose kcolumn =
krow = 15 and kcell = 8.
The tableau is first traversed from left to right, i.e. from the lowest sickness
duration band to the highest. Any column with fewer than kcolumn expected events
is merged with the column to the right, i.e. the next higher sickness duration band.
If the total number of expected number of events in this newly merged column is
still fewer than kcolumn, then it is merged with subsequent columns to the right until
at least kcolumn expected events is obtained in the new column. Such a grouping
procedure from left to right may result in the last column having fewer than kcolumn
expected events but can no longer be moved further to the right. In this case, this
last column will be merged together with the last preceding non-zero column with
enough events. Once this is done, no column in the tableau has fewer than kcolumn
expected events.
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The same procedure is then used to group the rows by traversing the tableau from
top to bottom, i.e. from the lowest age band to the highest age band. If the total
number of expected events in any row is fewer than krow, it is added to the subsequent
rows until at least krow expected events is obtained. This procedure may leave the
last row with fewer than krow expected events, in which case, it is merged with the
preceding non-zero row with enough events. At the end of this procedure, each row
has no fewer than krow expected events.
Lastly, individual cells within each row are compressed in a way such that when
the row is traversed from left to right, any cell with fewer than kcell expected events is
added to the subsequent cells to the right until kcell expected events is obtained. If the
last cell were left with fewer than kcell expected events, it is added to the preceding
cell on its left. At the end of this procedure, each cell has at least kcell expected events.
In order to group cells in a tableau, there should be at least kcell expected
events in a tableau. For each IP dataset by cause of sickness, we have a total of
2× 2× 5× 9 = 140 possible tableaux, one for each distinct combination of sex, rat-
ing indicator, deferred period and year band.
We first checked that the total expected events in the tableaux belonging to either
sex is at least kcell. If the total expected events in the tableaux belonging to any sex
is fewer than kcell, these tableaux are merged with their corresponding tableaux from
the opposite sex. Once this check is done, the total expected events in the resulting
tableaux for male, female, or both combined is greater than kcell.
The same procedure is then applied to non-rated and rated tableaux. If the total
expected events in the tableaux belonging to either rated or not-rated is fewer than
kcell, these tableaux are combined with their corresponding tableaux from another
rating indicator. At the end of this procedure, the total expected events in the
resulting tableaux for not-rated, rated, or both combined is greater than kcell.
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We then apply the same procedure on tableaux belonging to each deferred period,
from DP1 to DP52, so that if the total expected events for a tableaux belonging
to any of the deferred periods is fewer than kcell, they are merged together with
the corresponding tableaux from the next higher deferred period until kcell expected
events is obtained. At the end of this procedure, the total expected events for tableaux
belonging to each deferred period or merged deferred periods is at least kcell.
Lastly, the same procedure is then used to group tableaux for year bands. There
are 9 tableaux, one for each year band, and they are arranged from the lowest year
band to the highest. If any of these 9 tableaux has fewer than kcell expected events, it
is combined with the tableau on its right (i.e. the tableau for the higher year band)
until the total combined expected events is at least kcell. Such a grouping procedure
may leave the final tableau (i.e. the tableau for the highest year band) with fewer
than kcell expected events, in which case, it is merged with the preceding non-zero
tableau with enough events.
At the end of these procedures, each of the resulting tableaux has at least kcell
expected events. If the total expected number of events in a tableau is fewer than
twice kcell, then the entire tableau is compressed to a single cell.
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